1	Neuropharmacology	NNP	O	Neuropharmacology	_	0	SENT_1	[p1l837t81r1083b108],
2	57	CD	NUMBER	57	num	1	SENT_1	[p1l1093t82r1120b103],
3	(	CD	NUMBER	(	num	4	SENT_1	[p1l1131t81r1211b108],
4	2009	CD	DATE	2009	dep	1	SENT_1	[p1l1131t81r1211b108],
5	)	CD	NUMBER	)	num	6	SENT_1	[p1l1131t81r1211b108],
6	731-733	CD	NUMBER	731-733	dep	1	SENT_1	[p1l1222t82r1323b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l772t190r911b215],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l925t191r985b215],
3	available	JJ	O	available	amod	2	SENT_2	[p1l998t191r1138b215],
4	at	IN	O	at	_	0	SENT_2	[p1l1151t194r1179b215],
5	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1191t190r1408b215],

1	Neuropharmacology	NNP	O	Neuropharmacology	_	0	SENT_3	[p1l812t289r1367b347],

1	—	NN	O	—	_	0	SENT_4	[p1l34t388r51b397],
2	‘	SYM	O	‘	dep	6	SENT_4	[p1l34t388r51b397],
3	-	:	O	-	_	0	SENT_4	[p1l34t388r51b397],
4	.52	CD	NUMBER	.52	dep	6	SENT_4	[p1l64t387r89b400],
5	_	SYM	O	_	dep	4	SENT_4	[p1l107t388r233b400],
6	-	:	O	-	_	0	SENT_4	[p1l107t388r233b400],
7	.	.	O	.	_	0	SENT_4	[p1l107t388r233b400],

1	_	NN	O	_	_	0	SENT_5	[p1l107t388r233b400],
2	;	:	O	;	_	0	SENT_5	[p1l107t388r233b400],
3	~	NN	O	~	dep	1	SENT_5	[p1l107t388r233b400],
4	A	DT	O	a	dep	3	SENT_5	[p1l107t388r233b400],
5	—	NN	O	—	dep	4	SENT_5	[p1l107t388r233b400],
6	,	,	O	,	_	0	SENT_5	[p1l107t388r233b400],
7	:	:	O	:	_	0	SENT_5	[p1l107t388r233b400],
8	,	,	O	,	_	0	SENT_5	[p1l107t388r233b400],
9	f	FW	O	f	nn	12	SENT_5	[p1l107t388r233b400],
10	ELSEVIER	FW	O	elsevier	nn	12	SENT_5	[p1l253t394r257b397, p1l15t421r253b458],
11	journal	NN	O	journal	nn	12	SENT_5	[p1l532t422r665b452],
12	homepage	NN	O	homepage	appos	1	SENT_5	[p1l685t422r891b452],
13	:	:	O	:	_	0	SENT_5	[p1l685t422r891b452],
14	www	NN	O	www	dep	1	SENT_5	[p1l909t421r1643b452],
15	.	.	O	.	_	0	SENT_5	[p1l909t421r1643b452],

1	e	LS	O	e	_	0	SENT_6	[p1l909t421r1643b452],
2	|	CD	NUMBER	|	num	3	SENT_6	[p1l909t421r1643b452],
3	sevier.com/locate/neuropharm	NN	O	sevier.com/locate/neuropharm	nsubj	1	SENT_6	[p1l909t421r1643b452],

1	Carboxylesterase	NN	O	carboxylesterase	nn	4	SENT_7	[p1l6t568r450b624],
2	1	CD	NUMBER	1	num	4	SENT_7	[p1l501t571r522b612],
3	gene	NN	O	gene	nn	4	SENT_7	[p1l575t581r699b624],
4	polymorphism	NN	O	polymorphism	dep	14	SENT_7	[p1l747t568r1134b624],
5	and	CC	O	and	_	0	SENT_7	[p1l1182t568r1277b613],
6	methylphenidate	NN	O	methylphenidate	nn	7	SENT_7	[p1l1326t568r1775b624],
7	response	NN	O	response	dep	14	SENT_7	[p1l1824t581r2057b624],
8	in	IN	O	in	_	0	SENT_7	[p1l2106t569r2154b612],
9	ADHD	NNP	MISC	ADHD	nn	11	SENT_7	[p1l6t638r168b681],
10	Zsoﬁa	NNP	MISC	Zsoﬁa	nn	11	SENT_7	[p1l186t645r307b681],
11	Nemoda	NNP	MISC	Nemoda	prep_in	4	SENT_7	[p1l325t645r497b681],
12	“	CD	NUMBER	“	dep	14	SENT_7	[p1l507t643r560b687],
13	"	``	O	"	punct	14	SENT_7	[p1l507t643r560b687],
14	*	NN	O	*	_	0	SENT_7	[p1l507t643r560b687],
15	,	,	O	,	_	0	SENT_7	[p1l507t643r560b687],
16	Nora	NNP	PERSON	Nora	nn	17	SENT_7	[p1l579t647r677b681],
17	Angyala	NNP	PERSON	Angyala	appos	14	SENT_7	[p1l692t643r869b690],
18	,	,	O	,	_	0	SENT_7	[p1l692t643r869b690],
19	Zsanett	NNP	PERSON	Zsanett	nn	20	SENT_7	[p1l887t647r1040b681],
20	Tarnok	NNP	PERSON	Tarnok	appos	14	SENT_7	[p1l1055t645r1199b681],
21	'	POS	O	'	_	0	SENT_7	[p1l1207t636r1235b687],
22	3	CD	NUMBER	3	dep	20	SENT_7	[p1l1207t636r1235b687],
23	,	,	O	,	_	0	SENT_7	[p1l1207t636r1235b687],
24	Julia	NNP	PERSON	Julia	nn	25	SENT_7	[p1l1248t645r1342b690],
25	Gadoros	NNP	PERSON	Gadoros	appos	22	SENT_7	[p1l1360t645r1528b681],
26	'	POS	O	'	_	0	SENT_7	[p1l1538t636r1566b686],
27	3	CD	NUMBER	3	dep	25	SENT_7	[p1l1538t636r1566b686],
28	,	,	O	,	_	0	SENT_7	[p1l1538t636r1566b686],
29	Maria	NNP	PERSON	Maria	nn	32	SENT_7	[p1l1585t646r1703b681],
30	Sasvari-Szekelya	NNP	PERSON	Sasvari-Szekelya	nn	32	SENT_7	[p1l1721t643r2064b690],
31	“	NNP	O	“	nn	32	SENT_7	[p1l6t729r120b752],
32	Institute	NNP	ORGANIZATION	Institute	appos	27	SENT_7	[p1l6t729r120b752],
33	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l131t730r157b757],
34	Medical	NNP	ORGANIZATION	Medical	nn	35	SENT_7	[p1l162t730r257b752],
35	Chemistry	NNP	ORGANIZATION	Chemistry	prep_of	32	SENT_7	[p1l267t730r391b757],
36	,	,	O	,	_	0	SENT_7	[p1l267t730r391b757],
37	Molecular	JJ	O	molecular	amod	38	SENT_7	[p1l402t730r524b752],
38	Biology	NN	O	biology	prep_of	32	SENT_7	[p1l533t730r621b757],
39	and	CC	O	and	_	0	SENT_7	[p1l631t730r676b752],
40	Pathobiochemistry	NN	O	pathobiochemistry	conj_and	35	SENT_7	[p1l685t730r912b757],
41	,	,	O	,	_	0	SENT_7	[p1l685t730r912b757],
42	Semmelweis	NNP	ORGANIZATION	Semmelweis	nn	50	SENT_7	[p1l923t730r1072b752],
43	University	NNP	ORGANIZATION	University	nn	50	SENT_7	[p1l1083t730r1207b757],
44	,	,	O	,	_	0	SENT_7	[p1l1083t730r1207b757],
45	Budapest	NNP	LOCATION	Budapest	appos	50	SENT_7	[p1l1218t730r1333b757],
46	,	,	O	,	_	0	SENT_7	[p1l1218t730r1333b757],
47	Hungary	NNP	LOCATION	Hungary	appos	50	SENT_7	[p1l1344t731r1449b757],
48	"	``	O	"	punct	50	SENT_7	[p1l6t760r17b775],
49	Vadaskert	NNP	O	Vadaskert	nn	50	SENT_7	[p1l24t766r142b788],
50	Child	NNP	O	Child	prep_of	32	SENT_7	[p1l152t766r212b788],
51	and	CC	O	and	_	0	SENT_7	[p1l222t766r267b788],
52	Adolescent	NNP	O	Adolescent	nn	54	SENT_7	[p1l275t766r407b788],
53	Psychiatric	NNP	O	Psychiatric	nn	54	SENT_7	[p1l415t766r546b793],
54	Clinic	NNP	O	Clinic	prep_of	32	SENT_7	[p1l556t766r626b791],
55	,	,	O	,	_	0	SENT_7	[p1l556t766r626b791],
56	Budapest	NNP	LOCATION	Budapest	nn	58	SENT_7	[p1l637t766r752b793],
57	,	,	O	,	_	0	SENT_7	[p1l637t766r752b793],
58	Hungary	NNP	LOCATION	Hungary	appos	14	SENT_7	[p1l763t767r868b793],

1	ARTICLEINFO	NNP	O	ARTICLEINFO	_	0	SENT_8	[p1l6t879r404b901],
2	ABSTRACT	NN	O	abstract	dep	1	SENT_8	[p1l691t879r974b901],

1	Article	NNP	O	Article	nn	2	SENT_9	[p1l6t957r85b979],
2	history	NN	O	history	_	0	SENT_9	[p1l96t957r185b984],
3	:	:	O	:	_	0	SENT_9	[p1l96t957r185b984],
4	Methylphenidate	NNP	O	Methylphenidate	dep	2	SENT_9	[p1l8t1013r249b1043],
5	(	CD	NUMBER	(	num	7	SENT_9	[p1l264t1013r354b1043],
6	MPH	NN	O	mph	nn	7	SENT_9	[p1l264t1013r354b1043],
7	)	NN	O	)	nsubj	13	SENT_9	[p1l264t1013r354b1043],
8	is	VBZ	O	be	cop	13	SENT_9	[p1l371t1013r391b1037],
9	the	DT	O	the	det	13	SENT_9	[p1l407t1013r451b1037],
10	most	RBS	O	most	advmod	11	SENT_9	[p1l468t1016r537b1037],
11	frequently	RB	O	frequently	advmod	12	SENT_9	[p1l553t1013r698b1043],
12	prescribed	VBN	O	prescribe	amod	13	SENT_9	[p1l713t1013r860b1043],
13	drug	NN	O	drug	rcmod	4	SENT_9	[p1l877t1013r942b1043],
14	in	IN	O	in	_	0	SENT_9	[p1l958t1013r983b1037],
15	the	DT	O	the	det	16	SENT_9	[p1l999t1013r1043b1037],
16	treatment	NN	O	treatment	prep_in	13	SENT_9	[p1l1059t1016r1200b1037],
17	of	IN	O	of	_	0	SENT_9	[p1l1215t1013r1244b1037],
18	attention	NN	O	attention	nn	19	SENT_9	[p1l1257t1013r1385b1037],
19	deﬁcit	NN	O	deﬁcit	prep_of	16	SENT_9	[p1l1401t1013r1488b1037],
20	Received	VBN	O	receive	partmod	19	SENT_9	[p1l7t1047r117b1069],
21	7	CD	DATE	7	num	22	SENT_9	[p1l128t1048r141b1068],
22	May	NNP	DATE	May	dobj	20	SENT_9	[p1l153t1048r206b1074],
23	2009	CD	DATE	2009	num	22	SENT_9	[p1l216t1048r279b1069],
24	Received	VBN	O	receive	partmod	22	SENT_9	[p1l7t1083r116b1104],
25	in	IN	O	in	_	0	SENT_9	[p1l128t1083r151b1104],
26	revised	JJ	O	revised	amod	27	SENT_9	[p1l162t1083r251b1104],
27	form	NN	O	form	prep_in	24	SENT_9	[p1l263t1083r322b1104],
28	18	CD	DATE	18	num	27	SENT_9	[p1l8t1120r34b1141],
29	August	NNP	DATE	August	tmod	27	SENT_9	[p1l45t1120r133b1146],
30	2009	CD	DATE	2009	num	29	SENT_9	[p1l143t1120r205b1141],
31	Accepted	JJ	O	accepted	amod	32	SENT_9	[p1l6t1155r120b1182],
32	25	CD	DATE	25	tmod	24	SENT_9	[p1l131t1156r160b1176],
33	August	NNP	DATE	August	dep	32	SENT_9	[p1l171t1156r259b1182],
34	2009	CD	DATE	2009	num	33	SENT_9	[p1l269t1156r331b1176],

1	hyperactivity	NN	O	hyperactivity	nn	2	SENT_10	[p1l7t1272r192b1302],
2	disorder	NN	O	disorder	_	0	SENT_10	[p1l200t1272r318b1296],
3	(	CD	NUMBER	(	num	5	SENT_10	[p1l326t1272r441b1302],
4	ADHD	NN	O	adhd	nn	5	SENT_10	[p1l326t1272r441b1302],
5	)	NN	O	)	dep	2	SENT_10	[p1l326t1272r441b1302],
6	.	.	O	.	_	0	SENT_10	[p1l326t1272r441b1302],

1	Several	JJ	O	several	amod	3	SENT_11	[p1l451t1272r552b1296],
2	pharmacogenetic	JJ	O	pharmacogenetic	amod	3	SENT_11	[p1l561t1272r805b1302],
3	studies	NNS	O	study	nsubj	4	SENT_11	[p1l814t1272r912b1296],
4	suggested	VBD	O	suggest	_	0	SENT_11	[p1l923t1272r1061b1302],
5	that	IN	O	that	complm	13	SENT_11	[p1l1071t1272r1127b1296],
6	catecholamine	NN	O	catecholamine	nn	9	SENT_11	[p1l1136t1272r1340b1296],
7	candidate	NN	O	candidate	nn	9	SENT_11	[p1l1350t1272r1487b1296],
8	genes	NNS	O	gene	nn	9	SENT_11	[p1l6t1319r86b1342],
9	inﬂuence	NN	O	inﬂuence	dep	13	SENT_11	[p1l98t1312r227b1336],
10	individual	JJ	O	individual	amod	13	SENT_11	[p1l240t1312r380b1336],
11	MPH	NN	O	mph	nn	13	SENT_11	[p1l393t1313r620b1342],
12	—	NN	O	—	nn	13	SENT_11	[p1l393t1313r620b1342],
13	responses	NNS	O	response	dep	4	SENT_11	[p1l393t1313r620b1342],
14	,	,	O	,	_	0	SENT_11	[p1l393t1313r620b1342],
15	but	CC	O	but	cc	20	SENT_11	[p1l633t1312r680b1336],
16	these	DT	O	these	det	17	SENT_11	[p1l691t1312r765b1336],
17	results	NNS	O	result	nsubj	20	SENT_11	[p1l778t1312r870b1336],
18	are	VBP	O	be	cop	20	SENT_11	[p1l882t1319r925b1336],
19	mostly	RB	O	mostly	advmod	20	SENT_11	[p1l938t1312r1033b1342],
20	contradictory	JJ	O	contradictory	ccomp	4	SENT_11	[p1l1044t1312r1238b1342],
21	.	.	O	.	_	0	SENT_11	[p1l1044t1312r1238b1342],

1	Genetic	JJ	O	genetic	amod	2	SENT_12	[p1l1251t1312r1357b1336],
2	analyses	NNS	O	analysis	_	0	SENT_12	[p1l1369t1312r1486b1342],
3	"	``	O	"	punct	5	SENT_12	[p1l1599t1296r1724b1335],
4	“	CD	NUMBER	“	num	5	SENT_12	[p1l1599t1296r1724b1335],
5	YW	NN	O	yw	dep	2	SENT_12	[p1l1599t1296r1724b1335],
6	°	NN	O	°	dep	5	SENT_12	[p1l1599t1296r1724b1335],
7	.	.	O	.	_	0	SENT_12	[p1l1599t1296r1724b1335],

1	“	NN	O	“	_	0	SENT_13	[p1l1599t1296r1724b1335],
2	'	''	O	'	_	0	SENT_13	[p1l1599t1296r1724b1335],
3	5	LS	NUMBER	5	dep	1	SENT_13	[p1l1599t1296r1724b1335],
4	-	:	O	-	_	0	SENT_13	[p1l1599t1296r1724b1335],
5	'	''	O	'	_	0	SENT_13	[p1l1599t1296r1724b1335],
6	. . .	CD	NUMBER	. . .	dep	1	SENT_13	[p1l1950t1332r1953b1335],[p1l1790t1332r1793b1335],
7	,	,	O	,	_	0	SENT_13	[p1l251t1352r255b1356],
8	.	.	O	.	_	0	SENT_13	[p1l275t1352r279b1356],

1	,	,	O	,	_	0	SENT_14	[p1l1136t1352r1140b1356],
2	Attention	NN	O	attention	nn	4	SENT_14	[p1l1598t1333r1717b1353],
3	deﬁcit	NN	O	deﬁcit	nn	4	SENT_14	[p1l1728t1332r1806b1353],
4	hyperactivity	NN	O	hyperactivity	nsubj	7	SENT_14	[p1l1816t1332r1980b1359],
5	of	IN	O	of	_	0	SENT_14	[p1l6t1352r35b1376],
6	MPH	NN	O	mph	prep_of	4	SENT_14	[p1l49t1353r116b1376],
7	metabolizing	VBG	O	metabolize	_	0	SENT_14	[p1l133t1352r317b1382],
8	carboxylesterase	NN	O	carboxylesterase	nn	10	SENT_14	[p1l333t1352r567b1382],
9	1	CD	NUMBER	1	num	10	SENT_14	[p1l585t1353r596b1376],
10	enzyme	NN	O	enzyme	dobj	7	SENT_14	[p1l617t1359r726b1382],
11	(	CD	NUMBER	(	num	12	SENT_14	[p1l743t1352r834b1382],
12	CES1	NN	O	ces1	nsubjpass	17	SENT_14	[p1l743t1352r834b1382],
13	)	CD	NUMBER	)	dep	12	SENT_14	[p1l743t1352r834b1382],
14	have	VBP	O	have	aux	17	SENT_14	[p1l851t1352r916b1376],
15	not	RB	O	not	neg	17	SENT_14	[p1l933t1355r979b1376],
16	been	VBN	O	be	auxpass	17	SENT_14	[p1l994t1352r1062b1376],
17	carried	VBN	O	carry	rcmod	10	SENT_14	[p1l1079t1352r1175b1376],
18	out	RP	O	out	prt	17	SENT_14	[p1l1193t1355r1245b1380],
19	,	,	O	,	_	0	SENT_14	[p1l1193t1355r1245b1380],
20	whereas	IN	O	whereas	mark	36	SENT_14	[p1l1261t1352r1387b1380],
21	,	,	O	,	_	0	SENT_14	[p1l1261t1352r1387b1380],
22	meta	NN	O	meta	amod	32	SENT_14	[p1l1404t1355r1486b1376],
23	-	:	O	-	_	0	SENT_14	[p1l1404t1355r1486b1376],
24	disorder	NN	O	disorder	nn	27	SENT_14	[p1l1599t1367r1704b1389],
25	(	CD	NUMBER	(	num	27	SENT_14	[p1l1714t1368r1810b1394],
26	ADHD	NN	O	adhd	nn	27	SENT_14	[p1l1714t1368r1810b1394],
27	)	NN	O	)	dep	22	SENT_14	[p1l1714t1368r1810b1394],
28	analysis	NN	O	analysis	dep	27	SENT_14	[p1l6t1392r116b1422],
29	of	IN	O	of	_	0	SENT_14	[p1l129t1392r158b1416],
30	CYP2D6	NN	O	cyp2d6	prep_of	28	SENT_14	[p1l166t1393r277b1416],
31	genetic	JJ	O	genetic	amod	32	SENT_14	[p1l288t1392r391b1422],
32	variants	NNS	O	variant	nsubjpass	36	SENT_14	[p1l401t1392r513b1416],
33	has	VBZ	O	have	aux	36	SENT_14	[p1l526t1392r572b1416],
34	been	VBN	O	be	auxpass	36	SENT_14	[p1l584t1392r651b1416],
35	already	RB	O	already	advmod	36	SENT_14	[p1l663t1392r767b1422],
36	indicated	VBN	O	indicate	advcl	17	SENT_14	[p1l778t1392r907b1416],
37	signiﬁcant	JJ	O	signiﬁcant	amod	39	SENT_14	[p1l920t1392r1066b1422],
38	pharmacogenetic	JJ	O	pharmacogenetic	amod	39	SENT_14	[p1l1077t1392r1321b1422],
39	differences	NNS	O	difference	dobj	36	SENT_14	[p1l1333t1392r1486b1416],
40	Methylphenidate	NNP	O	Methylphenidate	tmod	36	SENT_14	[p1l1600t1403r1813b1430],
41	(	CD	NUMBER	(	num	43	SENT_14	[p1l1824t1403r1904b1430],
42	MPH	NN	O	mph	nn	43	SENT_14	[p1l1824t1403r1904b1430],
43	)	NN	O	)	dep	40	SENT_14	[p1l1824t1403r1904b1430],

1	in	IN	O	in	_	0	SENT_15	[p1l7t1506r32b1529],
2	atomoxetine	NN	O	atomoxetine	nn	3	SENT_15	[p1l47t1506r223b1529],
3	treatment	NN	O	treatment	pobj	1	SENT_15	[p1l238t1509r385b1530],
4	.	.	O	.	_	0	SENT_15	[p1l238t1509r385b1530],

1	Here	RB	O	here	advmod	3	SENT_16	[p1l401t1507r467b1529],
2	we	PRP	O	we	nsubj	3	SENT_16	[p1l481t1512r522b1529],
3	present	VBP	DATE	present	_	0	SENT_16	[p1l537t1509r643b1535],
4	an	DT	O	a	det	6	SENT_16	[p1l657t1512r690b1529],
5	association	NN	O	association	nn	6	SENT_16	[p1l705t1506r860b1529],
6	analysis	NN	O	analysis	dobj	3	SENT_16	[p1l875t1505r985b1535],
7	of	IN	O	of	_	0	SENT_16	[p1l1000t1505r1029b1529],
8	the	DT	O	the	det	10	SENT_16	[p1l1041t1505r1085b1529],
9	CES1	NN	O	ces1	nn	10	SENT_16	[p1l1100t1506r1165b1529],
10	Gly143Glu	NN	O	gly143glu	npadvmod	11	SENT_16	[p1l1183t1505r1330b1535],
11	functional	JJ	O	functional	amod	12	SENT_16	[p1l1345t1505r1486b1529],
12	polymorphism	NN	O	polymorphism	prep_of	6	SENT_16	[p1l6t1545r213b1575],
13	in	IN	O	in	dep	19	SENT_16	[p1l225t1545r251b1569],
14	a	DT	O	a	det	17	SENT_16	[p1l263t1552r277b1569],
15	Hungarian	JJ	MISC	hungarian	amod	17	SENT_16	[p1l289t1546r436b1575],
16	ADHD	NN	O	adhd	nn	17	SENT_16	[p1l447t1546r534b1569],
17	group	NN	O	group	pobj	13	SENT_16	[p1l545t1552r627b1575],
18	(	CD	NUMBER	(	num	19	SENT_16	[p1l639t1545r666b1575],
19	n	NN	O	n	dep	3	SENT_16	[p1l639t1545r666b1575],
20	2	CD	NUMBER	2	number	21	SENT_16	[p1l679t1558r700b1565],
21	173	CD	NUMBER	173	num	22	SENT_16	[p1l713t1545r778b1575],
22	)	NN	O	)	dep	19	SENT_16	[p1l713t1545r778b1575],
23	.	.	O	.	_	0	SENT_16	[p1l713t1545r778b1575],

1	The	DT	O	the	det	3	SENT_17	[p1l789t1545r841b1569],
2	genotype	NN	O	genotype	nn	3	SENT_17	[p1l852t1549r982b1575],
3	frequencies	NNS	O	frequency	nsubj	5	SENT_17	[p1l994t1545r1155b1575],
4	were	VBD	O	be	cop	5	SENT_17	[p1l1167t1552r1236b1569],
5	similar	JJ	O	similar	_	0	SENT_17	[p1l1248t1545r1345b1569],
6	to	TO	O	to	_	0	SENT_17	[p1l1356t1549r1383b1569],
7	that	DT	O	that	prep_to	5	SENT_17	[p1l1394t1545r1450b1569],
8	of	IN	O	of	_	0	SENT_17	[p1l1461t1545r1490b1569],
9	the	DT	O	the	det	11	SENT_17	[p1l6t1585r50b1609],
10	general	JJ	O	general	amod	11	SENT_17	[p1l61t1585r165b1615],
11	population	NN	O	population	prep_of	7	SENT_17	[p1l177t1585r330b1615],
12	(	CD	PERCENT	(	number	13	SENT_17	[p1l341t1585r413b1615],
13	5.8	CD	PERCENT	5.8	num	14	SENT_17	[p1l341t1585r413b1615],
14	%	NN	PERCENT	%	dep	11	SENT_17	[p1l341t1585r413b1615],
15	vs	CC	O	vs	_	0	SENT_17	[p1l423t1592r452b1609],
16	4.1	CD	PERCENT	4.1	num	17	SENT_17	[p1l463t1586r522b1609],
17	%	NN	PERCENT	%	dep	11	SENT_17	[p1l463t1586r522b1609],
18	of	IN	O	of	_	0	SENT_17	[p1l533t1585r562b1609],
19	Gly/Glu	NN	O	gly/glu	nn	21	SENT_17	[p1l570t1585r675b1615],
20	heterozygote	NN	O	heterozygote	nn	21	SENT_17	[p1l687t1585r888b1615],
21	)	NN	O	)	prep_of	7	SENT_17	[p1l687t1585r888b1615],
22	.	.	O	.	_	0	SENT_17	[p1l687t1585r888b1615],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_18	[p1l900t1585r1142b1615],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_18	[p1l1153t1585r1264b1615],
3	was	VBD	O	be	auxpass	4	SENT_18	[p1l1274t1592r1328b1609],
4	conducted	VBN	O	conduct	_	0	SENT_18	[p1l1340t1585r1487b1609],
5	among	IN	O	among	_	0	SENT_18	[p1l6t1632r102b1655],
6	122	CD	NUMBER	122	num	8	SENT_18	[p1l115t1626r162b1649],
7	ADHD	NN	O	adhd	nn	8	SENT_18	[p1l173t1626r260b1649],
8	children	NNS	O	child	prep_among	4	SENT_18	[p1l271t1625r387b1649],
9	treated	VBN	O	treat	partmod	8	SENT_18	[p1l397t1625r497b1649],
10	with	IN	O	with	_	0	SENT_18	[p1l508t1625r572b1649],
11	MPH	NN	O	mph	prep_with	9	SENT_18	[p1l584t1626r657b1649],
12	.	.	O	.	_	0	SENT_18	[p1l584t1626r657b1649],

1	Neither	CC	O	neither	dep	4	SENT_19	[p1l669t1625r775b1649],
2	the	DT	O	the	det	4	SENT_19	[p1l785t1625r829b1649],
3	categorical	JJ	O	categorical	amod	4	SENT_19	[p1l840t1625r991b1655],
4	analysis	NN	O	analysis	_	0	SENT_19	[p1l1003t1625r1113b1655],
5	comparing	VBG	O	compare	partmod	4	SENT_19	[p1l1124t1625r1275b1655],
6	90	CD	NUMBER	90	num	8	SENT_19	[p1l1285t1626r1319b1649],
7	responders	NNS	O	responder	nn	8	SENT_19	[p1l1331t1625r1486b1655],
8	pharmacogenetics	NNS	O	pharmacogenetic	dobj	5	SENT_19	[p1l6t1664r232b1691],
9	vs	CC	O	vs	_	0	SENT_19	[p1l696t1664r725b1681],
10	32	CD	NUMBER	32	num	13	SENT_19	[p1l743t1658r776b1681],
11	non	JJ	O	non	amod	13	SENT_19	[p1l796t1657r1026b1687],
12	—	NN	O	—	nn	13	SENT_19	[p1l796t1657r1026b1687],
13	responders	NNS	O	responder	conj_vs	8	SENT_19	[p1l796t1657r1026b1687],
14	,	,	O	,	_	0	SENT_19	[p1l796t1657r1026b1687],
15	nor	CC	O	nor	_	0	SENT_19	[p1l1046t1664r1094b1681],
16	the	DT	O	the	det	18	SENT_19	[p1l1111t1657r1156b1681],
17	dimensional	JJ	O	dimensional	amod	18	SENT_19	[p1l1175t1657r1348b1681],
18	analysis	NN	O	analysis	conj_nor	8	SENT_19	[p1l1367t1657r1477b1687],
19	of	IN	O	of	_	0	SENT_19	[p1l1496t1657r1525b1681],
20	Inattention	NN	O	inattention	prep_of	18	SENT_19	[p1l1540t1658r1696b1681],
21	and	CC	O	and	_	0	SENT_19	[p1l1715t1657r1765b1681],
22	Hyperactivity	NN	O	hyperactivity	prep_of	18	SENT_19	[p1l1785t1657r2154b1687],
23	.	.	O	.	_	0	SENT_19	[p1l1785t1657r2154b1687],

1	—	NN	O	—	_	0	SENT_20	[p1l1785t1657r2154b1687],
2	.	.	O	.	_	0	SENT_20	[p1l1785t1657r2154b1687],

1	Impulsivity	NN	O	impulsivity	nn	3	SENT_21	[p1l1785t1657r2154b1687],
2	score	NN	NUMBER	score	nn	3	SENT_21	[p1l6t1703r78b1720],
3	Carboxylesterase	NN	O	carboxylesterase	nsubj	9	SENT_21	[p1l95t1699r306b1726],
4	1	CD	NUMBER	1	number	5	SENT_21	[p1l323t1700r333b1720],
5	(	CD	NUMBER	(	num	6	SENT_21	[p1l351t1699r432b1726],
6	CES1	NN	O	ces1	dep	3	SENT_21	[p1l351t1699r432b1726],
7	)	CD	NUMBER	)	num	8	SENT_21	[p1l351t1699r432b1726],
8	reduction	NN	O	reduction	dep	3	SENT_21	[p1l795t1696r930b1720],
9	showed	VBD	O	show	_	0	SENT_21	[p1l946t1696r1055b1720],
10	a	DT	O	a	det	14	SENT_21	[p1l1071t1703r1086b1720],
11	signiﬁcant	JJ	O	signiﬁcant	amod	14	SENT_21	[p1l1102t1696r1248b1726],
12	main	JJ	O	main	amod	14	SENT_21	[p1l1264t1696r1334b1720],
13	genotype	NN	O	genotype	nn	14	SENT_21	[p1l1349t1700r1479b1726],
14	effect	NN	O	effect	dobj	9	SENT_21	[p1l1496t1696r1580b1721],
15	.	.	O	.	_	0	SENT_21	[p1l1496t1696r1580b1721],

1	However	RB	O	however	advmod	9	SENT_22	[p1l1596t1698r1727b1724],
2	,	,	O	,	_	0	SENT_22	[p1l1596t1698r1727b1724],
3	analyzing	VBG	O	analyze	partmod	9	SENT_22	[p1l1742t1696r1877b1726],
4	the	DT	O	the	det	6	SENT_22	[p1l1889t1696r1934b1720],
5	daily	JJ	SET	daily	amod	6	SENT_22	[p1l1948t1696r2016b1726],
6	dose	NN	O	dose	dobj	3	SENT_22	[p1l2029t1696r2099b1724],
7	,	,	O	,	_	0	SENT_22	[p1l2029t1696r2099b1724],
8	we	PRP	O	we	nsubj	9	SENT_22	[p1l2113t1703r2154b1720],
9	observed	VBD	O	observe	_	0	SENT_22	[p1l6t1735r133b1759],
10	an	DT	O	a	det	11	SENT_22	[p1l142t1742r175b1759],
11	association	NN	O	association	dobj	9	SENT_22	[p1l6t1775r161b1799],
12	with	IN	O	with	_	0	SENT_22	[p1l167t1774r231b1799],
13	the	DT	O	the	det	15	SENT_22	[p1l241t1774r286b1799],
14	rare	JJ	O	rare	amod	15	SENT_22	[p1l297t1781r351b1799],
15	143Glu-variant	NN	O	143glu-variant	prep_with	9	SENT_22	[p1l364t1774r583b1799],
16	:	:	O	:	_	0	SENT_22	[p1l364t1774r583b1799],
17	5	CD	NUMBER	5	num	18	SENT_22	[p1l595t1776r610b1799],
18	patients	NNS	O	patient	dep	15	SENT_22	[p1l622t1775r735b1805],
19	in	IN	O	in	_	0	SENT_22	[p1l746t1775r772b1799],
20	the	DT	O	the	det	22	SENT_22	[p1l782t1774r827b1799],
21	responder	NN	O	responder	nn	22	SENT_22	[p1l838t1774r981b1805],
22	group	NN	O	group	prep_in	18	SENT_22	[p1l987t1781r1069b1805],
23	carrying	VBG	O	carry	partmod	22	SENT_22	[p1l1080t1775r1196b1805],
24	the	DT	O	the	det	25	SENT_22	[p1l1206t1774r1251b1799],
25	Glu-allele	NN	MISC	glu-allele	nsubj	26	SENT_22	[p1l1262t1774r1397b1799],
26	required	VBD	O	require	ccomp	23	SENT_22	[p1l1409t1774r1527b1805],
27	lower	JJR	O	lower	amod	28	SENT_22	[p1l1542t1774r1622b1799],
28	doses	NNS	O	dose	dobj	26	SENT_22	[p1l1628t1774r1705b1799],
29	of	IN	O	of	_	0	SENT_22	[p1l1716t1774r1745b1799],
30	MPH	NN	O	mph	prep_of	28	SENT_22	[p1l1749t1776r1816b1799],
31	for	IN	O	for	_	0	SENT_22	[p1l1827t1774r1866b1799],
32	symptom	NN	O	symptom	nn	33	SENT_22	[p1l1876t1778r2009b1805],
33	reduction	NN	O	reduction	prep_for	26	SENT_22	[p1l2020t1774r2154b1799],
34	(	CD	NUMBER	(	number	35	SENT_22	[p1l30t1814r114b1845],
35	0.410	CD	NUMBER	0.410	dep	33	SENT_22	[p1l30t1814r114b1845],
36	:	:	O	:	_	0	SENT_22	[p1l122t1827r143b1839],
37	:	:	O	:	_	0	SENT_22	[p1l122t1827r143b1839],
38	0.127	CD	NUMBER	0.127	dep	15	SENT_22	[p1l151t1815r222b1839],
39	vs	CC	O	vs	_	0	SENT_22	[p1l229t1821r258b1839],
40	0.572	CD	NUMBER	0.572	dep	15	SENT_22	[p1l266t1815r340b1839],
41	:	:	O	:	_	0	SENT_22	[p1l348t1827r369b1839],
42	:	:	O	:	_	0	SENT_22	[p1l348t1827r369b1839],
43	0.153	CD	NUMBER	0.153	num	44	SENT_22	[p1l377t1815r448b1839],
44	mg/kg	NN	O	mg/kg	dep	38	SENT_22	[p1l457t1814r552b1845],
45	,	,	O	,	_	0	SENT_22	[p1l457t1814r552b1845],
46	t	NN	O	t	appos	44	SENT_22	[p1l560t1815r577b1845],
47	(	CD	NUMBER	(	number	48	SENT_22	[p1l560t1815r577b1845],
48	1,88	CD	NUMBER	1,88	num	49	SENT_22	[p1l583t1815r648b1845],
49	)	NN	O	)	dep	46	SENT_22	[p1l583t1815r648b1845],
50	=	JJ	O	=	amod	49	SENT_22	[p1l656t1827r677b1835],
51	2.33	CD	NUMBER	2.33	tmod	50	SENT_22	[p1l685t1815r750b1842],
52	,	,	O	,	_	0	SENT_22	[p1l685t1815r750b1842],
53	p	NN	O	p	appos	44	SENT_22	[p1l755t1821r773b1845],
54	=	JJ	O	=	amod	56	SENT_22	[p1l781t1827r801b1835],
55	0.022	CD	NUMBER	0.022	tmod	54	SENT_22	[p1l809t1814r904b1845],
56	)	NN	O	)	dep	53	SENT_22	[p1l809t1814r904b1845],
57	.	.	O	.	_	0	SENT_22	[p1l809t1814r904b1845],

1	This	DT	O	this	det	3	SENT_23	[p1l915t1814r973b1839],
2	result	NN	O	result	nn	3	SENT_23	[p1l983t1814r1063b1839],
3	warrants	NNS	O	warrant	_	0	SENT_23	[p1l1071t1818r1196b1839],
4	for	IN	O	for	_	0	SENT_23	[p1l1207t1814r1246b1839],
5	further	JJ	O	further	amod	6	SENT_23	[p1l1255t1814r1354b1839],
6	investigations	NNS	O	investigation	prep_for	3	SENT_23	[p1l1363t1814r1558b1845],
7	of	IN	O	of	_	0	SENT_23	[p1l1568t1814r1597b1839],
8	the	DT	O	the	det	10	SENT_23	[p1l1604t1814r1648b1839],
9	CES1	NN	O	ces1	nn	10	SENT_23	[p1l1658t1815r1722b1839],
10	gene	NN	O	gene	prep_of	3	SENT_23	[p1l1735t1821r1802b1845],
11	in	IN	O	in	_	0	SENT_23	[p1l1812t1814r1837b1839],
12	larger	JJR	O	larger	amod	14	SENT_23	[p1l1848t1814r1930b1845],
13	ADHD	NN	O	adhd	nn	14	SENT_23	[p1l1937t1815r2024b1839],
14	samples	NNS	O	sample	prep_in	3	SENT_23	[p1l2034t1814r2154b1845],
15	.	.	O	.	_	0	SENT_23	[p1l2034t1814r2154b1845],

1	1	LS	NUMBER	1	_	0	SENT_24	[p1l11t2123r58b2172],
2	.	.	O	.	_	0	SENT_24	[p1l11t2123r58b2172],

1	Introduction	NN	O	introduction	_	0	SENT_25	[p1l101t2120r512b2172],

1	Attention	NN	O	attention	nn	3	SENT_26	[p1l105t2291r394b2342],
2	deﬁcit	NN	O	deﬁcit	nn	3	SENT_26	[p1l428t2290r618b2342],
3	hyperactivity	NN	O	hyperactivity	nsubj	9	SENT_26	[p1l651t2290r1051b2354],
4	disorder	NN	O	disorder	nn	7	SENT_26	[p1l1084t2290r1338b2342],
5	(	CD	NUMBER	(	num	7	SENT_26	[p1l1370t2290r1604b2354],
6	ADHD	NN	O	adhd	nn	7	SENT_26	[p1l1370t2290r1604b2354],
7	)	NN	O	)	dep	3	SENT_26	[p1l1370t2290r1604b2354],
8	is	VBZ	O	be	cop	9	SENT_26	[p1l1640t2291r1683b2342],
9	one	CD	NUMBER	one	_	0	SENT_26	[p1l1719t2305r1828b2342],
10	of	IN	O	of	_	0	SENT_26	[p1l1863t2290r1926b2342],
11	the	DT	O	the	det	16	SENT_26	[p1l1953t2290r2049b2342],
12	most	RBS	O	most	advmod	13	SENT_26	[p1l10t2381r161b2425],
13	prevalent	JJ	O	prevalent	amod	16	SENT_26	[p1l183t2373r471b2437],
14	chi1dhood	NN	O	chi1dhood	nn	16	SENT_26	[p1l493t2373r994b2425],
15	—	NN	O	—	nn	16	SENT_26	[p1l493t2373r994b2425],
16	onset	NN	O	onset	prep_of	9	SENT_26	[p1l493t2373r994b2425],
17	psychiatric	JJ	O	psychiatric	amod	18	SENT_26	[p1l1015t2373r1346b2437],
18	disorders	NNS	O	disorder	dep	16	SENT_26	[p1l1368t2373r1664b2432],
19	,	,	O	,	_	0	SENT_26	[p1l1368t2373r1664b2432],
20	affecting	VBG	O	affect	partmod	16	SENT_26	[p1l1688t2373r1951b2437],
21	5	CD	PERCENT	5	num	22	SENT_26	[p1l1974t2376r2049b2425],
22	%	NN	PERCENT	%	nsubj	29	SENT_26	[p1l1974t2376r2049b2425],
23	of	IN	O	of	_	0	SENT_26	[p1l10t2455r73b2507],
24	school	NN	O	school	nn	27	SENT_26	[p1l127t2455r451b2520],
25	—	CD	NUMBER	—	num	27	SENT_26	[p1l127t2455r451b2520],
26	age	NN	O	age	nn	27	SENT_26	[p1l127t2455r451b2520],
27	children	NNS	O	child	prep_of	22	SENT_26	[p1l513t2455r762b2507],
28	worldwide	JJ	O	worldwide	amod	29	SENT_26	[p1l819t2455r1149b2507],
29	(	CD	NUMBER	(	xcomp	20	SENT_26	[p1l1210t2455r1541b2520],
30	Polanczyk	NNP	O	Polanczyk	dep	29	SENT_26	[p1l1210t2455r1541b2520],
31	et	FW	O	et	nn	32	SENT_26	[p1l1600t2463r1657b2507],
32	al.	FW	O	al.	dep	29	SENT_26	[p1l1716t2455r1796b2515],
33	,	,	O	,	_	0	SENT_26	[p1l1716t2455r1796b2515],
34	2007	CD	DATE	2007	num	35	SENT_26	[p1l1857t2455r2048b2519],
35	)	NN	O	)	appos	32	SENT_26	[p1l1857t2455r2048b2519],
36	.	.	O	.	_	0	SENT_26	[p1l1857t2455r2048b2519],

1	Psychostimulant	JJ	O	psychostimulant	amod	2	SENT_27	[p1l10t2538r514b2603],
2	drugs	NNS	O	drug	nsubj	13	SENT_27	[p1l570t2538r738b2603],
3	such	JJ	O	such	_	0	SENT_27	[p1l797t2538r934b2590],
4	as	IN	O	as	_	0	SENT_27	[p1l991t2553r1050b2590],
5	methylphenidate	NN	O	methylphenidate	nn	8	SENT_27	[p1l1109t2538r1628b2603],
6	(	CD	NUMBER	(	num	8	SENT_27	[p1l1686t2538r1880b2603],
7	MPH	NN	O	mph	nn	8	SENT_27	[p1l1686t2538r1880b2603],
8	)	NN	O	)	prep_such_as	2	SENT_27	[p1l1686t2538r1880b2603],
9	and	CC	O	and	_	0	SENT_27	[p1l1938t2538r2048b2590],
10	amphetamines	NNS	O	amphetamine	prep_such_as	2	SENT_27	[p1l10t2622r462b2686],
11	are	VBP	O	be	cop	13	SENT_27	[p1l489t2636r581b2673],
12	ﬁrst-line	JJ	O	ﬁrst-line	amod	13	SENT_27	[p1l609t2621r869b2673],
13	treatments	NNS	O	treatment	_	0	SENT_27	[p1l895t2629r1227b2673],
14	for	IN	O	for	_	0	SENT_27	[p1l1256t2621r1340b2673],
15	this	DT	O	this	det	16	SENT_27	[p1l1364t2622r1474b2673],
16	disorder	NN	O	disorder	prep_for	13	SENT_27	[p1l1501t2622r1764b2681],
17	,	,	O	,	_	0	SENT_27	[p1l1501t2622r1764b2681],
18	but	CC	O	but	_	0	SENT_27	[p1l1791t2622r1892b2673],
19	they	PRP	O	they	nsubj	21	SENT_27	[p1l1916t2622r2052b2686],
20	are	VBP	O	be	cop	21	SENT_27	[p1l10t2720r101b2756],
21	effective	JJ	O	effective	conj_but	13	SENT_27	[p1l125t2704r380b2756],
22	only	RB	O	only	quantmod	23	SENT_27	[p1l403t2705r535b2769],
23	70	CD	PERCENT	70	num	24	SENT_27	[p1l557t2707r671b2756],
24	%	NN	PERCENT	%	nsubj	28	SENT_27	[p1l557t2707r671b2756],
25	of	IN	O	of	_	0	SENT_27	[p1l693t2704r756b2756],
26	the	DT	O	the	det	27	SENT_27	[p1l771t2705r867b2756],
27	cases	NNS	O	case	prep_of	24	SENT_27	[p1l891t2720r1046b2756],
28	(	VBP	O	(	ccomp	21	SENT_27	[p1l1070t2705r1424b2769],
29	Biederman	NNP	PERSON	Biederman	dobj	28	SENT_27	[p1l1070t2705r1424b2769],
30	and	CC	O	and	_	0	SENT_27	[p1l1447t2705r1557b2756],
31	Spencer	NNP	LOCATION	Spencer	dobj	28	SENT_27	[p1l1581t2707r1832b2769],
32	,	,	O	,	_	0	SENT_27	[p1l1581t2707r1832b2769],
33	2008	CD	DATE	2008	num	34	SENT_27	[p1l1857t2705r2048b2769],
34	)	NN	O	)	appos	29	SENT_27	[p1l1857t2705r2048b2769],
35	.	.	O	.	_	0	SENT_27	[p1l1857t2705r2048b2769],

1	With	IN	O	with	_	0	SENT_28	[p1l7t2787r161b2839],
2	global	JJ	O	global	amod	3	SENT_28	[p1l213t2787r396b2852],
3	rise	NN	O	rise	prep_with	16	SENT_28	[p1l450t2788r557b2839],
4	in	IN	O	in	_	0	SENT_28	[p1l611t2788r667b2838],
5	ADHD	NNP	MISC	ADHD	nn	6	SENT_28	[p1l718t2789r905b2838],
6	diagnosis	NN	O	diagnosis	prep_in	3	SENT_28	[p1l960t2787r1257b2852],
7	,	,	O	,	_	0	SENT_28	[p1l960t2787r1257b2852],
8	the	DT	O	the	det	11	SENT_28	[p1l1312t2787r1408b2839],
9	international	JJ	O	international	amod	11	SENT_28	[p1l1462t2787r1855b2839],
10	drug	NN	O	drug	nn	11	SENT_28	[p1l1910t2787r2050b2852],
11	consumption	NN	O	consumption	nsubj	16	SENT_28	[p1l10t2872r409b2935],
12	of	IN	O	of	_	0	SENT_28	[p1l434t2871r497b2923],
13	stimulants	NNS	O	stimulant	prep_of	11	SENT_28	[p1l515t2871r833b2923],
14	has	VBZ	O	have	aux	16	SENT_28	[p1l858t2871r957b2923],
15	been	VBN	O	be	aux	16	SENT_28	[p1l982t2871r1128b2923],
16	increasing	VBG	O	increase	_	0	SENT_28	[p1l1153t2872r1464b2935],
17	in	IN	O	in	_	0	SENT_28	[p1l1488t2872r1543b2922],
18	the	DT	DATE	the	det	20	SENT_28	[p1l1567t2871r1663b2923],
19	past	JJ	DATE	past	amod	20	SENT_28	[p1l1689t2879r1814b2935],
20	decade	NN	DATE	decade	prep_in	16	SENT_28	[p1l1837t2871r2049b2923],
21	(	CD	NUMBER	(	num	22	SENT_28	[p1l10t2953r217b3018],
22	Singh	NNP	PERSON	Singh	dobj	16	SENT_28	[p1l10t2953r217b3018],
23	,	,	O	,	_	0	SENT_28	[p1l10t2953r217b3018],
24	2008	CD	DATE	2008	num	25	SENT_28	[p1l269t2953r460b3018],
25	)	NN	O	)	appos	22	SENT_28	[p1l269t2953r460b3018],
26	,	,	O	,	_	0	SENT_28	[p1l269t2953r460b3018],
27	therefore	RB	O	therefore	advmod	25	SENT_28	[p1l511t2953r806b3013],
28	,	,	O	,	_	0	SENT_28	[p1l511t2953r806b3013],
29	identifying	VBG	O	identify	xcomp	16	SENT_28	[p1l858t2953r1189b3018],
30	genetic	JJ	O	genetic	amod	31	SENT_28	[p1l1238t2954r1458b3018],
31	and/or	NN	O	and/or	dobj	29	SENT_28	[p1l1507t2953r1709b3018],
32	biological	JJ	O	biological	amod	33	SENT_28	[p1l1757t2953r2048b3018],
33	markers	NNS	O	marker	nsubj	38	SENT_28	[p1l10t3037r256b3088],
34	predicting	VBG	O	predict	partmod	33	SENT_28	[p1l284t3037r596b3101],
35	drug	NN	O	drug	nn	36	SENT_28	[p1l622t3037r762b3101],
36	response	NN	O	response	dobj	34	SENT_28	[p1l789t3052r1058b3101],
37	has	VBZ	O	have	aux	38	SENT_28	[p1l1086t3037r1185b3088],
38	turned	VBN	O	turn	rcmod	31	SENT_28	[p1l1212t3037r1416b3088],
39	into	IN	O	into	_	0	SENT_28	[p1l1444t3037r1561b3088],
40	a	DT	O	a	det	43	SENT_28	[p1l1588t3052r1619b3088],
41	public	JJ	O	public	amod	43	SENT_28	[p1l1646t3037r1832b3101],
42	health	NN	O	health	nn	43	SENT_28	[p1l1859t3037r2049b3088],
43	concern	NN	O	concern	prep_into	38	SENT_28	[p1l10t3134r265b3172],
44	.	.	O	.	_	0	SENT_28	[p1l10t3134r265b3172],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_29	[p1l331t3120r855b3184],
2	studies	NNS	O	study	nsubj	5	SENT_29	[p1l919t3120r1132b3171],
3	would	MD	O	would	aux	5	SENT_29	[p1l1196t3120r1386b3171],
4	hopefully	RB	O	hopefully	advmod	5	SENT_29	[p1l1452t3119r1740b3184],
5	lead	VB	O	lead	_	0	SENT_29	[p1l1802t3120r1926b3171],
6	to	TO	O	to	_	0	SENT_29	[p1l1991t3127r2048b3171],
7	individualized	JJ	O	individualized	amod	9	SENT_29	[p1l10t3202r442b3254],
8	treatment	NN	O	treatment	nn	9	SENT_29	[p1l466t3210r771b3254],
9	protocols	NNS	O	protocol	prep_to	5	SENT_29	[p1l794t3202r1073b3267],
10	in	IN	O	in	_	0	SENT_29	[p1l1098t3203r1154b3253],
11	the	DT	DATE	the	det	13	SENT_29	[p1l1177t3202r1273b3254],
12	near	JJ	DATE	near	amod	13	SENT_29	[p1l1298t3217r1433b3254],
13	future	NN	DATE	future	prep_in	9	SENT_29	[p1l1455t3202r1639b3254],
14	by	IN	O	by	_	0	SENT_29	[p1l1662t3202r1735b3267],
15	providing	VBG	O	provide	prepc_by	5	SENT_29	[p1l1757t3202r2050b3267],
16	a	DT	O	a	det	17	SENT_29	[p1l10t3300r40b3337],
17	panel	NN	O	panel	dobj	15	SENT_29	[p1l75t3285r240b3350],
18	of	IN	O	of	_	0	SENT_29	[p1l275t3285r338b3337],
19	informative	JJ	O	informative	amod	21	SENT_29	[p1l366t3285r719b3337],
20	genetic	JJ	O	genetic	amod	21	SENT_29	[p1l754t3286r974b3350],
21	markers	NNS	O	marker	prep_of	17	SENT_29	[p1l1009t3285r1255b3337],
22	to	TO	O	to	aux	23	SENT_29	[p1l1290t3293r1349b3337],
23	check	VB	O	check	xcomp	15	SENT_29	[p1l1384t3285r1556b3337],
24	before	IN	O	before	_	0	SENT_29	[p1l1589t3285r1780b3337],
25	starting	VBG	O	start	prepc_before	23	SENT_29	[p1l1817t3286r2050b3350],
26	a	DT	O	a	det	27	SENT_29	[p1l10t3383r40b3420],
27	pharmacotherapy	NN	O	pharmacotherapy	dobj	25	SENT_29	[p1l65t3368r616b3433],
28	.	.	O	.	_	0	SENT_29	[p1l65t3368r616b3433],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_30	[p1l107t3452r632b3516],
2	studies	NNS	O	study	nsubj	3	SENT_30	[p1l658t3451r870b3503],
3	try	VBP	O	try	_	0	SENT_30	[p1l897t3459r983b3516],
4	to	TO	O	to	aux	5	SENT_30	[p1l1007t3459r1064b3503],
5	explore	VB	O	explore	xcomp	3	SENT_30	[p1l1090t3451r1317b3516],
6	how	WRB	O	how	advmod	10	SENT_30	[p1l1343t3451r1476b3503],
7	individual	JJ	O	individual	amod	9	SENT_30	[p1l1500t3451r1804b3503],
8	genetic	JJ	O	genetic	amod	9	SENT_30	[p1l1829t3452r2050b3516],
9	variations	NNS	O	variation	nsubj	10	SENT_30	[p1l8t3536r308b3587],
10	inﬂuence	VBP	O	inﬂuence	ccomp	5	SENT_30	[p1l344t3535r623b3587],
11	the	DT	O	the	det	15	SENT_30	[p1l657t3535r753b3587],
12	pharmacokinetic	JJ	O	pharmacokinetic	amod	15	SENT_30	[p1l788t3535r1302b3599],
13	and	CC	O	and	_	0	SENT_30	[p1l1335t3535r1445b3587],
14	pharmacodynamic	JJ	O	pharmacodynamic	conj_and	12	SENT_30	[p1l1481t3535r2050b3599],
15	properties	NNS	O	property	dobj	10	SENT_30	[p1l10t3618r320b3682],
16	of	IN	O	of	_	0	SENT_30	[p1l369t3617r432b3669],
17	the	DT	O	the	det	21	SENT_30	[p1l473t3618r569b3669],
18	medicine	NN	O	medicine	nn	21	SENT_30	[p1l618t3618r896b3669],
19	(	CD	NUMBER	(	num	21	SENT_30	[p1l945t3618r1110b3682],
20	drug	NN	O	drug	nn	21	SENT_30	[p1l945t3618r1110b3682],
21	metabolism	NN	O	metabolism	prep_of	15	SENT_30	[p1l1158t3618r1530b3677],
22	,	,	O	,	_	0	SENT_30	[p1l1158t3618r1530b3677],
23	efﬁciency	NN	O	efﬁciency	appos	21	SENT_30	[p1l1579t3617r1880b3682],
24	,	,	O	,	_	0	SENT_30	[p1l1579t3617r1880b3682],
25	side	NN	O	side	appos	23	SENT_30	[p1l1930t3618r2049b3669],

1	*	NN	O	*	_	0	SENT_31	[p2l52t81r72b104],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_31	[p2l105t80r464b132],
3	author	NN	O	author	dobj	2	SENT_31	[p2l480t80r642b122],
4	at	IN	O	at	prep	2	SENT_31	[p2l658t86r716b122],
5	:	:	O	:	_	0	SENT_31	[p2l658t86r716b122],
6	Institute	NNP	ORGANIZATION	Institute	dep	1	SENT_31	[p2l737t81r941b122],
7	of	IN	ORGANIZATION	of	_	0	SENT_31	[p2l958t80r1008b122],
8	Medical	NNP	ORGANIZATION	Medical	nn	9	SENT_31	[p2l1020t80r1210b122],
9	Chemistry	NNP	ORGANIZATION	Chemistry	prep_of	6	SENT_31	[p2l1228t80r1486b132],
10	,	,	O	,	_	0	SENT_31	[p2l1228t80r1486b132],
11	Molecular	JJ	O	molecular	amod	12	SENT_31	[p2l1504t80r1749b122],
12	Biology	NN	O	biology	appos	9	SENT_31	[p2l1765t80r1946b132],
13	and	CC	O	and	_	0	SENT_31	[p2l1960t80r2049b122],
14	Pathobiochemistry	NN	O	pathobiochemistry	appos	9	SENT_31	[p2l10t149r477b202],
15	,	,	O	,	_	0	SENT_31	[p2l10t149r477b202],
16	Semmelweis	NNP	ORGANIZATION	Semmelweis	nn	17	SENT_31	[p2l501t149r809b191],
17	University	NNP	ORGANIZATION	University	appos	9	SENT_31	[p2l831t150r1089b202],
18	,	,	O	,	_	0	SENT_31	[p2l831t150r1089b202],
19	Budapest	NNP	LOCATION	Budapest	appos	9	SENT_31	[p2l1113t149r1347b202],
20	,	,	O	,	_	0	SENT_31	[p2l1113t149r1347b202],
21	POB	NN	ORGANIZATION	pob	appos	9	SENT_31	[p2l1371t151r1468b191],
22	260	CD	NUMBER	260	num	21	SENT_31	[p2l1490t151r1591b197],
23	,	,	O	,	_	0	SENT_31	[p2l1490t151r1591b197],
24	H-1444	NN	O	h-1444	appos	9	SENT_31	[p2l1615t151r1807b197],
25	,	,	O	,	_	0	SENT_31	[p2l1615t151r1807b197],
26	Hungary	NNP	LOCATION	Hungary	appos	9	SENT_31	[p2l1830t152r2049b202],
27	.	.	O	.	_	0	SENT_31	[p2l1830t152r2049b202],

1	Tel.	NNP	O	Tel.	_	0	SENT_32	[p2l7t218r104b260],
2	:	:	O	:	_	0	SENT_32	[p2l7t218r104b260],
3	+36	CD	NUMBER	+36	number	4	SENT_32	[p2l130t220r228b263],
4	1	CD	NUMBER	1	dep	1	SENT_32	[p2l251t220r270b259],
5	4591500x60134	NN	O	4591500x60134	dep	4	SENT_32	[p2l292t220r697b266],
6	;	:	O	;	_	0	SENT_32	[p2l292t220r697b266],
7	fax	NN	O	fax	dep	1	SENT_32	[p2l723t218r808b260],
8	:	:	O	:	_	0	SENT_32	[p2l723t218r808b260],
9	+36	CD	NUMBER	+36	number	10	SENT_32	[p2l835t220r934b263],
10	1	CD	NUMBER	1	dep	7	SENT_32	[p2l956t220r975b259],
11	2662615	CD	NUMBER	2662615	dep	10	SENT_32	[p2l1000t220r1220b260],
12	.	.	O	.	_	0	SENT_32	[p2l1000t220r1220b260],

1	E-mail	NN	O	e-mail	nn	2	SENT_33	[p2l105t287r259b329],
2	address	NN	O	address	_	0	SENT_33	[p2l279t287r471b329],
3	:	:	O	:	_	0	SENT_33	[p2l279t287r471b329],
4	zsoﬁa.nemoda@eol	NN	O	zsoﬁa.nemoda@eol	dep	2	SENT_33	[p2l493t287r1164b329],
5	<	JJR	O	<	dep	4	SENT_33	[p2l493t287r1164b329],
6	.	.	O	.	_	0	SENT_33	[p2l493t287r1164b329],

1	sote	NN	O	sote	_	0	SENT_34	[p2l493t287r1164b329],
2	.	.	O	.	_	0	SENT_34	[p2l493t287r1164b329],

1	hu	NN	O	hu	_	0	SENT_35	[p2l493t287r1164b329],
2	(	CD	NUMBER	(	num	5	SENT_35	[p2l1186t287r1244b339],
3	Z.	NNP	PERSON	Z.	nn	5	SENT_35	[p2l1186t287r1244b339],
4	Nemoda	NNP	PERSON	Nemoda	nn	5	SENT_35	[p2l1266t287r1501b339],
5	)	NN	O	)	dep	1	SENT_35	[p2l1266t287r1501b339],
6	.	.	O	.	_	0	SENT_35	[p2l1266t287r1501b339],

1	0028-3908	CD	DURATION	0028-3908	_	0	SENT_36	[p2l9t436r323b490],
2	/	:	O	/	punct	1	SENT_36	[p2l9t436r323b490],
3	$	$	MONEY	$	nsubj	5	SENT_36	[p2l9t436r323b490],
4	—	CD	MONEY	—	num	3	SENT_36	[p2l345t462r371b467],
5	see	VBP	O	see	dep	1	SENT_36	[p2l394t450r469b479],
6	front	JJ	O	front	amod	7	SENT_36	[p2l492t437r611b479],
7	matter	NN	O	matter	dobj	5	SENT_36	[p2l631t444r795b479],
8	©	CD	NUMBER	©	num	11	SENT_36	[p2l815t443r853b479],
9	2009	CD	DATE	2009	num	11	SENT_36	[p2l875t440r997b479],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_36	[p2l1019t437r1209b479],
11	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_36	[p2l1230t437r1315b480],
12	.	.	O	.	_	0	SENT_36	[p2l1230t437r1315b480],

1	All	DT	O	all	det	2	SENT_37	[p2l1336t437r1401b479],
2	rights	NNS	O	rights	nsubj	3	SENT_37	[p2l1423t438r1561b490],
3	reserved	VBN	O	reserve	_	0	SENT_37	[p2l1583t437r1803b480],
4	.	.	O	.	_	0	SENT_37	[p2l1583t437r1803b480],

1	doi	FW	O	doi	_	0	SENT_38	[p2l9t507r952b560],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_38	[p2l9t507r952b560],
3	/	:	O	/	punct	5	SENT_38	[p2l9t507r952b560],
4	j.	NN	O	j.	nn	5	SENT_38	[p2l9t507r952b560],
5	neuropharm	NN	O	neuropharm	dep	2	SENT_38	[p2l9t507r952b560],
6	.2009.08.014	CD	NUMBER	.2009.08.014	dep	2	SENT_38	[p2l9t507r952b560],

1	©	RB	O	©	advmod	2	SENT_39	[p2l1002t595r1045b637],
2	2009	CD	DATE	2009	_	0	SENT_39	[p2l1072t591r1211b636],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_39	[p2l1237t588r1458b636],
4	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_39	[p2l1481t588r1580b637],
5	.	.	O	.	_	0	SENT_39	[p2l1481t588r1580b637],

1	All	DT	O	all	det	2	SENT_40	[p2l1604t588r1680b636],
2	rights	NNS	O	rights	nsubj	3	SENT_40	[p2l1705t588r1865b648],
3	reserved	VBN	O	reserve	_	0	SENT_40	[p2l1891t588r2146b637],
4	.	.	O	.	_	0	SENT_40	[p2l1891t588r2146b637],

1	effects	NNS	O	effect	_	0	SENT_41	[p2l55t850r295b917],
2	)	CD	NUMBER	)	num	1	SENT_41	[p2l55t850r295b917],
3	.	.	O	.	_	0	SENT_41	[p2l55t850r295b917],

1	Most	JJS	O	most	nsubj	9	SENT_42	[p2l322t854r478b904],
2	of	IN	O	of	_	0	SENT_42	[p2l502t850r567b904],
3	the	DT	O	the	det	4	SENT_42	[p2l586t851r684b904],
4	studies	NNS	O	study	prep_of	1	SENT_42	[p2l712t851r930b904],
5	investigating	VBG	O	investigate	partmod	4	SENT_42	[p2l958t851r1361b917],
6	MPH-response	NN	O	mph-response	dobj	5	SENT_42	[p2l1386t854r1845b917],
7	in	IN	O	in	_	0	SENT_42	[p2l1872t851r1930b903],
8	ADHD	NNP	O	ADHD	prep_in	6	SENT_42	[p2l1953t853r2145b903],
9	focused	VBD	O	focus	_	0	SENT_42	[p2l55t936r292b990],
10	on	IN	O	on	_	0	SENT_42	[p2l324t952r401b990],
11	genetic	JJ	O	genetic	amod	12	SENT_42	[p2l433t937r658b1003],
12	variants	NNS	O	variant	prep_on	9	SENT_42	[p2l688t937r937b990],
13	of	IN	O	of	_	0	SENT_42	[p2l971t936r1035b990],
14	drug	NN	O	drug	nn	15	SENT_42	[p2l1060t937r1204b1003],
15	targets	NNS	O	target	prep_of	12	SENT_42	[p2l1235t945r1463b1003],
16	,	,	O	,	_	0	SENT_42	[p2l1235t945r1463b1003],
17	such	JJ	O	such	_	0	SENT_42	[p2l1497t937r1637b990],
18	as	IN	O	as	_	0	SENT_42	[p2l1670t952r1730b990],
19	transporters	NNS	O	transporter	prep_such_as	9	SENT_42	[p2l1763t945r2146b1003],
20	and	CC	O	and	_	0	SENT_42	[p2l54t1022r168b1075],
21	receptors	NNS	O	receptor	conj_and	19	SENT_42	[p2l198t1030r486b1089],
22	(	VBP	O	(	rcmod	19	SENT_42	[p2l518t1022r829b1088],
23	reviewed	VBN	O	review	dep	22	SENT_42	[p2l518t1022r829b1088],
24	by	IN	O	by	_	0	SENT_42	[p2l859t1022r934b1089],
25	Stein	NNP	PERSON	Stein	prep_by	23	SENT_42	[p2l962t1023r1114b1075],
26	and	CC	O	and	_	0	SENT_42	[p2l1144t1022r1257b1075],
27	McGough	NNP	PERSON	McGough	conj_and	25	SENT_42	[p2l1288t1022r1602b1089],
28	,	,	O	,	_	0	SENT_42	[p2l1288t1022r1602b1089],
29	2008	CD	DATE	2008	num	30	SENT_42	[p2l1633t1022r1829b1088],
30	)	NN	O	)	appos	25	SENT_42	[p2l1633t1022r1829b1088],
31	,	,	O	,	_	0	SENT_42	[p2l1633t1022r1829b1088],
32	and	CC	O	and	_	0	SENT_42	[p2l1860t1022r1973b1075],
33	little	JJ	O	little	amod	34	SENT_42	[p2l2004t1022r2146b1075],
34	attention	NN	O	attention	nsubjpass	37	SENT_42	[p2l54t1109r339b1161],
35	has	VBZ	O	have	aux	37	SENT_42	[p2l358t1108r460b1161],
36	been	VBN	O	be	auxpass	37	SENT_42	[p2l479t1108r628b1161],
37	paid	VBN	O	pay	conj_and	9	SENT_42	[p2l645t1108r778b1175],
38	to	TO	O	to	_	0	SENT_42	[p2l796t1116r856b1161],
39	genetic	JJ	O	genetic	amod	40	SENT_42	[p2l874t1109r1100b1175],
40	variability	NN	O	variability	prep_to	37	SENT_42	[p2l1116t1108r1433b1175],
41	of	IN	O	of	_	0	SENT_42	[p2l1449t1108r1514b1161],
42	drug	NN	O	drug	nn	43	SENT_42	[p2l1525t1108r1669b1175],
43	metabolism	NN	O	metabolism	prep_of	40	SENT_42	[p2l1687t1108r2069b1162],
44	.	.	O	.	_	0	SENT_42	[p2l1687t1108r2069b1162],

1	In	IN	O	in	_	0	SENT_43	[p2l2089t1111r2146b1161],
2	contrast	NN	O	contrast	prep_in	22	SENT_43	[p2l55t1202r302b1248],
3	to	TO	O	to	_	0	SENT_43	[p2l315t1202r373b1248],
4	amphetamine	NN	O	amphetamine	prep_to	2	SENT_43	[p2l391t1194r814b1261],
5	and	CC	O	and	_	0	SENT_43	[p2l831t1194r942b1248],
6	atomoxetine	NN	O	atomoxetine	prep_to	2	SENT_43	[p2l959t1195r1354b1256],
7	,	,	O	,	_	0	SENT_43	[p2l959t1195r1354b1256],
8	which	WDT	O	which	nsubjpass	10	SENT_43	[p2l1370t1194r1558b1248],
9	are	VBP	O	be	auxpass	10	SENT_43	[p2l1575t1210r1666b1248],
10	metabolized	VBN	O	metabolize	rcmod	2	SENT_43	[p2l1684t1194r2057b1248],
11	by	IN	O	by	_	0	SENT_43	[p2l2074t1194r2148b1261],
12	hepatic	JJ	O	hepatic	amod	14	SENT_43	[p2l55t1280r278b1347],
13	cytochrome	NN	O	cytochrome	nn	14	SENT_43	[p2l290t1281r648b1347],
14	P450	NN	O	p450	agent	10	SENT_43	[p2l663t1283r813b1334],
15	(	CD	NUMBER	(	num	18	SENT_43	[p2l827t1280r991b1347],
16	CYP	NN	O	cyp	nn	18	SENT_43	[p2l827t1280r991b1347],
17	)	NN	O	)	nn	18	SENT_43	[p2l827t1280r991b1347],
18	enzymes	NNS	O	enzyme	dep	14	SENT_43	[p2l1006t1296r1288b1347],
19	,	,	O	,	_	0	SENT_43	[p2l1006t1296r1288b1347],
20	MPH	NN	O	mph	nsubjpass	22	SENT_43	[p2l1302t1284r1449b1333],
21	is	VBZ	O	be	auxpass	22	SENT_43	[p2l1464t1281r1509b1334],
22	converted	VBN	O	convert	_	0	SENT_43	[p2l1523t1280r1824b1334],
23	to	TO	O	to	_	0	SENT_43	[p2l1838t1288r1896b1334],
24	inactive	JJ	O	inactive	amod	26	SENT_43	[p2l1911t1281r2146b1334],
25	ritalinic	JJ	O	ritalinic	amod	26	SENT_43	[p2l55t1367r287b1420],
26	acid	NN	O	acid	prep_to	22	SENT_43	[p2l313t1367r434b1420],
27	by	IN	O	by	_	0	SENT_43	[p2l463t1367r536b1433],
28	carboxylesterase	NN	O	carboxylesterase	agent	22	SENT_43	[p2l561t1367r1078b1433],
29	.	.	O	.	_	0	SENT_43	[p2l561t1367r1078b1433],

1	Liver	NN	O	liver	nn	2	SENT_44	[p2l1108t1368r1255b1420],
2	carboxylesterase	NN	O	carboxylesterase	nn	6	SENT_44	[p2l1281t1367r1785b1433],
3	1	CD	NUMBER	1	number	4	SENT_44	[p2l1816t1370r1840b1419],
4	(	CD	NUMBER	(	num	5	SENT_44	[p2l1876t1367r2073b1433],
5	CES1	NN	O	ces1	dep	2	SENT_44	[p2l1876t1367r2073b1433],
6	)	NN	O	)	_	0	SENT_44	[p2l1876t1367r2073b1433],
7	is	VBZ	O	be	cop	8	SENT_44	[p2l2102t1368r2145b1420],
8	responsible	JJ	O	responsible	dep	6	SENT_44	[p2l55t1453r401b1519],
9	for	IN	O	for	_	0	SENT_44	[p2l418t1452r502b1506],
10	the	DT	O	the	det	11	SENT_44	[p2l517t1453r613b1506],
11	hydrolysis	NN	O	hydrolysis	prep_for	8	SENT_44	[p2l631t1453r938b1519],
12	of	IN	O	of	_	0	SENT_44	[p2l955t1452r1019b1506],
13	both	CC	O	both	dep	14	SENT_44	[p2l1027t1453r1165b1506],
14	13	CD	NUMBER	13	prep_of	11	SENT_44	[p2l1181t1470r1237b1505],
15	-	:	O	-	_	0	SENT_44	[p2l1181t1470r1237b1505],
16	and	CC	O	and	_	0	SENT_44	[p2l1255t1452r1366b1506],
17	L-isomer	NN	O	l-isomer	prep_of	11	SENT_44	[p2l1383t1453r1642b1506],
18	of	IN	O	of	_	0	SENT_44	[p2l1656t1452r1719b1506],
19	MPH	NN	O	mph	prep_of	17	SENT_44	[p2l1729t1456r1876b1505],
20	(	CD	NUMBER	(	num	19	SENT_44	[p2l1893t1452r2013b1519],
21	the	DT	O	the	det	23	SENT_44	[p2l1893t1452r2013b1519],
22	two	CD	NUMBER	two	num	23	SENT_44	[p2l2030t1460r2146b1506],
23	components	NNS	O	component	dep	17	SENT_44	[p2l55t1547r429b1605],
24	of	IN	O	of	_	0	SENT_44	[p2l451t1539r515b1592],
25	Ritalin	NNP	O	Ritalin	prep_of	23	SENT_44	[p2l529t1539r737b1600],
26	,	,	O	,	_	0	SENT_44	[p2l529t1539r737b1600],
27	one	CD	NUMBER	one	conj_and	14	SENT_44	[p2l758t1554r868b1592],
28	of	IN	O	of	_	0	SENT_44	[p2l890t1539r954b1592],
29	the	DT	O	the	det	33	SENT_44	[p2l967t1539r1064b1592],
30	most	RBS	O	most	advmod	31	SENT_44	[p2l1086t1547r1237b1592],
31	frequently	RB	O	frequently	advmod	32	SENT_44	[p2l1257t1539r1570b1605],
32	prescribed	VBN	O	prescribe	amod	33	SENT_44	[p2l1589t1539r1907b1605],
33	drug	NN	O	drug	prep_of	27	SENT_44	[p2l1928t1539r2069b1605],
34	in	IN	O	in	_	0	SENT_44	[p2l2090t1540r2147b1591],
35	ADHD	NNP	MISC	ADHD	prep_in	33	SENT_44	[p2l52t1625r280b1691],
36	)	CD	NUMBER	)	num	35	SENT_44	[p2l52t1625r280b1691],
37	,	,	O	,	_	0	SENT_44	[p2l52t1625r280b1691],
38	and	CC	O	and	_	0	SENT_44	[p2l304t1625r415b1678],
39	for	IN	O	for	prep_of	11	SENT_44	[p2l441t1625r525b1678],
40	the	DT	O	the	det	42	SENT_44	[p2l547t1625r643b1678],
41	resulting	VBG	O	result	amod	42	SENT_44	[p2l668t1625r936b1691],
42	ﬁrst	NN	O	ﬁrst	pobj	39	SENT_44	[p2l960t1625r1237b1691],
43	—	CD	NUMBER	—	num	45	SENT_44	[p2l960t1625r1237b1691],
44	pass	NN	O	pass	nn	45	SENT_44	[p2l960t1625r1237b1691],
45	metabolism	NN	O	metabolism	dep	6	SENT_44	[p2l1261t1625r1621b1678],
46	of	IN	O	of	_	0	SENT_44	[p2l1644t1625r1708b1678],
47	the	DT	O	the	det	50	SENT_44	[p2l1724t1625r1821b1678],
48	drug	NN	O	drug	nn	50	SENT_44	[p2l1845t1625r1987b1691],
49	(	NNP	O	(	nn	50	SENT_44	[p2l2010t1625r2147b1691],
50	Sun	NNP	O	Sun	prep_of	45	SENT_44	[p2l2010t1625r2147b1691],
51	et	FW	O	et	nn	52	SENT_44	[p2l55t1718r112b1763],
52	al.	FW	O	al.	dep	45	SENT_44	[p2l141t1710r220b1772],
53	,	,	O	,	_	0	SENT_44	[p2l141t1710r220b1772],
54	2004	CD	DATE	2004	num	55	SENT_44	[p2l253t1710r445b1776],
55	)	NN	O	)	appos	6	SENT_44	[p2l253t1710r445b1776],
56	.	.	O	.	_	0	SENT_44	[p2l253t1710r445b1776],

1	Therefore	RB	O	therefore	advmod	4	SENT_45	[p2l474t1710r782b1772],
2	,	,	O	,	_	0	SENT_45	[p2l474t1710r782b1772],
3	we	PRP	O	we	nsubj	4	SENT_45	[p2l812t1726r903b1763],
4	selected	VBD	O	select	_	0	SENT_45	[p2l935t1710r1178b1763],
5	a	DT	O	a	det	9	SENT_45	[p2l1210t1726r1242b1763],
6	recently	RB	DATE	recently	advmod	7	SENT_45	[p2l1273t1710r1519b1777],
7	reported	VBN	O	report	amod	9	SENT_45	[p2l1549t1710r1809b1777],
8	functional	JJ	O	functional	amod	9	SENT_45	[p2l1841t1710r2145b1763],
9	variant	NN	O	variant	dobj	4	SENT_45	[p2l53t1797r268b1850],
10	of	IN	O	of	_	0	SENT_45	[p2l285t1796r349b1850],
11	the	DT	O	the	det	13	SENT_45	[p2l362t1797r459b1850],
12	CES1	NN	O	ces1	nn	13	SENT_45	[p2l480t1799r620b1850],
13	gene	NN	O	gene	prep_of	9	SENT_45	[p2l647t1812r791b1863],
14	for	IN	O	for	_	0	SENT_45	[p2l812t1796r897b1850],
15	pharmacogenetic	JJ	O	pharmacogenetic	amod	16	SENT_45	[p2l916t1797r1442b1863],
16	analysis	NN	O	analysis	prep_for	13	SENT_45	[p2l1461t1797r1713b1863],
17	.	.	O	.	_	0	SENT_45	[p2l1461t1797r1713b1863],

1	Zhu	NNP	PERSON	Zhu	_	0	SENT_46	[p2l153t1883r272b1936],
2	et	FW	O	et	nn	4	SENT_46	[p2l309t1891r367b1936],
3	al.	FW	O	al.	nn	4	SENT_46	[p2l403t1883r469b1936],
4	(	FW	O	(	dep	1	SENT_46	[p2l507t1883r713b1949],
5	2008	CD	DATE	2008	num	6	SENT_46	[p2l507t1883r713b1949],
6	)	CD	NUMBER	)	dep	4	SENT_46	[p2l507t1883r713b1949],
7	identiﬁed	VBN	O	identiﬁed	partmod	6	SENT_46	[p2l752t1882r1050b1936],
8	two	CD	NUMBER	two	num	10	SENT_46	[p2l1088t1891r1205b1936],
9	CES1	NN	O	ces1	nn	10	SENT_46	[p2l1243t1885r1387b1936],
10	variants	NNS	O	variant	dobj	7	SENT_46	[p2l1429t1883r1678b1936],
11	with	IN	O	with	_	0	SENT_46	[p2l1715t1883r1859b1936],
12	reduced	VBN	O	reduce	amod	14	SENT_46	[p2l1896t1883r2145b1936],
13	enzyme	NN	O	enzyme	nn	14	SENT_46	[p2l55t1984r298b2035],
14	activity	NN	O	activity	prep_with	7	SENT_46	[p2l323t1969r553b2035],
15	in	IN	O	in	_	0	SENT_46	[p2l576t1969r633b2021],
16	a	DT	O	a	det	18	SENT_46	[p2l658t1984r690b2021],
17	compound	NN	O	compound	nn	18	SENT_46	[p2l714t1968r1047b2035],
18	heterozygote	NN	O	heterozygote	prep_in	14	SENT_46	[p2l1073t1968r1478b2035],
19	subject	JJ	O	subject	advmod	20	SENT_46	[p2l1503t1968r1724b2035],
20	participating	VBG	O	participate	partmod	18	SENT_46	[p2l1747t1969r2147b2035],
21	in	IN	O	in	_	0	SENT_46	[p2l55t2055r112b2107],
22	an	DT	O	a	det	25	SENT_46	[p2l130t2070r204b2107],
23	MPH	NN	O	mph	nn	25	SENT_46	[p2l222t2057r371b2107],
24	pharmacokinetics	NNS	O	pharmacokinetic	nn	25	SENT_46	[p2l390t2054r945b2121],
25	study	NN	O	study	prep_in	20	SENT_46	[p2l965t2054r1146b2121],
26	.	.	O	.	_	0	SENT_46	[p2l965t2054r1146b2121],

1	The	DT	O	the	det	2	SENT_47	[p2l1163t2054r1277b2107],
2	428G	NN	O	428g	_	0	SENT_47	[p2l1294t2056r1534b2107],
3	.	.	O	.	_	0	SENT_47	[p2l1294t2056r1534b2107],

1	—	NN	O	—	_	0	SENT_48	[p2l1294t2056r1534b2107],
2	.	.	O	.	_	0	SENT_48	[p2l1294t2056r1534b2107],

1	A	DT	O	a	det	2	SENT_49	[p2l1294t2056r1534b2107],
2	transition	NN	O	transition	nsubj	10	SENT_49	[p2l1549t2055r1852b2107],
3	in	IN	O	in	_	0	SENT_49	[p2l1870t2055r1928b2107],
4	exon	NN	O	exon	prep_in	2	SENT_49	[p2l1945t2070r2092b2107],
5	4	CD	NUMBER	4	num	4	SENT_49	[p2l2109t2057r2146b2107],
6	of	IN	O	of	_	0	SENT_49	[p2l55t2140r119b2194],
7	the	DT	O	the	det	9	SENT_49	[p2l160t2140r260b2194],
8	CES1	NN	O	ces1	nn	9	SENT_49	[p2l309t2143r452b2194],
9	gene	NN	O	gene	prep_of	4	SENT_49	[p2l508t2156r655b2207],
10	results	VBZ	O	result	_	0	SENT_49	[p2l705t2140r909b2194],
11	in	IN	O	in	_	0	SENT_49	[p2l960t2141r1017b2193],
12	glycine	NN	O	glycine	nn	15	SENT_49	[p2l1065t2140r1722b2207],
13	—	CD	NUMBER	—	num	15	SENT_49	[p2l1065t2140r1722b2207],
14	to-glutamate	NN	O	to-glutamate	nn	15	SENT_49	[p2l1065t2140r1722b2207],
15	substitution	NN	O	substitution	prep_in	10	SENT_49	[p2l1773t2140r2146b2194],
16	(	CD	NUMBER	(	num	18	SENT_49	[p2l55t2226r727b2293],
17	Gly143Glu	NN	O	gly143glu	nn	18	SENT_49	[p2l55t2226r727b2293],
18	)	NN	O	)	dobj	10	SENT_49	[p2l55t2226r727b2293],
19	,	,	O	,	_	0	SENT_49	[p2l55t2226r727b2293],
20	whereas	IN	O	whereas	mark	32	SENT_49	[p2l55t2226r727b2293],
21	a	DT	O	a	det	22	SENT_49	[p2l748t2242r780b2279],
22	l	NN	O	l	nsubj	32	SENT_49	[p2l803t2226r943b2293],
23	—	CD	NUMBER	—	num	24	SENT_49	[p2l803t2226r943b2293],
24	bp	NN	O	bp	dep	22	SENT_49	[p2l803t2226r943b2293],
25	deletion	NN	O	deletion	nn	28	SENT_49	[p2l964t2226r1219b2279],
26	(	CD	NUMBER	(	num	28	SENT_49	[p2l1240t2226r1539b2292],
27	780delT	NN	O	780delt	nn	28	SENT_49	[p2l1240t2226r1539b2292],
28	)	NN	O	)	dep	22	SENT_49	[p2l1240t2226r1539b2292],
29	in	IN	O	in	_	0	SENT_49	[p2l1561t2227r1618b2279],
30	exon	NN	O	exon	prep_in	28	SENT_49	[p2l1639t2242r1786b2279],
31	6	CD	NUMBER	6	num	30	SENT_49	[p2l1807t2229r1842b2279],
32	produces	VBZ	O	produce	dep	18	SENT_49	[p2l1863t2226r2145b2293],
33	a	DT	O	a	det	37	SENT_49	[p2l55t2328r86b2366],
34	frameshift	NN	O	frameshift	nn	37	SENT_49	[p2l116t2312r438b2366],
35	and	CC	O	and	_	0	SENT_49	[p2l466t2313r579b2366],
36	premature	JJ	O	premature	conj_and	34	SENT_49	[p2l611t2321r939b2379],
37	truncation	NN	O	truncation	dobj	32	SENT_49	[p2l969t2313r1295b2366],
38	of	IN	O	of	_	0	SENT_49	[p2l1324t2312r1390b2366],
39	the	DT	O	the	det	40	SENT_49	[p2l1412t2313r1511b2366],
40	protein	NN	O	protein	prep_of	37	SENT_49	[p2l1542t2313r1767b2379],
41	(	CD	NUMBER	(	num	42	SENT_49	[p2l1796t2312r2145b2379],
42	Asp260fs	NNS	O	asp260f	dep	40	SENT_49	[p2l1796t2312r2145b2379],
43	)	CD	NUMBER	)	dep	42	SENT_49	[p2l1796t2312r2145b2379],
44	.	.	O	.	_	0	SENT_49	[p2l1796t2312r2145b2379],

1	Since	IN	O	since	mark	6	SENT_50	[p2l55t2399r216b2452],
2	the	DT	O	the	det	3	SENT_50	[p2l235t2399r334b2452],
3	Asp260fs	NN	O	asp260f	nsubj	6	SENT_50	[p2l351t2398r637b2465],
4	is	VBZ	O	be	cop	6	SENT_50	[p2l658t2399r702b2452],
5	extremely	RB	O	extremely	advmod	6	SENT_50	[p2l723t2399r1038b2465],
6	rare	JJ	O	rare	advcl	24	SENT_50	[p2l1056t2414r1176b2452],
7	variant	JJ	O	variant	amod	8	SENT_50	[p2l1194t2399r1415b2452],
8	(	NN	O	(	nsubj	18	SENT_50	[p2l1433t2399r1534b2465],
9	no	DT	O	no	det	11	SENT_50	[p2l1433t2399r1534b2465],
10	other	JJ	O	other	amod	11	SENT_50	[p2l1555t2399r1721b2452],
11	person	NN	O	person	npadvmod	8	SENT_50	[p2l1739t2414r1951b2465],
12	out	IN	O	out	_	0	SENT_50	[p2l1970t2407r2072b2452],
13	of	IN	O	of	_	0	SENT_50	[p2l2090t2398r2154b2452],
14	the	DT	O	the	det	17	SENT_50	[p2l54t2484r153b2537],
15	reported	VBN	O	report	amod	17	SENT_50	[p2l199t2484r466b2551],
16	925	CD	NUMBER	925	num	17	SENT_50	[p2l512t2487r624b2537],
17	subjects	NNS	O	subject	prep_out_of	8	SENT_50	[p2l673t2484r922b2551],
18	carried	VBD	O	carry	ccomp	6	SENT_50	[p2l968t2484r1184b2537],
19	this	DT	O	this	det	21	SENT_50	[p2l1230t2484r1343b2537],
20	variant	JJ	O	variant	amod	21	SENT_50	[p2l1386t2484r1646b2550],
21	)	NN	O	)	dobj	18	SENT_50	[p2l1386t2484r1646b2550],
22	,	,	O	,	_	0	SENT_50	[p2l1386t2484r1646b2550],
23	we	PRP	O	we	nsubj	24	SENT_50	[p2l1691t2500r1783b2537],
24	chose	VBD	O	choose	_	0	SENT_50	[p2l1827t2484r2002b2537],
25	the	DT	O	the	det	27	SENT_50	[p2l2047t2484r2146b2537],
26	Glyl43Glu	NN	O	glyl43glu	nn	27	SENT_50	[p2l55t2570r379b2637],
27	polymorphism	NN	O	polymorphism	dobj	24	SENT_50	[p2l399t2570r859b2637],
28	which	WDT	O	which	nsubj	29	SENT_50	[p2l873t2570r1066b2623],
29	had	VBD	O	have	rcmod	27	SENT_50	[p2l1086t2570r1198b2623],
30	3.7	CD	PERCENT	3.7	number	31	SENT_50	[p2l1217t2573r1352b2624],
31	%	NN	PERCENT	%	amod	34	SENT_50	[p2l1217t2573r1352b2624],
32	minor	JJ	O	minor	amod	34	SENT_50	[p2l1371t2571r1561b2623],
33	allele	NN	O	allele	nn	34	SENT_50	[p2l1578t2570r1740b2623],
34	frequency	NN	O	frequency	dobj	29	SENT_50	[p2l1761t2570r2071b2637],
35	in	IN	O	in	_	0	SENT_50	[p2l2089t2571r2146b2623],
36	Caucasian	JJ	LOCATION	caucasian	amod	37	SENT_50	[p2l55t2657r363b2710],
37	population	NN	O	population	prep_in	29	SENT_50	[p2l405t2656r759b2723],
38	.	.	O	.	_	0	SENT_50	[p2l405t2656r759b2723],

1	None	NN	O	none	nsubj	9	SENT_51	[p2l804t2660r965b2710],
2	of	IN	O	of	prep	1	SENT_51	[p2l1009t2656r1074b2710],
3	the	DT	O	the	det	4	SENT_51	[p2l1110t2656r1208b2710],
4	previously	RB	DATE	previously	pobj	2	SENT_51	[p2l1253t2656r1580b2723],
5	described	VBN	O	describe	partmod	4	SENT_51	[p2l1621t2656r1920b2710],
6	single	JJ	O	single	amod	8	SENT_51	[p2l1966t2656r2146b2723],
7	nucleotide	NN	O	nucleotide	nn	8	SENT_51	[p2l55t2742r382b2796],
8	polymorphisms	NNS	O	polymorphism	dobj	5	SENT_51	[p2l410t2742r899b2809],
9	(	VBP	O	(	dep	17	SENT_51	[p2l928t2743r1128b2809],
10	SNPs	NNS	O	snp	dobj	9	SENT_51	[p2l928t2743r1128b2809],
11	)	CD	NUMBER	)	num	10	SENT_51	[p2l928t2743r1128b2809],
12	in	IN	O	in	_	0	SENT_51	[p2l1158t2743r1215b2795],
13	the	DT	O	the	det	15	SENT_51	[p2l1242t2742r1341b2796],
14	CES1	NN	O	ces1	nn	15	SENT_51	[p2l1370t2745r1513b2796],
15	gene	NN	O	gene	prep_in	10	SENT_51	[p2l1548t2758r1694b2809],
16	was	VBD	O	be	auxpass	17	SENT_51	[p2l1720t2758r1840b2796],
17	regarded	VBN	O	regard	_	0	SENT_51	[p2l1869t2742r2146b2809],
18	as	IN	O	as	_	0	SENT_51	[p2l55t2844r115b2882],
19	functional	JJ	O	functional	prep_as	17	SENT_51	[p2l137t2829r466b2890],
20	,	,	O	,	_	0	SENT_51	[p2l137t2829r466b2890],
21	because	IN	O	because	mark	25	SENT_51	[p2l488t2829r735b2882],
22	they	PRP	O	they	nsubjpass	25	SENT_51	[p2l755t2829r894b2895],
23	were	VBD	O	be	auxpass	25	SENT_51	[p2l911t2844r1066b2882],
24	not	RB	O	not	neg	25	SENT_51	[p2l1088t2837r1191b2882],
25	associated	VBN	O	associate	advcl	17	SENT_51	[p2l1209t2829r1528b2882],
26	with	IN	O	with	_	0	SENT_51	[p2l1549t2829r1693b2882],
27	altered	JJ	O	altered	amod	29	SENT_51	[p2l1713t2829r1929b2882],
28	mRNA	NN	O	mrna	nn	29	SENT_51	[p2l1951t2831r2148b2882],
29	levels	NNS	O	level	prep_with	25	SENT_51	[p2l55t2915r229b2968],
30	in	IN	O	in	_	0	SENT_51	[p2l255t2915r312b2967],
31	either	CC	O	either	preconj	32	SENT_51	[p2l337t2915r522b2968],
32	normal	JJ	O	normal	prep_in	25	SENT_51	[p2l546t2915r768b2968],
33	or	CC	O	or	_	0	SENT_51	[p2l793t2930r858b2968],
34	tumor	NN	O	tumor	prep_in	25	SENT_51	[p2l880t2923r1075b2968],
35	tissue	NN	O	tissue	nn	37	SENT_51	[p2l1098t2915r1276b2968],
36	(	CD	NUMBER	(	num	37	SENT_51	[p2l1302t2915r1522b2981],
37	Marsh	NNP	PERSON	Marsh	nsubjpass	17	SENT_51	[p2l1302t2915r1522b2981],
38	et	FW	O	et	nn	39	SENT_51	[p2l1548t2923r1606b2968],
39	al.	FW	O	al.	dep	37	SENT_51	[p2l1629t2915r1711b2976],
40	,	,	O	,	_	0	SENT_51	[p2l1629t2915r1711b2976],
41	2004	CD	DATE	2004	num	42	SENT_51	[p2l1737t2915r1934b2981],
42	)	NN	O	)	appos	39	SENT_51	[p2l1737t2915r1934b2981],
43	.	.	O	.	_	0	SENT_51	[p2l1737t2915r1934b2981],

1	732	CD	NUMBER	732	num	3	SENT_52	[p2l367t3057r409b3078],
2	Z.	NNP	PERSON	Z.	nn	3	SENT_52	[p2l1103t3058r1122b3078],
3	Nemoda	NNP	PERSON	Nemoda	_	0	SENT_52	[p2l1133t3056r1229b3078],
4	et	FW	O	et	nn	5	SENT_52	[p2l1239t3059r1261b3078],
5	al.	FW	O	al.	dep	3	SENT_52	[p2l1270t3056r1294b3078],
6	/	:	O	/	punct	3	SENT_52	[p2l1303t3056r1314b3083],
7	Neuropharmacology	NNP	O	Neuropharmacology	dep	3	SENT_52	[p2l1322t3056r1558b3083],
8	57	CD	NUMBER	57	number	9	SENT_52	[p2l1568t3058r1597b3078],
9	(	CD	NUMBER	(	num	10	SENT_52	[p2l1606t3056r1683b3083],
10	2009	CD	DATE	2009	dep	7	SENT_52	[p2l1606t3056r1683b3083],
11	)	CD	NUMBER	)	number	12	SENT_52	[p2l1606t3056r1683b3083],
12	731-733	CD	NUMBER	731-733	num	10	SENT_52	[p2l1695t3057r1793b3078],

1	2	LS	NUMBER	2	_	0	SENT_53	[p2l8t3188r52b3230],
2	.	.	O	.	_	0	SENT_53	[p2l8t3188r52b3230],

1	Methods	NNS	O	method	_	0	SENT_54	[p2l97t3186r330b3230],
2	and	CC	O	and	_	0	SENT_54	[p2l351t3186r451b3230],
3	materials	NNS	O	material	conj_and	1	SENT_54	[p2l472t3186r724b3230],

1	Previously	RB	DATE	previously	advmod	2	SENT_55	[p3l111t58r376b112],
2	published	VBN	O	publish	csubj	50	SENT_55	[p3l395t58r644b112],
3	ADHD	NN	O	adhd	nn	5	SENT_55	[p3l663t60r820b101],
4	patient	NN	O	patient	nn	5	SENT_55	[p3l841t59r1022b112],
5	population	NN	O	population	dobj	2	SENT_55	[p3l1041t58r1318b112],
6	(	CD	NUMBER	(	num	7	SENT_55	[p3l1338t58r1387b112],
7	n	NN	O	n	nsubj	11	SENT_55	[p3l1338t58r1387b112],
8	=	JJ	O	=	amod	7	SENT_55	[p3l1409t80r1447b94],
9	173	CD	NUMBER	173	tmod	8	SENT_55	[p3l1471t60r1567b108],
10	,	,	O	,	_	0	SENT_55	[p3l1471t60r1567b108],
11	mean	VB	O	mean	rcmod	5	SENT_55	[p3l1589t70r1729b101],
12	age	NN	O	age	dobj	11	SENT_55	[p3l1749t70r1850b112],
13	:	:	O	:	_	0	SENT_55	[p3l1749t70r1850b112],
14	9.14	CD	NUMBER	9.14	conj_and	5	SENT_55	[p3l1873t60r1973b102],
15	i	FW	O	i	dep	14	SENT_55	[p3l1993t64r2031b101],
16	2.6	CD	NUMBER	2.6	dep	14	SENT_55	[p3l2052t60r2142b108],
17	;	:	O	;	_	0	SENT_55	[p3l2052t60r2142b108],
18	87.3	CD	PERCENT	87.3	num	19	SENT_55	[p3l9t131r145b173],
19	%	NN	PERCENT	%	conj_and	5	SENT_55	[p3l9t131r145b173],
20	male	NN	O	male	dep	19	SENT_55	[p3l167t129r289b173],
21	and	CC	O	and	_	0	SENT_55	[p3l311t129r404b173],
22	12.7	CD	PERCENT	12.7	num	23	SENT_55	[p3l429t131r565b173],
23	%	NN	PERCENT	%	conj_and	5	SENT_55	[p3l429t131r565b173],
24	female	JJ	O	female	amod	25	SENT_55	[p3l587t129r777b183],
25	)	NN	O	)	nsubjpass	27	SENT_55	[p3l587t129r777b183],
26	was	VBD	O	be	auxpass	27	SENT_55	[p3l798t142r895b173],
27	analyzed	VBN	O	analyze	rcmod	23	SENT_55	[p3l918t129r1142b184],
28	in	IN	O	in	_	0	SENT_55	[p3l1165t130r1212b172],
29	this	DT	O	this	det	30	SENT_55	[p3l1233t129r1325b173],
30	study	NN	O	study	prep_in	27	SENT_55	[p3l1348t129r1496b184],
31	,	,	O	,	_	0	SENT_55	[p3l1348t129r1496b184],
32	122	CD	NUMBER	122	num	33	SENT_55	[p3l1517t131r1604b172],
33	children	NNS	O	child	appos	30	SENT_55	[p3l1628t129r1838b173],
34	(	VBP	O	(	dep	33	SENT_55	[p3l1859t129r2020b183],
35	mean	JJ	O	mean	amod	36	SENT_55	[p3l1859t129r2020b183],
36	age	NN	O	age	dobj	34	SENT_55	[p3l2041t142r2142b184],
37	:	:	O	:	_	0	SENT_55	[p3l2041t142r2142b184],
38	9.6	CD	NUMBER	9.6	dobj	2	SENT_55	[p3l8t202r83b244],
39	i	FW	O	i	dep	38	SENT_55	[p3l100t207r138b243],
40	2.6	CD	NUMBER	2.6	dep	38	SENT_55	[p3l156t202r246b250],
41	;	:	O	;	_	0	SENT_55	[p3l156t202r246b250],
42	88.5	CD	PERCENT	88.5	number	43	SENT_55	[p3l267t202r408b244],
43	%	NN	PERCENT	%	amod	44	SENT_55	[p3l267t202r408b244],
44	male	NN	O	male	conj_and	5	SENT_55	[p3l424t200r547b244],
45	and	CC	O	and	_	0	SENT_55	[p3l564t200r656b244],
46	11.5	CD	PERCENT	11.5	num	47	SENT_55	[p3l676t202r805b244],
47	%	NN	PERCENT	%	conj_and	5	SENT_55	[p3l676t202r805b244],
48	female	JJ	O	female	amod	49	SENT_55	[p3l821t200r1012b254],
49	)	JJ	O	)	amod	47	SENT_55	[p3l821t200r1012b254],
50	participated	VBD	O	participate	_	0	SENT_55	[p3l1030t200r1336b254],
51	in	IN	O	in	_	0	SENT_55	[p3l1354t201r1401b243],
52	a	DT	O	a	det	58	SENT_55	[p3l1417t213r1443b244],
53	prospective	JJ	O	prospective	amod	58	SENT_55	[p3l1460t201r1753b254],
54	MPH	NN	O	mph	nn	58	SENT_55	[p3l1770t203r2146b254],
55	—	NN	O	—	nn	58	SENT_55	[p3l1770t203r2146b254],
56	response	NN	O	response	nn	58	SENT_55	[p3l1770t203r2146b254],
57	analysis	NN	O	analysis	nn	58	SENT_55	[p3l8t271r208b325],
58	(	NN	O	(	prep_in	50	SENT_55	[p3l233t270r325b324],
59	for	IN	O	for	mark	65	SENT_55	[p3l233t270r325b324],
60	detailed	JJ	O	detailed	amod	61	SENT_55	[p3l348t270r552b314],
61	demographic	JJ	O	demographic	nsubj	65	SENT_55	[p3l578t270r915b325],
62	and	CC	O	and	_	0	SENT_55	[p3l938t270r1031b314],
63	clinical	JJ	O	clinical	amod	64	SENT_55	[p3l1056t270r1234b314],
64	characteristics	NNS	O	characteristic	conj_and	61	SENT_55	[p3l1259t271r1624b314],
65	see	VBP	O	see	advcl	50	SENT_55	[p3l1650t283r1730b314],
66	Supplementary	NNP	O	Supplementary	nn	67	SENT_55	[p3l1755t270r2147b325],
67	Table	NNP	O	Table	nsubj	69	SENT_55	[p3l6t342r140b385],
68	1	CD	NUMBER	1	num	69	SENT_55	[p3l163t342r222b396],
69	)	CD	NUMBER	)	xcomp	65	SENT_55	[p3l163t342r222b396],
70	.	.	O	.	_	0	SENT_55	[p3l163t342r222b396],

1	The	DT	O	the	det	2	SENT_56	[p3l241t342r335b385],
2	study	NN	O	study	nsubjpass	4	SENT_56	[p3l357t342r497b396],
3	was	VBD	O	be	auxpass	4	SENT_56	[p3l515t354r613b385],
4	approved	VBN	O	approve	_	0	SENT_56	[p3l634t342r873b396],
5	by	IN	O	by	_	0	SENT_56	[p3l893t342r955b396],
6	the	DT	O	the	det	8	SENT_56	[p3l973t342r1054b385],
7	Local	JJ	ORGANIZATION	local	amod	8	SENT_56	[p3l1075t342r1202b385],
8	Ethics	NNPS	ORGANIZATION	Ethics	agent	4	SENT_56	[p3l1223t342r1373b385],
9	Committee	NNP	ORGANIZATION	Committee	dep	8	SENT_56	[p3l1395t342r1675b385],
10	(	CD	NUMBER	(	num	9	SENT_56	[p3l1697t342r1920b396],
11	TUKEB	NNP	O	TUKEB	dep	8	SENT_56	[p3l1697t342r1920b396],
12	)	CD	NUMBER	)	num	11	SENT_56	[p3l1697t342r1920b396],
13	,	,	O	,	_	0	SENT_56	[p3l1697t342r1920b396],
14	patients	NNS	O	patient	agent	4	SENT_56	[p3l1941t342r2145b396],
15	and	CC	O	and	_	0	SENT_56	[p3l8t413r101b457],
16	their	PRP$	O	they	poss	17	SENT_56	[p3l116t413r238b457],
17	parents	NNS	O	parent	agent	4	SENT_56	[p3l252t419r442b467],
18	provided	VBN	O	provide	partmod	17	SENT_56	[p3l458t413r684b467],
19	written	VBN	O	write	dep	18	SENT_56	[p3l699t414r889b457],
20	informed	VBN	O	inform	amod	21	SENT_56	[p3l904t413r1138b457],
21	consent	NN	O	consent	dobj	19	SENT_56	[p3l1154t419r1354b457],
22	for	IN	O	for	_	0	SENT_56	[p3l1368t413r1439b457],
23	their	PRP$	O	they	poss	24	SENT_56	[p3l1452t413r1574b457],
24	participation	NN	O	participation	prep_for	21	SENT_56	[p3l1588t414r1927b467],
25	.	.	O	.	_	0	SENT_56	[p3l1588t414r1927b467],

1	Patients	NNS	O	patient	nsubjpass	8	SENT_57	[p3l1943t414r2146b457],
2	participating	VBG	O	participate	partmod	1	SENT_57	[p3l9t484r335b538],
3	in	IN	O	in	_	0	SENT_57	[p3l362t484r409b527],
4	the	DT	O	the	det	6	SENT_57	[p3l435t483r516b527],
5	drug-response	JJ	O	drug-response	amod	6	SENT_57	[p3l543t483r913b538],
6	study	NN	O	study	prep_in	2	SENT_57	[p3l940t483r1081b538],
7	were	VBD	O	be	auxpass	8	SENT_57	[p3l1105t496r1231b527],
8	given	VBN	O	give	_	0	SENT_57	[p3l1257t484r1395b538],
9	10-30	CD	NUMBER	10-30	num	11	SENT_57	[p3l1424t486r1576b527],
10	mg	NN	O	mg	nn	11	SENT_57	[p3l1604t496r1683b538],
11	methylphenidate	NN	O	methylphenidate	dobj	8	SENT_57	[p3l1709t483r2145b538],
12	according	VBG	O	accord	_	0	SENT_57	[p3l8t555r257b609],
13	to	TO	O	to	prepc_according_to	8	SENT_57	[p3l278t561r327b598],
14	their	PRP$	O	they	poss	16	SENT_57	[p3l349t555r472b598],
15	body	NN	O	body	nn	16	SENT_57	[p3l492t555r619b609],
16	weight	NN	O	weight	pobj	8	SENT_57	[p3l640t555r828b609],
17	,	,	O	,	_	0	SENT_57	[p3l640t555r828b609],
18	in	IN	O	in	_	0	SENT_57	[p3l853t556r900b598],
19	two	CD	NUMBER	two	num	20	SENT_57	[p3l923t561r1020b598],
20	doses	NNS	O	dose	prep_in	8	SENT_57	[p3l1043t555r1183b598],
21	(	CD	NUMBER	(	num	22	SENT_57	[p3l1206t555r1446b609],
22	morning	NN	TIME	morning	tmod	20	SENT_57	[p3l1206t555r1446b609],
23	and	CC	O	and	_	0	SENT_57	[p3l1469t555r1561b598],
24	noon	NN	TIME	noon	nn	25	SENT_57	[p3l1586t555r1746b609],
25	)	NN	O	)	prep_in	8	SENT_57	[p3l1586t555r1746b609],
26	.	.	O	.	_	0	SENT_57	[p3l1586t555r1746b609],

1	The	DT	O	the	det	3	SENT_58	[p3l1768t555r1861b598],
2	daily	JJ	SET	daily	amod	3	SENT_58	[p3l1885t555r2009b609],
3	dose	NN	O	dose	nsubj	5	SENT_58	[p3l2030t555r2145b598],
4	thereby	RB	O	thereby	advmod	5	SENT_58	[p3l8t626r205b681],
5	ranged	VBD	O	range	_	0	SENT_58	[p3l231t626r405b681],
6	from	IN	O	from	_	0	SENT_58	[p3l434t626r555b670],
7	0.22	CD	NUMBER	0.22	prep_from	5	SENT_58	[p3l582t628r687b670],
8	to	TO	NUMBER	to	_	0	SENT_58	[p3l716t633r765b670],
9	0.95	CD	NUMBER	0.95	num	10	SENT_58	[p3l793t628r897b670],
10	mg/kg/day	NN	O	mg/kg/day	prep_to	5	SENT_58	[p3l927t626r1209b681],
11	,	,	O	,	_	0	SENT_58	[p3l927t626r1209b681],
12	in	IN	O	in	_	0	SENT_58	[p3l1238t627r1285b669],
13	average	JJ	O	average	amod	15	SENT_58	[p3l1312t639r1506b681],
14	0.55	CD	NUMBER	0.55	number	15	SENT_58	[p3l1534t628r1639b670],
15	:1	CD	NUMBER	:1	prep_in	5	SENT_58	[p3l1670t633r1707b669],
16	:	:	O	:	_	0	SENT_58	[p3l1670t633r1707b669],
17	0.15	CD	NUMBER	0.15	num	18	SENT_58	[p3l1736t628r1834b670],
18	mg/kg/day	NN	O	mg/kg/day	dep	15	SENT_58	[p3l1863t626r2145b681],
19	.	.	O	.	_	0	SENT_58	[p3l1863t626r2145b681],

1	Categorization	NN	O	categorization	nsubj	6	SENT_59	[p3l9t697r378b751],
2	of	IN	O	of	_	0	SENT_59	[p3l403t696r456b740],
3	the	DT	O	the	det	5	SENT_59	[p3l476t697r556b740],
4	non-responder	JJ	O	non-responder	amod	5	SENT_59	[p3l583t696r966b751],
5	children	NNS	O	child	prep_of	1	SENT_59	[p3l989t696r1199b740],
6	(	VBP	O	(	dep	19	SENT_59	[p3l1225t697r1273b751],
7	n	NN	O	n	dobj	6	SENT_59	[p3l1225t697r1273b751],
8	=	JJ	O	=	amod	10	SENT_59	[p3l1300t719r1338b732],
9	32	CD	NUMBER	32	num	10	SENT_59	[p3l1364t697r1446b750],
10	)	NN	O	)	nsubjpass	12	SENT_59	[p3l1364t697r1446b750],
11	was	VBD	O	be	auxpass	12	SENT_59	[p3l1471t709r1569b740],
12	done	VBN	O	do	rcmod	7	SENT_59	[p3l1595t696r1720b740],
13	during	IN	O	during	_	0	SENT_59	[p3l1747t696r1915b751],
14	the	DT	O	the	det	15	SENT_59	[p3l1940t696r2020b740],
15	ﬁrst	NN	O	ﬁrst	prep_during	12	SENT_59	[p3l2046t696r2147b740],
16	three	CD	DURATION	three	num	17	SENT_59	[p3l8t768r141b812],
17	months	NNS	NUMBER	month	tmod	15	SENT_59	[p3l174t768r367b812],
18	(	RB	O	(	advmod	19	SENT_59	[p3l401t768r501b822],
19	see	VBP	O	see	_	0	SENT_59	[p3l401t768r501b822],
20	Kereszturi	NNP	PERSON	Kereszturi	dobj	19	SENT_59	[p3l534t769r793b812],
21	et	FW	O	et	nn	22	SENT_59	[p3l826t775r874b812],
22	al.	FW	O	al.	nsubj	19	SENT_59	[p3l905t768r972b818],
23	,	,	O	,	_	0	SENT_59	[p3l905t768r972b818],
24	2008	CD	DATE	2008	appos	22	SENT_59	[p3l1007t770r1132b812],
25	for	IN	O	for	_	0	SENT_59	[p3l1167t768r1238b812],
26	details	NNS	O	detail	prep_for	24	SENT_59	[p3l1269t768r1468b822],
27	)	CD	NUMBER	)	dep	24	SENT_59	[p3l1269t768r1468b822],
28	.	.	O	.	_	0	SENT_59	[p3l1269t768r1468b822],

1	Drug	NN	O	drug	nn	2	SENT_60	[p3l1502t771r1626b823],
2	response	NN	O	response	nsubjpass	5	SENT_60	[p3l1659t781r1884b823],
3	was	VBD	O	be	auxpass	5	SENT_60	[p3l1916t781r2015b812],
4	also	RB	O	also	advmod	5	SENT_60	[p3l2048t768r2146b812],
5	assessed	VBN	O	assess	_	0	SENT_60	[p3l8t839r224b882],
6	by	IN	O	by	_	0	SENT_60	[p3l242t839r303b893],
7	dimensional	JJ	O	dimensional	amod	8	SENT_60	[p3l319t839r633b882],
8	approach	NN	O	approach	agent	5	SENT_60	[p3l650t839r887b893],
9	using	VBG	O	use	xcomp	5	SENT_60	[p3l904t839r1041b893],
10	the	DT	O	the	det	15	SENT_60	[p3l1057t839r1138b882],
11	ADHD	NNP	MISC	ADHD	nn	15	SENT_60	[p3l1153t841r1311b882],
12	Rating	NNP	MISC	Rating	nn	15	SENT_60	[p3l1329t839r1491b893],
13	Scale	NNP	MISC	Scale	nn	15	SENT_60	[p3l1508t839r1635b882],
14	(	CD	NUMBER	(	num	15	SENT_60	[p3l1652t839r1931b893],
15	ADHD-RS	NN	O	adhd-r	dobj	9	SENT_60	[p3l1652t839r1931b893],
16	;	:	O	;	_	0	SENT_60	[p3l1652t839r1931b893],
17	DuPaul	NNP	O	DuPaul	nsubj	28	SENT_60	[p3l1953t839r2145b889],
18	,	,	O	,	_	0	SENT_60	[p3l1953t839r2145b889],
19	1998	CD	DATE	1998	num	21	SENT_60	[p3l11t910r151b964],
20	)	CD	NUMBER	)	num	21	SENT_60	[p3l11t910r151b964],
21	Inattention	NN	O	inattention	nsubj	28	SENT_60	[p3l169t911r453b954],
22	and	CC	O	and	_	0	SENT_60	[p3l470t910r563b954],
23	Hyperactivity	NN	O	hyperactivity	nn	25	SENT_60	[p3l582t910r1251b964],
24	—	NN	O	—	nn	25	SENT_60	[p3l582t910r1251b964],
25	lmpulsivity	NN	O	lmpulsivity	nsubj	28	SENT_60	[p3l582t910r1251b964],
26	severity	NN	O	severity	nn	27	SENT_60	[p3l1267t911r1469b964],
27	scores	NNS	O	score	dep	25	SENT_60	[p3l1485t923r1640b954],
28	(	VBP	O	(	parataxis	5	SENT_60	[p3l1658t910r1770b964],
29	0-3	CD	NUMBER	0-3	num	30	SENT_60	[p3l1658t910r1770b964],
30	points	NNS	O	point	dobj	28	SENT_60	[p3l1790t911r1946b964],
31	for	IN	O	for	_	0	SENT_60	[p3l1965t910r2036b954],
32	9-9	CD	NUMBER	9-9	num	33	SENT_60	[p3l2052t912r2145b954],
33	items	NNS	O	item	prep_for	30	SENT_60	[p3l9t981r181b1034],
34	)	CD	NUMBER	)	dep	33	SENT_60	[p3l9t981r181b1034],
35	.	.	O	.	_	0	SENT_60	[p3l9t981r181b1034],

1	Analysis	NN	O	analysis	nsubjpass	17	SENT_61	[p3l196t980r406b1035],
2	of	IN	O	of	_	0	SENT_61	[p3l423t980r476b1024],
3	variance	NN	O	variance	prep_of	1	SENT_61	[p3l485t981r699b1024],
4	investigating	VBG	O	investigate	partmod	3	SENT_61	[p3l717t981r1046b1035],
5	the	DT	O	the	det	6	SENT_61	[p3l1062t980r1142b1024],
6	effect	NN	O	effect	dobj	4	SENT_61	[p3l1160t980r1300b1024],
7	of	IN	O	of	_	0	SENT_61	[p3l1315t980r1368b1024],
8	MPH	NN	O	mph	prep_of	6	SENT_61	[p3l1379t983r1500b1024],
9	on	IN	O	on	_	0	SENT_61	[p3l1518t993r1580b1024],
10	ADHD-RS	NN	O	adhd-r	nn	11	SENT_61	[p3l1595t982r1839b1024],
11	scores	NNS	O	score	prep_on	8	SENT_61	[p3l1857t993r2012b1024],
12	after	IN	O	after	_	0	SENT_61	[p3l2029t980r2147b1024],
13	the	DT	DATE	the	det	15	SENT_61	[p3l8t1052r89b1095],
14	ﬁrst	JJ	DATE	ﬁrst	amod	15	SENT_61	[p3l105t1052r206b1095],
15	month	NN	DATE	month	prep_after	4	SENT_61	[p3l221t1052r389b1095],
16	was	VBD	O	be	auxpass	17	SENT_61	[p3l404t1064r501b1095],
17	carried	VBN	O	carry	_	0	SENT_61	[p3l518t1052r694b1095],
18	out	RP	O	out	prt	17	SENT_61	[p3l711t1058r795b1095],
19	in	IN	O	in	_	0	SENT_61	[p3l809t1053r856b1095],
20	a	DT	O	a	det	23	SENT_61	[p3l872t1064r898b1095],
21	repeated	VBN	O	repeat	amod	23	SENT_61	[p3l913t1052r1135b1106],
22	measures	NNS	O	measure	nn	23	SENT_61	[p3l1152t1064r1393b1095],
23	design	NN	O	design	prep_in	17	SENT_61	[p3l1409t1052r1574b1106],
24	including	VBG	O	include	_	0	SENT_61	[p3l1591t1052r1830b1106],
25	genotype	NN	O	genotype	prep_including	23	SENT_61	[p3l1844t1058r2079b1106],
26	as	IN	O	as	_	0	SENT_61	[p3l2095t1064r2145b1095],
27	a	DT	O	a	det	29	SENT_61	[p3l8t1136r34b1167],
28	between-subject	JJ	O	between-subject	amod	29	SENT_61	[p3l54t1123r482b1177],
29	factor	NN	O	factor	prep_as	25	SENT_61	[p3l502t1123r656b1167],
30	.	.	O	.	_	0	SENT_61	[p3l502t1123r656b1167],

1	Genotyping	NN	O	genotyping	nsubjpass	11	SENT_62	[p3l110t1194r408b1248],
2	of	IN	O	of	_	0	SENT_62	[p3l424t1193r477b1237],
3	the	DT	O	the	det	5	SENT_62	[p3l489t1194r570b1237],
4	CES1	NN	O	ces1	nn	5	SENT_62	[p3l588t1196r705b1237],
5	Gly143Glu	NN	O	gly143glu	prep_of	1	SENT_62	[p3l729t1194r995b1248],
6	SNP	NN	O	snp	nn	9	SENT_62	[p3l1013t1196r1112b1237],
7	(	CD	NUMBER	(	num	9	SENT_62	[p3l1130t1193r1465b1248],
8	rs71647871	NN	O	rs71647871	nn	9	SENT_62	[p3l1130t1193r1465b1248],
9	)	NN	O	)	dep	5	SENT_62	[p3l1130t1193r1465b1248],
10	was	VBD	O	be	auxpass	11	SENT_62	[p3l1482t1206r1579b1237],
11	done	VBN	O	do	dep	18	SENT_62	[p3l1598t1193r1723b1237],
12	using	VBG	O	use	xcomp	11	SENT_62	[p3l1741t1194r1878b1248],
13	published	VBN	O	publish	amod	14	SENT_62	[p3l1895t1193r2145b1248],
14	primers	NNS	O	primer	dobj	12	SENT_62	[p3l9t1266r206b1320],
15	and	CC	O	and	_	0	SENT_62	[p3l238t1265r331b1309],
16	TaqMan	NN	O	taqman	nn	17	SENT_62	[p3l360t1268r564b1320],
17	probes	NNS	O	probe	dobj	12	SENT_62	[p3l594t1265r764b1320],
18	(	VBP	O	(	_	0	SENT_62	[p3l796t1265r913b1319],
19	Zhu	NNP	PERSON	Zhu	nsubj	21	SENT_62	[p3l796t1265r913b1319],
20	et	FW	O	et	nn	21	SENT_62	[p3l944t1272r992b1309],
21	al.	FW	O	al.	xcomp	18	SENT_62	[p3l1021t1265r1088b1315],
22	,	,	O	,	_	0	SENT_62	[p3l1021t1265r1088b1315],
23	2008	CD	DATE	2008	num	24	SENT_62	[p3l1120t1265r1268b1319],
24	)	NN	O	)	appos	21	SENT_62	[p3l1120t1265r1268b1319],
25	on	IN	O	on	_	0	SENT_62	[p3l1300t1278r1362b1309],
26	7300	CD	NUMBER	7300	num	28	SENT_62	[p3l1395t1267r1520b1309],
27	Real-Time	NNP	MISC	Real-Time	nn	28	SENT_62	[p3l1552t1265r1805b1309],
28	PCR	NN	MISC	pcr	prep_on	24	SENT_62	[p3l1836t1267r1935b1309],
29	System	NNP	MISC	System	nn	32	SENT_62	[p3l1964t1267r2146b1320],
30	(	NNP	O	(	nn	32	SENT_62	[p3l9t1336r225b1390],
31	Applied	NNP	MISC	Applied	nn	32	SENT_62	[p3l9t1336r225b1390],
32	BioSystem	NNP	MISC	BioSystem	nsubj	18	SENT_62	[p3l242t1336r518b1390],
33	,	,	O	,	_	0	SENT_62	[p3l242t1336r518b1390],
34	Foster	NNP	LOCATION	Foster	nn	35	SENT_62	[p3l535t1338r689b1379],
35	City	NNP	LOCATION	City	appos	32	SENT_62	[p3l704t1336r811b1390],
36	,	,	O	,	_	0	SENT_62	[p3l704t1336r811b1390],
37	USA	NNP	LOCATION	USA	appos	35	SENT_62	[p3l827t1336r964b1390],
38	)	CD	NUMBER	)	num	37	SENT_62	[p3l827t1336r964b1390],
39	.	.	O	.	_	0	SENT_62	[p3l827t1336r964b1390],

1	The	DT	O	the	det	2	SENT_63	[p3l977t1336r1071b1379],
2	accuracy	NN	O	accuracy	nsubjpass	7	SENT_63	[p3l1087t1348r1309b1390],
3	of	IN	O	of	_	0	SENT_63	[p3l1323t1335r1375b1379],
4	the	DT	O	the	det	5	SENT_63	[p3l1385t1336r1466b1379],
5	method	NN	O	method	prep_of	2	SENT_63	[p3l1483t1336r1680b1379],
6	was	VBD	O	be	auxpass	7	SENT_63	[p3l1695t1348r1793b1379],
7	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_63	[p3l1809t1335r2070b1379],
8	by	IN	O	by	_	0	SENT_63	[p3l2086t1336r2148b1390],
9	sequencing	NN	O	sequencing	agent	7	SENT_63	[p3l9t1408r297b1461],
10	6	CD	NUMBER	6	num	9	SENT_63	[p3l320t1409r348b1451],
11	selected	VBN	O	select	amod	12	SENT_63	[p3l373t1407r578b1451],
12	samples	NNS	O	sample	nsubj	13	SENT_63	[p3l602t1407r807b1461],
13	(	VBP	O	(	rcmod	9	SENT_63	[p3l831t1407r881b1461],
14	4	CD	NUMBER	4	num	15	SENT_63	[p3l831t1407r881b1461],
15	heterozygotes	NNS	O	heterozygote	dobj	13	SENT_63	[p3l905t1407r1261b1461],
16	and	CC	O	and	_	0	SENT_63	[p3l1284t1407r1377b1451],
17	2	CD	NUMBER	2	num	18	SENT_63	[p3l1401t1409r1429b1450],
18	homozygotes	NNS	O	homozygote	conj_and	15	SENT_63	[p3l1454t1407r1826b1461],
19	)	CD	NUMBER	)	dep	18	SENT_63	[p3l1454t1407r1826b1461],
20	.	.	O	.	_	0	SENT_63	[p3l1454t1407r1826b1461],

1	In	IN	O	in	_	0	SENT_64	[p3l1850t1410r1897b1450],
2	addition	NN	O	addition	prep_in	8	SENT_64	[p3l1921t1407r2145b1457],
3	,	,	O	,	_	0	SENT_64	[p3l1921t1407r2145b1457],
4	the	DT	O	the	det	6	SENT_64	[p3l8t1478r89b1522],
5	ADHD	NN	O	adhd	nn	6	SENT_64	[p3l117t1480r274b1521],
6	samples	NNS	O	sample	nsubjpass	8	SENT_64	[p3l305t1478r510b1533],
7	were	VBD	O	be	auxpass	8	SENT_64	[p3l539t1491r665b1522],
8	checked	VBN	O	check	_	0	SENT_64	[p3l696t1478r901b1522],
9	by	IN	O	by	_	0	SENT_64	[p3l932t1478r993b1533],
10	Alul	NNP	PERSON	Alul	nn	11	SENT_64	[p3l1019t1478r1122b1522],
11	digestion	NN	O	digestion	agent	8	SENT_64	[p3l1152t1478r1386b1533],
12	(	CD	NUMBER	(	num	15	SENT_64	[p3l1415t1478r1681b1532],
13	Glu	NNP	O	Glu	nn	15	SENT_64	[p3l1415t1478r1681b1532],
14	—	CD	NUMBER	—	num	15	SENT_64	[p3l1415t1478r1681b1532],
15	allele	NN	O	allele	nsubj	16	SENT_64	[p3l1415t1478r1681b1532],
16	creates	VBZ	O	create	rcmod	11	SENT_64	[p3l1712t1485r1889b1522],
17	an	DT	O	a	det	20	SENT_64	[p3l1919t1491r1979b1522],
18	AGCT	NN	MISC	agct	nn	20	SENT_64	[p3l2006t1480r2147b1522],
19	restriction	NN	O	restriction	nn	20	SENT_64	[p3l9t1549r271b1592],
20	site	NN	O	site	dobj	16	SENT_64	[p3l297t1549r417b1603],
21	)	CD	NUMBER	)	num	20	SENT_64	[p3l297t1549r417b1603],
22	.	.	O	.	_	0	SENT_64	[p3l297t1549r417b1603],

1	The	DT	O	the	det	3	SENT_65	[p3l440t1549r533b1592],
2	PCR	NN	O	pcr	nn	3	SENT_65	[p3l560t1551r658b1592],
3	reaction	NN	O	reaction	nsubjpass	5	SENT_65	[p3l682t1549r888b1592],
4	was	VBD	O	be	auxpass	5	SENT_65	[p3l910t1561r1008b1592],
5	carried	VBN	O	carry	_	0	SENT_65	[p3l1035t1549r1211b1592],
6	out	RP	O	out	prt	5	SENT_65	[p3l1238t1555r1321b1592],
7	with	IN	O	with	_	0	SENT_65	[p3l1344t1549r1462b1592],
8	5	CD	NUMBER	5	number	9	SENT_65	[p3l1488t1549r2145b1592, p3l9t1620r175b1663],
9	’	CD	NUMBER	’	num	11	SENT_65	[p3l1488t1549r2145b1592, p3l9t1620r175b1663],
10	CCCAGGTGATGGTGTGGAT-3	NN	O	cccaggtgatggtgtggat-3	nn	11	SENT_65	[p3l1488t1549r2145b1592, p3l9t1620r175b1663],
11	’	NN	O	’	prep_with	5	SENT_65	[p3l1488t1549r2145b1592, p3l9t1620r175b1663],
12	forward	RB	O	forward	advmod	11	SENT_65	[p3l217t1620r418b1663],
13	and	CC	O	and	_	0	SENT_65	[p3l457t1620r550b1663],
14	5	CD	NUMBER	5	num	15	SENT_65	[p3l590t1620r1594b1663],
15	’	NN	O	’	prep_with	5	SENT_65	[p3l590t1620r1594b1663],
16	.	.	O	.	_	0	SENT_65	[p3l590t1620r1594b1663],

1	—	NN	O	—	_	0	SENT_66	[p3l590t1620r1594b1663],
2	.	.	O	.	_	0	SENT_66	[p3l590t1620r1594b1663],

1	GCCTTACTGTGGAACCTAGCTAAGG3	NN	O	gccttactgtggaacctagctaagg3	nsubjpass	16	SENT_67	[p3l590t1620r1594b1663],
2	’	CD	NUMBER	’	num	1	SENT_67	[p3l590t1620r1594b1663],
3	reverse	NN	O	reverse	nn	4	SENT_67	[p3l1637t1632r1821b1663],
4	primers	NNS	O	primer	nsubj	6	SENT_67	[p3l1860t1620r2058b1674],
5	to	TO	O	to	aux	6	SENT_67	[p3l2097t1626r2146b1663],
6	include	VB	O	include	infmod	1	SENT_67	[p3l9t1691r195b1735],
7	a	DT	O	a	det	10	SENT_67	[p3l218t1704r244b1735],
8	control	NN	O	control	nn	10	SENT_67	[p3l267t1691r447b1735],
9	restriction	NN	O	restriction	nn	10	SENT_67	[p3l470t1692r733b1735],
10	site	NN	O	site	nsubj	14	SENT_67	[p3l756t1692r843b1735],
11	(	CD	NUMBER	(	number	12	SENT_67	[p3l866t1691r937b1745],
12	51	CD	NUMBER	51	num	14	SENT_67	[p3l866t1691r937b1745],
13	bp	NN	O	bp	nn	14	SENT_67	[p3l967t1691r1029b1745],
14	fragment	NN	O	fragment	xcomp	6	SENT_67	[p3l1053t1691r1287b1745],
15	is	VBZ	O	be	auxpass	16	SENT_67	[p3l1309t1692r1346b1735],
16	cleaved	VBN	O	cleave	_	0	SENT_67	[p3l1369t1691r1558b1735],
17	from	IN	O	from	_	0	SENT_67	[p3l1582t1691r1704b1735],
18	the	DT	O	the	det	21	SENT_67	[p3l1725t1691r1806b1735],
19	251	CD	NUMBER	251	num	21	SENT_67	[p3l1829t1693r1913b1735],
20	bp	NN	O	bp	nn	21	SENT_67	[p3l1942t1691r2004b1745],
21	PCRfragment	NN	O	pcrfragment	prep_from	16	SENT_67	[p3l2028t1693r2145b1735, p3l9t1761r243b1816],
22	at	IN	O	at	_	0	SENT_67	[p3l264t1768r311b1805],
23	every	DT	O	every	det	25	SENT_67	[p3l332t1774r473b1816],
24	sample	NN	O	sample	nn	25	SENT_67	[p3l494t1762r707b1816],
25	)	NN	O	)	prep_at	16	SENT_67	[p3l494t1762r707b1816],
26	.	.	O	.	_	0	SENT_67	[p3l494t1762r707b1816],

1	The	DT	O	the	det	4	SENT_68	[p3l728t1761r822b1805],
2	Glu	NNP	O	Glu	nn	4	SENT_68	[p3l845t1761r1090b1805],
3	—	CD	NUMBER	—	num	4	SENT_68	[p3l845t1761r1090b1805],
4	allele	NN	O	allele	nsubjpass	10	SENT_68	[p3l845t1761r1090b1805],
5	speciﬁc	NN	O	speciﬁc	nn	8	SENT_68	[p3l1114t1761r1303b1816],
6	168	CD	NUMBER	168	num	8	SENT_68	[p3l1327t1764r1413b1805],
7	bp	NN	O	bp	nn	8	SENT_68	[p3l1438t1761r1500b1816],
8	fragment	NN	O	fragment	dep	4	SENT_68	[p3l1523t1761r1757b1816],
9	was	VBD	O	be	auxpass	10	SENT_68	[p3l1777t1774r1876b1805],
10	separated	VBN	O	separate	_	0	SENT_68	[p3l1899t1761r2145b1816],
11	from	IN	O	from	_	0	SENT_68	[p3l9t1833r130b1877],
12	the	DT	O	the	det	18	SENT_68	[p3l149t1833r230b1877],
13	Gly	JJ	O	gly	amod	18	SENT_68	[p3l251t1833r548b1888],
14	—	NN	O	—	nn	18	SENT_68	[p3l251t1833r548b1888],
15	speciﬁc	NN	O	speciﬁc	nn	18	SENT_68	[p3l251t1833r548b1888],
16	200	CD	NUMBER	200	num	18	SENT_68	[p3l568t1835r663b1877],
17	bp	NN	O	bp	nn	18	SENT_68	[p3l683t1833r746b1888],
18	fragment	NN	O	fragment	prep_from	10	SENT_68	[p3l767t1833r1001b1888],
19	by	IN	O	by	_	0	SENT_68	[p3l1019t1833r1080b1888],
20	2.5	CD	PERCENT	2.5	num	21	SENT_68	[p3l1099t1835r1209b1877],
21	%	NN	PERCENT	%	prep_by	18	SENT_68	[p3l1099t1835r1209b1877],
22	agarose	NN	O	agarose	nn	24	SENT_68	[p3l1228t1846r1421b1888],
23	gel	NN	O	gel	nn	24	SENT_68	[p3l1441t1833r1515b1888],
24	electrophoresis	NN	O	electrophoresis	dep	21	SENT_68	[p3l1535t1833r1937b1888],
25	.	.	O	.	_	0	SENT_68	[p3l1535t1833r1937b1888],

1	For	IN	O	for	_	0	SENT_69	[p3l111t1906r192b1947],
2	comparison	NN	O	comparison	nn	3	SENT_69	[p3l231t1904r530b1958],
3	reasons	NNS	O	reason	prep_for	15	SENT_69	[p3l573t1916r778b1954],
4	,	,	O	,	_	0	SENT_69	[p3l573t1916r778b1954],
5	allele	NN	O	allele	nn	8	SENT_69	[p3l820t1904r954b1947],
6	and	CC	O	and	_	0	SENT_69	[p3l997t1904r1090b1947],
7	genotype	NN	O	genotype	nn	8	SENT_69	[p3l1132t1910r1367b1958],
8	frequencies	NNS	O	frequency	nsubjpass	15	SENT_69	[p3l1411t1904r1702b1958],
9	of	IN	O	of	_	0	SENT_69	[p3l1746t1904r1799b1947],
10	the	DT	O	the	det	13	SENT_69	[p3l1835t1904r1916b1947],
11	general	JJ	O	general	amod	13	SENT_69	[p3l1958t1904r2145b1958],
12	Hungarian	JJ	MISC	hungarian	amod	13	SENT_69	[p3l9t1976r276b2029],
13	population	NN	O	population	prep_of	8	SENT_69	[p3l292t1975r570b2029],
14	were	VBD	O	be	auxpass	15	SENT_69	[p3l583t1988r709b2019],
15	assessed	VBN	O	assess	_	0	SENT_69	[p3l727t1975r943b2019],
16	by	IN	O	by	_	0	SENT_69	[p3l960t1975r1021b2029],
17	genotyping	VBG	O	genotype	agent	15	SENT_69	[p3l1034t1976r1323b2029],
18	268	CD	NUMBER	268	num	20	SENT_69	[p3l1339t1977r1432b2019],
19	control	JJ	O	control	amod	20	SENT_69	[p3l1451t1975r1631b2019],
20	subjects	NNS	O	subject	nsubj	25	SENT_69	[p3l1648t1975r1852b2029],
21	(	JJ	O	(	amod	23	SENT_69	[p3l1870t1975r2147b2029],
22	university	NN	O	university	nn	23	SENT_69	[p3l1870t1975r2147b2029],
23	students	NNS	O	student	dep	20	SENT_69	[p3l9t2046r238b2096],
24	,	,	O	,	_	0	SENT_69	[p3l9t2046r238b2096],
25	mean	VB	O	mean	ccomp	17	SENT_69	[p3l270t2059r410b2090],
26	age	NN	O	age	dobj	25	SENT_69	[p3l441t2059r541b2101],
27	:	:	O	:	_	0	SENT_69	[p3l441t2059r541b2101],
28	20.51	CD	NUMBER	20.51	dep	26	SENT_69	[p3l575t2048r704b2090],
29	:	:	O	:	_	0	SENT_69	[p3l742t2053r780b2089],
30	l	NN	O	l	dep	26	SENT_69	[p3l742t2053r780b2089],
31	:	:	O	:	_	0	SENT_69	[p3l742t2053r780b2089],
32	1.83	CD	NUMBER	1.83	dep	26	SENT_69	[p3l808t2048r919b2096],
33	,	,	O	,	_	0	SENT_69	[p3l808t2048r919b2096],
34	50.4	CD	PERCENT	50.4	num	36	SENT_69	[p3l951t2048r1092b2090],
35	%	NN	PERCENT	%	nn	36	SENT_69	[p3l951t2048r1092b2090],
36	male	NN	O	male	appos	26	SENT_69	[p3l1123t2046r1258b2096],
37	,	,	O	,	_	0	SENT_69	[p3l1123t2046r1258b2096],
38	49.6	CD	PERCENT	49.6	num	39	SENT_69	[p3l1288t2048r1431b2090],
39	%	NN	PERCENT	%	npadvmod	40	SENT_69	[p3l1288t2048r1431b2090],
40	female	JJ	O	female	amod	41	SENT_69	[p3l1462t2046r1665b2100],
41	)	NN	O	)	appos	26	SENT_69	[p3l1462t2046r1665b2100],
42	.	.	O	.	_	0	SENT_69	[p3l1462t2046r1665b2100],

1	Both	DT	O	both	preconj	5	SENT_70	[p3l1696t2046r1812b2090],
2	control	NN	O	control	nn	5	SENT_70	[p3l1843t2046r2022b2090],
3	and	CC	O	and	_	0	SENT_70	[p3l2053t2046r2145b2090],
4	patient	NN	O	patient	nn	5	SENT_70	[p3l9t2117r190b2171],
5	samples	NNS	O	sample	nsubj	6	SENT_70	[p3l226t2117r431b2171],
6	consisted	VBD	O	consist	_	0	SENT_70	[p3l468t2117r706b2160],
7	of	IN	O	of	_	0	SENT_70	[p3l743t2116r796b2160],
8	unrelated	JJ	O	unrelated	amod	9	SENT_70	[p3l826t2117r1071b2160],
9	individuals	NNS	O	individual	prep_of	6	SENT_70	[p3l1108t2117r1388b2160],
10	of	IN	O	of	_	0	SENT_70	[p3l1425t2117r1478b2160],
11	Caucasian	JJ	MISC	caucasian	amod	12	SENT_70	[p3l1508t2117r1760b2160],
12	origin	NN	O	origin	prep_of	9	SENT_70	[p3l1797t2117r1958b2171],
13	,	,	O	,	_	0	SENT_70	[p3l1797t2117r1958b2171],
14	hence	RB	O	hence	advmod	15	SENT_70	[p3l1996t2117r2145b2160],
15	creating	VBG	O	create	ccomp	6	SENT_70	[p3l9t2189r215b2242],
16	ethnically	RB	O	ethnically	advmod	17	SENT_70	[p3l246t2188r498b2242],
17	homogenous	JJ	O	homogenous	amod	18	SENT_70	[p3l530t2188r859b2242],
18	populations	NNS	O	population	dobj	15	SENT_70	[p3l892t2188r1206b2242],
19	.	.	O	.	_	0	SENT_70	[p3l892t2188r1206b2242],

1	No	DT	O	no	det	3	SENT_71	[p3l1241t2191r1309b2232],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_71	[p3l1343t2188r1608b2242],
3	deviation	NN	O	deviation	_	0	SENT_71	[p3l1640t2188r1878b2232],
4	from	IN	O	from	_	0	SENT_71	[p3l1911t2188r2032b2232],
5	the	DT	O	the	det	6	SENT_71	[p3l2065t2188r2145b2232],
6	Hardy	NNP	PERSON	Hardy	prep_from	3	SENT_71	[p3l9t2258r447b2313],
7	.	.	O	.	_	0	SENT_71	[p3l9t2258r447b2313],

1	—	NN	O	—	_	0	SENT_72	[p3l9t2258r447b2313],
2	.	.	O	.	_	0	SENT_72	[p3l9t2258r447b2313],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_73	[p3l9t2258r447b2313],
2	equilibrium	NN	O	equilibrium	nsubjpass	4	SENT_73	[p3l462t2258r760b2313],
3	was	VBD	O	be	auxpass	4	SENT_73	[p3l773t2271r871b2302],
4	detected	VBN	O	detect	_	0	SENT_73	[p3l888t2258r1106b2302],
5	(	NN	O	(	nn	6	SENT_73	[p3l1122t2259r1170b2313],
6	p	NN	O	p	dobj	4	SENT_73	[p3l1122t2259r1170b2313],
7	=	JJ	O	=	amod	6	SENT_73	[p3l1188t2281r1226b2294],
8	0.695	CD	NUMBER	0.695	tmod	7	SENT_73	[p3l1243t2261r1380b2302],
9	in	IN	O	in	_	0	SENT_73	[p3l1399t2259r1446b2302],
10	the	DT	O	the	det	12	SENT_73	[p3l1461t2258r1542b2302],
11	ADHD	NNP	O	ADHD	nn	12	SENT_73	[p3l1556t2260r1713b2302],
12	group	NN	O	group	prep_in	4	SENT_73	[p3l1729t2271r1891b2313],
13	,	,	O	,	_	0	SENT_73	[p3l1729t2271r1891b2313],
14	p	NN	O	p	dobj	4	SENT_73	[p3l1904t2271r1935b2313],
15	=	JJ	O	=	amod	14	SENT_73	[p3l1953t2281r1991b2294],
16	0.732	CD	NUMBER	0.732	tmod	15	SENT_73	[p3l2008t2261r2144b2302],
17	in	IN	O	in	_	0	SENT_73	[p3l9t2331r56b2373],
18	the	DT	O	the	det	20	SENT_73	[p3l90t2330r171b2373],
19	control	NN	O	control	nn	20	SENT_73	[p3l206t2330r386b2373],
20	group	NN	O	group	prep_in	4	SENT_73	[p3l420t2330r603b2384],
21	)	CD	NUMBER	)	dep	20	SENT_73	[p3l420t2330r603b2384],
22	.	.	O	.	_	0	SENT_73	[p3l420t2330r603b2384],

1	Since	IN	O	since	mark	3	SENT_74	[p3l639t2331r771b2373],
2	there	EX	O	there	expl	3	SENT_74	[p3l806t2330r939b2373],
3	was	VBD	O	be	advcl	13	SENT_74	[p3l972t2342r1069b2373],
4	no	DT	O	no	det	7	SENT_74	[p3l1106t2342r1168b2373],
5	Glu/Glu	NN	O	glu/glu	nn	7	SENT_74	[p3l1203t2330r1398b2384],
6	homozygote	NN	O	homozygote	nn	7	SENT_74	[p3l1433t2330r1747b2384],
7	genotype	NN	O	genotype	nsubj	3	SENT_74	[p3l1781t2336r2029b2384],
8	,	,	O	,	_	0	SENT_74	[p3l1781t2336r2029b2384],
9	the	DT	O	the	det	11	SENT_74	[p3l2065t2330r2145b2373],
10	chi-square	NN	O	chi-square	nn	11	SENT_74	[p3l9t2401r276b2455],
11	analyses	NNS	O	analysis	nsubjpass	13	SENT_74	[p3l296t2401r509b2455],
12	were	VBD	O	be	auxpass	13	SENT_74	[p3l528t2413r655b2444],
13	computed	VBN	O	compute	_	0	SENT_74	[p3l676t2401r932b2455],
14	for	IN	O	for	_	0	SENT_74	[p3l953t2401r1024b2444],
15	a	DT	O	a	det	17	SENT_74	[p3l1042t2413r1068b2444],
16	2	CD	NUMBER	2	num	17	SENT_74	[p3l1088t2403r1115b2444],
17	x	NN	O	x	prep_for	13	SENT_74	[p3l1144t2417r1171b2443],
18	2	CD	NUMBER	2	num	19	SENT_74	[p3l1198t2403r1225b2444],
19	table	NN	O	table	dep	17	SENT_74	[p3l1247t2401r1384b2445],
20	.	.	O	.	_	0	SENT_74	[p3l1247t2401r1384b2445],

1	3	LS	NUMBER	3	_	0	SENT_75	[p3l7t2610r63b2662],
2	.	.	O	.	_	0	SENT_75	[p3l7t2610r63b2662],

1	Results	NNS	O	result	_	0	SENT_76	[p3l109t2607r347b2661],

1	A	DT	O	a	det	4	SENT_77	[p3l108t2787r156b2839],
2	control	NN	O	control	nn	4	SENT_77	[p3l182t2784r406b2839],
3	Hungarian	JJ	MISC	hungarian	amod	4	SENT_77	[p3l437t2785r771b2853],
4	sample	NN	O	sample	nsubjpass	6	SENT_77	[p3l801t2784r1027b2853],
5	was	VBD	O	be	auxpass	6	SENT_77	[p3l1055t2800r1177b2839],
6	genotyped	VBN	O	genotype	_	0	SENT_77	[p3l1206t2784r1542b2853],
7	in	IN	O	in	_	0	SENT_77	[p3l1573t2785r1631b2839],
8	addition	NN	O	addition	prep_in	6	SENT_77	[p3l1661t2784r1926b2839],
9	to	TO	O	to	_	0	SENT_77	[p3l1955t2792r2016b2839],
10	the	DT	O	the	det	12	SENT_77	[p3l2044t2784r2145b2839],
11	ADHD	NN	O	adhd	nn	12	SENT_77	[p3l6t2876r203b2928],
12	sample	NN	O	sample	prep_to	6	SENT_77	[p3l235t2873r460b2942],
13	to	TO	O	to	aux	14	SENT_77	[p3l491t2882r552b2928],
14	compare	VB	O	compare	xcomp	6	SENT_77	[p3l583t2889r858b2942],
15	allele	NN	O	allele	nn	18	SENT_77	[p3l889t2873r1055b2928],
16	and	CC	O	and	_	0	SENT_77	[p3l1086t2873r1202b2928],
17	genotype	NN	O	genotype	nn	18	SENT_77	[p3l1232t2882r1528b2942],
18	frequencies	NNS	O	frequency	dobj	14	SENT_77	[p3l1559t2873r1924b2942],
19	of	IN	O	of	_	0	SENT_77	[p3l1955t2873r2021b2928],
20	the	DT	O	the	det	23	SENT_77	[p3l2044t2873r2145b2928],
21	CES1	NN	O	ces1	nn	23	SENT_77	[p3l9t2966r155b3018],
22	Gly143Glu	NN	O	gly143glu	nn	23	SENT_77	[p3l200t2963r532b3031],
23	polymorphism	NN	O	polymorphism	prep_of	18	SENT_77	[p3l568t2963r1052b3031],
24	.	.	O	.	_	0	SENT_77	[p3l568t2963r1052b3031],

1	No	DT	O	no	det	4	SENT_78	[p3l1090t2966r1176b3018],
2	Glu/Glu	NN	O	glu/glu	nn	4	SENT_78	[p3l1212t2963r1455b3031],
3	homozygote	NN	O	homozygote	nn	4	SENT_78	[p3l1492t2963r1883b3031],
4	subject	NN	O	subject	nsubjpass	6	SENT_78	[p3l1921t2963r2147b3031],
5	was	VBD	O	be	auxpass	6	SENT_78	[p3l7t3067r130b3107],
6	found	VBN	O	find	_	0	SENT_78	[p3l165t3051r348b3107],
7	in	IN	O	in	prep	6	SENT_78	[p3l383t3052r441b3106],
8	either	CC	O	either	prep	6	SENT_78	[p3l475t3052r664b3107],
9	groups	NNS	O	group	dep	8	SENT_78	[p3l694t3067r927b3120],
10	.	.	O	.	_	0	SENT_78	[p3l694t3067r927b3120],

1	The	DT	O	the	det	4	SENT_79	[p3l959t3052r1076b3107],
2	Gly/Glu	NN	O	gly/glu	nn	4	SENT_79	[p3l1110t3051r1349b3120],
3	heterozygote	NN	O	heterozygote	nn	4	SENT_79	[p3l1383t3052r1797b3120],
4	frequency	NN	O	frequency	nsubj	7	SENT_79	[p3l1831t3051r2148b3120],
5	was	VBD	O	be	cop	7	SENT_79	[p3l7t3156r130b3195],
6	4.1	CD	PERCENT	4.1	number	7	SENT_79	[p3l151t3143r284b3196],
7	%	NN	PERCENT	%	_	0	SENT_79	[p3l151t3143r284b3196],
8	in	IN	O	in	_	0	SENT_79	[p3l306t3141r364b3195],
9	the	DT	O	the	det	11	SENT_79	[p3l386t3140r487b3195],
10	control	NN	O	control	nn	11	SENT_79	[p3l509t3140r734b3195],
11	group	NN	O	group	prep_in	7	SENT_79	[p3l755t3156r942b3209],
12	(	CD	NUMBER	(	num	13	SENT_79	[p3l964t3140r1051b3209],
13	11	CD	NUMBER	11	npadvmod	14	SENT_79	[p3l964t3140r1051b3209],
14	out	IN	O	out	_	0	SENT_79	[p3l1081t3148r1186b3195],
15	of	IN	O	of	_	0	SENT_79	[p3l1205t3140r1271b3195],
16	268	CD	NUMBER	268	num	17	SENT_79	[p3l1285t3140r1428b3209],
17	)	NN	O	)	prep_out_of	11	SENT_79	[p3l1285t3140r1428b3209],
18	and	CC	O	and	_	0	SENT_79	[p3l1451t3140r1567b3195],
19	5.8	CD	PERCENT	5.8	num	20	SENT_79	[p3l1590t3143r1726b3196],
20	%	NN	PERCENT	%	prep_out_of	11	SENT_79	[p3l1590t3143r1726b3196],
21	in	IN	O	in	_	0	SENT_79	[p3l1748t3141r1806b3195],
22	the	DT	O	the	det	24	SENT_79	[p3l1827t3140r1929b3195],
23	ADHD	NNP	O	ADHD	nn	24	SENT_79	[p3l1949t3143r2145b3195],
24	group	NN	O	group	prep_in	7	SENT_79	[p3l8t3245r194b3298],
25	(	CD	NUMBER	(	num	26	SENT_79	[p3l228t3229r325b3297],
26	10	CD	NUMBER	10	npadvmod	24	SENT_79	[p3l228t3229r325b3297],
27	out	IN	O	out	_	0	SENT_79	[p3l360t3237r465b3284],
28	of	IN	O	of	_	0	SENT_79	[p3l496t3229r563b3284],
29	173	CD	NUMBER	173	num	30	SENT_79	[p3l592t3229r738b3297],
30	)	NN	O	)	prep_out_of	24	SENT_79	[p3l592t3229r738b3297],
31	,	,	O	,	_	0	SENT_79	[p3l592t3229r738b3297],
32	indicating	VBG	O	indicate	xcomp	7	SENT_79	[p3l774t3229r1092b3298],
33	no	DT	O	no	det	35	SENT_79	[p3l1125t3245r1202b3284],
34	signiﬁcant	NN	O	signiﬁcant	nn	35	SENT_79	[p3l1238t3229r1568b3298],
35	difference	NN	O	difference	dobj	32	SENT_79	[p3l1600t3229r1917b3284],
36	in	IN	O	in	_	0	SENT_79	[p3l1952t3230r2011b3283],
37	the	DT	O	the	det	42	SENT_79	[p3l2044t3229r2145b3284],
38	genotype	NN	O	genotype	nn	42	SENT_79	[p3l8t3326r303b3386],
39	distribution	NN	O	distribution	nn	42	SENT_79	[p3l330t3318r705b3372],
40	(	CD	NUMBER	(	num	42	SENT_79	[p3l732t3318r1008b3386],
41	Pearson	NNP	PERSON	Pearson	nn	42	SENT_79	[p3l732t3318r1008b3386],
42	X2	NN	O	x2	prep_in	32	SENT_79	[p3l1035t3303r1101b3386],
43	=	JJ	O	=	amod	42	SENT_79	[p3l1130t3346r1178b3363],
44	0.651	CD	NUMBER	0.651	tmod	43	SENT_79	[p3l1206t3320r1385b3381],
45	,	,	O	,	_	0	SENT_79	[p3l1206t3320r1385b3381],
46	df	NN	O	df	dep	47	SENT_79	[p3l1413t3317r1481b3372],
47	=	JJ	O	=	ccomp	7	SENT_79	[p3l1501t3346r1548b3363],
48	1	CD	NUMBER	1	tmod	47	SENT_79	[p3l1580t3321r1622b3381],
49	,	,	O	,	_	0	SENT_79	[p3l1580t3321r1622b3381],
50	p	NN	O	p	dep	53	SENT_79	[p3l1645t3334r1684b3386],
51	=	JJ	O	=	amod	53	SENT_79	[p3l1713t3346r1760b3363],
52	0.420	CD	NUMBER	0.420	num	53	SENT_79	[p3l1789t3318r2004b3386],
53	)	NN	O	)	ccomp	7	SENT_79	[p3l1789t3318r2004b3386],
54	.	.	O	.	_	0	SENT_79	[p3l1789t3318r2004b3386],

1	The	DT	O	the	det	4	SENT_80	[p3l2029t3318r2145b3372],
2	minor	JJ	O	minor	amod	4	SENT_80	[p3l10t3407r203b3461],
3	allele	NN	O	allele	nn	4	SENT_80	[p3l234t3406r401b3461],
4	frequency	NN	O	frequency	nsubj	15	SENT_80	[p3l436t3406r752b3475],
5	(	CD	NUMBER	(	num	6	SENT_80	[p3l785t3406r972b3475],
6	MAF	NN	O	maf	dep	4	SENT_80	[p3l785t3406r972b3475],
7	:	:	O	:	_	0	SENT_80	[p3l785t3406r972b3475],
8	2.1	CD	PERCENT	2.1	number	12	SENT_80	[p3l1012t3409r1143b3462],
9	%	NN	PERCENT	%	dep	12	SENT_80	[p3l1012t3409r1143b3462],
10	and	CC	O	and	_	0	SENT_80	[p3l1176t3406r1292b3461],
11	2.9	CD	PERCENT	2.9	dep	4	SENT_80	[p3l1327t3407r1488b3475],
12	%	NN	PERCENT	%	dep	4	SENT_80	[p3l1327t3407r1488b3475],
13	)	CD	NUMBER	)	dep	12	SENT_80	[p3l1327t3407r1488b3475],
14	was	VBD	O	be	cop	15	SENT_80	[p3l1521t3422r1643b3461],
15	comparable	JJ	O	comparable	_	0	SENT_80	[p3l1678t3406r2051b3475],
16	to	TO	O	to	_	0	SENT_80	[p3l2084t3414r2145b3461],
17	earlier	JJR	O	earlier	amod	18	SENT_80	[p4l9t17r214b72],
18	report	NN	O	report	prep_to	15	SENT_80	[p4l238t25r435b85],
19	(	CD	PERCENT	(	number	20	SENT_80	[p4l459t17r636b85],
20	3.7	CD	PERCENT	3.7	num	21	SENT_80	[p4l459t17r636b85],
21	%	NN	PERCENT	%	dep	18	SENT_80	[p4l459t17r636b85],
22	,	,	O	,	_	0	SENT_80	[p4l459t17r636b85],
23	Zhu	NNP	PERSON	Zhu	appos	18	SENT_80	[p4l662t17r783b72],
24	et	FW	O	et	nn	25	SENT_80	[p4l809t25r868b72],
25	al.	FW	O	al.	dep	23	SENT_80	[p4l892t17r976b80],
26	,	,	O	,	_	0	SENT_80	[p4l892t17r976b80],
27	2008	CD	DATE	2008	num	28	SENT_80	[p4l1003t17r1203b85],
28	)	NN	O	)	appos	25	SENT_80	[p4l1003t17r1203b85],
29	.	.	O	.	_	0	SENT_80	[p4l1003t17r1203b85],

1	Methylphenidate	NN	O	methylphenidate	nn	2	SENT_81	[p4l111t106r642b174],
2	response	NN	O	response	nsubjpass	4	SENT_81	[p4l674t121r949b174],
3	was	VBD	O	be	auxpass	4	SENT_81	[p4l977t121r1097b161],
4	assessed	VBN	O	assess	_	0	SENT_81	[p4l1129t106r1391b161],
5	in	IN	O	in	_	0	SENT_81	[p4l1423t106r1481b160],
6	122	CD	NUMBER	122	num	8	SENT_81	[p4l1515t108r1622b160],
7	ADHD	NN	O	adhd	nn	8	SENT_81	[p4l1651t108r1845b160],
8	children	NNS	O	child	prep_in	4	SENT_81	[p4l1876t105r2144b161],
9	.	.	O	.	_	0	SENT_81	[p4l1876t105r2144b161],

1	Using	VBG	O	use	partmod	14	SENT_82	[p4l8t195r183b263],
2	the	DT	O	the	det	5	SENT_82	[p4l223t194r321b249],
3	categorical	JJ	O	categorical	amod	5	SENT_82	[p4l362t194r694b263],
4	grouping	NN	O	grouping	nn	5	SENT_82	[p4l733t195r1015b263],
5	system	NN	O	system	dobj	1	SENT_82	[p4l1056t202r1285b263],
6	,	,	O	,	_	0	SENT_82	[p4l1056t202r1285b263],
7	90	CD	NUMBER	90	num	8	SENT_82	[p4l1326t197r1401b249],
8	patients	NNS	O	patient	nsubjpass	14	SENT_82	[p4l1443t195r1690b263],
9	(	IN	O	(	_	0	SENT_82	[p4l1731t194r1952b262],
10	73.8	CD	PERCENT	73.8	number	11	SENT_82	[p4l1731t194r1952b262],
11	%	NN	PERCENT	%	num	12	SENT_82	[p4l1731t194r1952b262],
12	)	CD	NUMBER	)	prep_(	8	SENT_82	[p4l1731t194r1952b262],
13	were	VBD	O	be	auxpass	14	SENT_82	[p4l1990t210r2145b249],
14	described	VBN	O	describe	_	0	SENT_82	[p4l9t283r306b338],
15	as	IN	O	as	_	0	SENT_82	[p4l357t299r418b338],
16	responder	NN	O	responder	prep_as	14	SENT_82	[p4l470t283r794b352],
17	,	,	O	,	_	0	SENT_82	[p4l470t283r794b352],
18	while	IN	O	while	mark	27	SENT_82	[p4l844t283r1017b338],
19	32	CD	PERCENT	32	number	20	SENT_82	[p4l1067t286r1142b338],
20	(	CD	PERCENT	(	nsubj	27	SENT_82	[p4l1194t283r1416b351],
21	26.2	CD	PERCENT	26.2	num	22	SENT_82	[p4l1194t283r1416b351],
22	%	NN	PERCENT	%	dep	20	SENT_82	[p4l1194t283r1416b351],
23	)	CD	NUMBER	)	dep	20	SENT_82	[p4l1194t283r1416b351],
24	were	VBD	O	be	cop	27	SENT_82	[p4l1464t299r1619b338],
25	non	JJ	O	non	amod	27	SENT_82	[p4l1671t283r2144b352],
26	—	NN	O	—	nn	27	SENT_82	[p4l1671t283r2144b352],
27	responder	NN	O	responder	advcl	14	SENT_82	[p4l1671t283r2144b352],
28	.	.	O	.	_	0	SENT_82	[p4l1671t283r2144b352],

1	Genotype	NN	O	genotype	nn	2	SENT_83	[p4l9t375r307b441],
2	frequencies	NNS	O	frequency	nsubj	5	SENT_83	[p4l328t372r681b441],
3	did	VBD	O	do	aux	5	SENT_83	[p4l703t372r800b427],
4	not	RB	O	not	neg	5	SENT_83	[p4l821t380r923b427],
5	differ	VB	O	differ	_	0	SENT_83	[p4l942t372r1108b427],
6	between	IN	O	between	_	0	SENT_83	[p4l1125t372r1394b427],
7	the	DT	O	the	det	10	SENT_83	[p4l1414t372r1513b427],
8	two	CD	NUMBER	two	num	10	SENT_83	[p4l1533t380r1652b427],
9	patient	NN	O	patient	nn	10	SENT_83	[p4l1673t373r1892b441],
10	groups	NNS	O	group	prep_between	5	SENT_83	[p4l1910t388r2141b441],
11	:	:	O	:	_	0	SENT_83	[p4l1910t388r2141b441],
12	there	EX	O	there	expl	13	SENT_83	[p4l9t461r170b516],
13	were	VBD	O	be	parataxis	5	SENT_83	[p4l201t477r355b516],
14	5	CD	NUMBER	5	num	16	SENT_83	[p4l391t465r424b516],
15	Gly/Glu	NN	O	gly/glu	nn	16	SENT_83	[p4l459t461r692b530],
16	heterozygotes	NNS	O	heterozygote	nsubj	13	SENT_83	[p4l726t461r1156b530],
17	among	IN	O	among	_	0	SENT_83	[p4l1191t477r1405b530],
18	the	DT	O	the	det	19	SENT_83	[p4l1437t461r1535b516],
19	responders	NNS	O	responder	prep_among	16	SENT_83	[p4l1570t461r1929b530],
20	,	,	O	,	_	0	SENT_83	[p4l1570t461r1929b530],
21	and	CC	O	and	_	0	SENT_83	[p4l1962t461r2075b516],
22	2	CD	NUMBER	2	num	23	SENT_83	[p4l2110t464r2144b516],
23	heterozygotes	NNS	O	heterozygote	conj_and	16	SENT_83	[p4l10t550r440b618],
24	in	IN	O	in	_	0	SENT_83	[p4l466t551r523b604],
25	the	DT	O	the	det	29	SENT_83	[p4l547t550r645b605],
26	non	JJ	O	non	amod	29	SENT_83	[p4l671t550r1136b618],
27	—	NN	O	—	nn	29	SENT_83	[p4l671t550r1136b618],
28	responder	NN	O	responder	nn	29	SENT_83	[p4l671t550r1136b618],
29	group	NN	O	group	prep_in	23	SENT_83	[p4l1157t566r1340b618],
30	(	CD	PERCENT	(	number	31	SENT_83	[p4l1363t550r1521b618],
31	5.6	CD	PERCENT	5.6	dep	32	SENT_83	[p4l1363t550r1521b618],
32	%	NN	PERCENT	%	dep	29	SENT_83	[p4l1363t550r1521b618],
33	vs	CC	O	vs	_	0	SENT_83	[p4l1543t566r1608b605],
34	6.3	CD	PERCENT	6.3	num	35	SENT_83	[p4l1633t553r1779b613],
35	%	NN	PERCENT	%	conj_and	16	SENT_83	[p4l1633t553r1779b613],
36	,	,	O	,	_	0	SENT_83	[p4l1633t553r1779b613],
37	X2	NN	O	x2	appos	35	SENT_83	[p4l1804t535r1869b619],
38	=	JJ	O	=	amod	37	SENT_83	[p4l1896t579r1943b595],
39	0.021	CD	NUMBER	0.021	tmod	38	SENT_83	[p4l1970t553r2145b613],
40	,	,	O	,	_	0	SENT_83	[p4l1970t553r2145b613],
41	df	NN	O	df	appos	37	SENT_83	[p4l9t638r76b694],
42	=	JJ	O	=	amod	41	SENT_83	[p4l98t667r145b684],
43	1	CD	NUMBER	1	tmod	42	SENT_83	[p4l180t642r221b702],
44	,	,	O	,	_	0	SENT_83	[p4l180t642r221b702],
45	Fisher	NNP	PERSON	Fisher	poss	52	SENT_83	[p4l251t639r480b694],
46	's	POS	O	's	_	0	SENT_83	[p4l251t639r480b694],
47	exact	JJ	O	exact	amod	52	SENT_83	[p4l510t647r672b694],
48	test	NN	O	test	nn	52	SENT_83	[p4l699t647r813b694],
49	p	NN	O	p	nn	52	SENT_83	[p4l834t654r873b707],
50	=	JJ	O	=	amod	52	SENT_83	[p4l903t667r951b684],
51	0.591	CD	NUMBER	0.591	num	52	SENT_83	[p4l982t639r1188b707],
52	)	NN	O	)	appos	37	SENT_83	[p4l982t639r1188b707],
53	.	.	O	.	_	0	SENT_83	[p4l982t639r1188b707],

1	In	IN	O	in	_	0	SENT_84	[p4l1218t642r1276b693],
2	the	DT	O	the	det	4	SENT_84	[p4l1304t639r1403b694],
3	dimensional	JJ	O	dimensional	amod	4	SENT_84	[p4l1432t639r1813b694],
4	approach	NN	O	approach	prep_in	12	SENT_84	[p4l1843t639r2144b707],
5	,	,	O	,	_	0	SENT_84	[p4l1843t639r2144b707],
6	repeated	VBN	O	repeat	amod	7	SENT_84	[p4l10t727r279b796],
7	measures	NNS	O	measure	appos	4	SENT_84	[p4l307t743r599b782],
8	analyses	NNS	O	analysis	nsubjpass	12	SENT_84	[p4l626t727r884b796],
9	of	IN	O	of	_	0	SENT_84	[p4l911t727r976b782],
10	variance	NN	O	variance	prep_of	8	SENT_84	[p4l992t728r1252b782],
11	were	VBD	O	be	auxpass	12	SENT_84	[p4l1276t743r1431b782],
12	carried	VBN	O	carry	_	0	SENT_84	[p4l1457t727r1671b782],
13	out	RP	O	out	prt	12	SENT_84	[p4l1699t735r1801b782],
14	to	TO	O	to	aux	15	SENT_84	[p4l1824t735r1884b782],
15	test	VB	O	test	xcomp	12	SENT_84	[p4l1909t735r2023b782],
16	the	DT	O	the	det	17	SENT_84	[p4l2046t727r2145b782],
17	effect	NN	O	effect	dobj	15	SENT_84	[p4l9t816r180b871],
18	of	IN	O	of	_	0	SENT_84	[p4l202t816r266b871],
19	MPH	NN	O	mph	prep_of	17	SENT_84	[p4l284t819r433b871],
20	on	IN	O	on	_	0	SENT_84	[p4l459t832r536b871],
21	ADHD	NNP	O	ADHD	prep_on	15	SENT_84	[p4l558t818r857b871],
22	.	.	O	.	_	0	SENT_84	[p4l558t818r857b871],

1	—	NN	O	—	_	0	SENT_85	[p4l558t818r857b871],
2	.	.	O	.	_	0	SENT_85	[p4l558t818r857b871],

1	RS	NN	O	r	nn	2	SENT_86	[p4l558t818r857b871],
2	scores	NNS	O	score	_	0	SENT_86	[p4l883t832r1086b879],
3	,	,	O	,	_	0	SENT_86	[p4l883t832r1086b879],
4	and	CC	O	and	dep	2	SENT_86	[p4l1111t816r1224b871],
5	its	PRP$	O	its	poss	7	SENT_86	[p4l1251t817r1320b871],
6	potential	JJ	O	potential	amod	7	SENT_86	[p4l1345t816r1620b885],
7	interaction	NN	O	interaction	dep	2	SENT_86	[p4l1646t817r1981b871],
8	with	IN	O	with	dep	7	SENT_86	[p4l2002t816r2146b871],
9	CES1	NN	O	ces1	nn	10	SENT_86	[p4l10t908r152b960],
10	genotype	NN	O	genotype	pobj	8	SENT_86	[p4l180t913r482b974],
11	.	.	O	.	_	0	SENT_86	[p4l180t913r482b974],

1	MPH	NN	O	mph	nsubj	3	SENT_87	[p4l504t909r654b960],
2	signiﬁcantly	RB	O	signiﬁcantly	advmod	3	SENT_87	[p4l676t905r1054b974],
3	reduced	VBD	O	reduce	_	0	SENT_87	[p4l1073t905r1321b960],
4	ADHD	NNP	O	ADHD	dobj	3	SENT_87	[p4l1340t908r1639b960],
5	.	.	O	.	_	0	SENT_87	[p4l1340t908r1639b960],

1	—	NN	O	—	_	0	SENT_88	[p4l1340t908r1639b960],
2	.	.	O	.	_	0	SENT_88	[p4l1340t908r1639b960],

1	RS	NN	O	r	_	0	SENT_89	[p4l1340t908r1639b960],
2	scores	NNS	O	score	dep	1	SENT_89	[p4l1662t921r1849b960],
3	after	IN	O	after	_	0	SENT_89	[p4l1871t905r2015b960],
4	one	CD	DURATION	one	num	5	SENT_89	[p4l2033t921r2145b960],
5	month	NN	NUMBER	month	prep_after	2	SENT_89	[p4l10t994r216b1048],
6	of	IN	O	of	_	0	SENT_89	[p4l231t993r296b1048],
7	treatment	NN	O	treatment	nn	9	SENT_89	[p4l302t1002r614b1048],
8	(	CD	NUMBER	(	num	9	SENT_89	[p4l627t994r886b1062],
9	F	NN	O	f	prep_of	5	SENT_89	[p4l627t994r886b1062],
10	(	CD	NUMBER	(	number	11	SENT_89	[p4l627t994r886b1062],
11	2,119	CD	NUMBER	2,119	num	12	SENT_89	[p4l627t994r886b1062],
12	)	NN	O	)	dep	1	SENT_89	[p4l627t994r886b1062],
13	=	JJ	O	=	amod	12	SENT_89	[p4l901t1022r949b1039],
14	27.63	CD	NUMBER	27.63	tmod	13	SENT_89	[p4l966t996r1141b1057],
15	,	,	O	,	_	0	SENT_89	[p4l966t996r1141b1057],
16	p	NN	O	p	appos	1	SENT_89	[p4l1152t1010r1191b1062],
17	<	JJR	O	<	dep	16	SENT_89	[p4l1209t1011r1253b1050],
18	0.001	CD	NUMBER	0.001	dep	1	SENT_89	[p4l1272t996r1449b1057],
19	,	,	O	,	_	0	SENT_89	[p4l1272t996r1449b1057],
20	712	CD	NUMBER	712	num	24	SENT_89	[p4l1465t979r1528b1062],
21	=	JJ	O	=	amod	24	SENT_89	[p4l1544t1022r1591b1039],
22	0.317	CD	NUMBER	0.317	tmod	21	SENT_89	[p4l1609t996r1777b1057],
23	,	,	O	,	_	0	SENT_89	[p4l1609t996r1777b1057],
24	power	NN	O	power	appos	18	SENT_89	[p4l1793t1010r1991b1062],
25	=	JJ	O	=	amod	27	SENT_89	[p4l2005t1022r2053b1039],
26	1	CD	NUMBER	1	tmod	25	SENT_89	[p4l2073t993r2145b1062],
27	)	NN	O	)	dep	1	SENT_89	[p4l2073t993r2145b1062],
28	,	,	O	,	_	0	SENT_89	[p4l2073t993r2145b1062],
29	for	IN	O	for	_	0	SENT_89	[p4l10t1082r96b1137],
30	both	DT	O	both	det	33	SENT_89	[p4l127t1082r268b1137],
31	lnattention	NN	O	lnattention	nn	33	SENT_89	[p4l302t1083r646b1137],
32	(	NN	O	(	nn	33	SENT_89	[p4l679t1082r942b1150],
33	F	NN	O	f	prep_for	27	SENT_89	[p4l679t1082r942b1150],
34	(	CD	NUMBER	(	num	36	SENT_89	[p4l679t1082r942b1150],
35	1,120	CD	NUMBER	1,120	num	36	SENT_89	[p4l679t1082r942b1150],
36	)	NN	O	)	dep	1	SENT_89	[p4l679t1082r942b1150],
37	=	JJ	O	=	amod	36	SENT_89	[p4l976t1111r1024b1127],
38	40.17	CD	NUMBER	40.17	tmod	37	SENT_89	[p4l1058t1085r1226b1145],
39	,	,	O	,	_	0	SENT_89	[p4l1058t1085r1226b1145],
40	p	NN	O	p	dep	41	SENT_89	[p4l1255t1098r1294b1150],
41	<	JJR	O	<	appos	1	SENT_89	[p4l1332t1099r1375b1139],
42	0.001	CD	NUMBER	0.001	dep	41	SENT_89	[p4l1414t1085r1591b1145],
43	,	,	O	,	_	0	SENT_89	[p4l1414t1085r1591b1145],
44	112	CD	NUMBER	112	num	47	SENT_89	[p4l1626t1068r1688b1151],
45	=	JJ	O	=	amod	47	SENT_89	[p4l1725t1110r1772b1127],
46	0.251	CD	NUMBER	0.251	tmod	45	SENT_89	[p4l1808t1082r1997b1150],
47	)	NN	O	)	appos	1	SENT_89	[p4l1808t1082r1997b1150],
48	and	CC	O	and	_	0	SENT_89	[p4l2031t1082r2145b1137],
49	Hyperactivity	NN	O	hyperactivity	appos	1	SENT_89	[p4l10t1169r821b1238],
50	.	.	O	.	_	0	SENT_89	[p4l10t1169r821b1238],

1	—	NN	O	—	_	0	SENT_90	[p4l10t1169r821b1238],
2	.	.	O	.	_	0	SENT_90	[p4l10t1169r821b1238],

1	Impulsivity	NN	O	impulsivity	_	0	SENT_91	[p4l10t1169r821b1238],
2	(	CD	NUMBER	(	num	3	SENT_91	[p4l846t1169r1108b1238],
3	F	NN	O	f	dep	1	SENT_91	[p4l846t1169r1108b1238],
4	(	CD	NUMBER	(	num	6	SENT_91	[p4l846t1169r1108b1238],
5	1,120	CD	NUMBER	1,120	num	6	SENT_91	[p4l846t1169r1108b1238],
6	)	NN	O	)	dep	3	SENT_91	[p4l846t1169r1108b1238],
7	=	JJ	O	=	amod	8	SENT_91	[p4l1137t1198r1184b1215],
8	55.33	CD	NUMBER	55.33	dep	1	SENT_91	[p4l1215t1172r1397b1233],
9	,	,	O	,	_	0	SENT_91	[p4l1215t1172r1397b1233],
10	p	NN	O	p	appos	8	SENT_91	[p4l1421t1186r1460b1238],
11	<	JJR	O	<	dep	1	SENT_91	[p4l1492t1186r1535b1226],
12	0.001	CD	NUMBER	0.001	dep	11	SENT_91	[p4l1567t1172r1745b1233],
13	,	,	O	,	_	0	SENT_91	[p4l1567t1172r1745b1233],
14	112	CD	NUMBER	112	num	17	SENT_91	[p4l1773t1155r1836b1238],
15	=	JJ	O	=	amod	17	SENT_91	[p4l1866t1198r1914b1214],
16	0.316	CD	NUMBER	0.316	tmod	15	SENT_91	[p4l1944t1169r2145b1237],
17	)	NN	O	)	appos	1	SENT_91	[p4l1944t1169r2145b1237],
18	.	.	O	.	_	0	SENT_91	[p4l1944t1169r2145b1237],

1	Although	IN	O	although	mark	13	SENT_92	[p4l6t1258r295b1327],
2	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_92	[p4l317t1258r637b1327],
3	multivariate	JJ	O	multivariate	amod	4	SENT_92	[p4l657t1258r1033b1313],
4	interaction	NN	O	interaction	nsubjpass	13	SENT_92	[p4l1054t1259r1390b1313],
5	of	IN	O	of	_	0	SENT_92	[p4l1411t1258r1476b1313],
6	MPH	NN	O	mph	nn	8	SENT_92	[p4l1489t1258r1840b1313],
7	—	NN	O	—	nn	8	SENT_92	[p4l1489t1258r1840b1313],
8	effect	NN	O	effect	prep_of	4	SENT_92	[p4l1489t1258r1840b1313],
9	and	CC	O	and	_	0	SENT_92	[p4l1859t1258r1973b1313],
10	CES1	NN	O	ces1	nn	11	SENT_92	[p4l1994t1261r2137b1313],
11	genotype	NN	O	genotype	prep_of	4	SENT_92	[p4l8t1355r296b1415],
12	was	VBD	O	be	auxpass	13	SENT_92	[p4l332t1363r452b1401],
13	observed	VBN	O	observe	advcl	38	SENT_92	[p4l492t1346r772b1401],
14	(	RB	O	(	advmod	13	SENT_92	[p4l811t1347r1069b1415],
15	F	NN	O	f	nn	33	SENT_92	[p4l811t1347r1069b1415],
16	(	CD	NUMBER	(	number	17	SENT_92	[p4l811t1347r1069b1415],
17	2,119	CD	NUMBER	2,119	num	18	SENT_92	[p4l811t1347r1069b1415],
18	)	NN	O	)	dep	15	SENT_92	[p4l811t1347r1069b1415],
19	=	JJ	O	=	amod	18	SENT_92	[p4l1110t1375r1157b1392],
20	5.02	CD	NUMBER	5.02	tmod	19	SENT_92	[p4l1199t1349r1342b1410],
21	,	,	O	,	_	0	SENT_92	[p4l1199t1349r1342b1410],
22	p	NN	O	p	appos	18	SENT_92	[p4l1377t1363r1415b1415],
23	=	JJ	O	=	amod	22	SENT_92	[p4l1456t1375r1504b1392],
24	0.008	CD	NUMBER	0.008	tmod	23	SENT_92	[p4l1545t1349r1731b1410],
25	,	,	O	,	_	0	SENT_92	[p4l1545t1349r1731b1410],
26	112	CD	NUMBER	112	num	30	SENT_92	[p4l1769t1332r1833b1415],
27	=	JJ	O	=	amod	30	SENT_92	[p4l1873t1375r1921b1392],
28	0.078	CD	NUMBER	0.078	tmod	27	SENT_92	[p4l1962t1349r2145b1410],
29	,	,	O	,	_	0	SENT_92	[p4l1962t1349r2145b1410],
30	power	NN	O	power	appos	18	SENT_92	[p4l9t1451r209b1504],
31	=	JJ	O	=	amod	33	SENT_92	[p4l231t1464r279b1481],
32	0.807	CD	NUMBER	0.807	tmod	31	SENT_92	[p4l305t1436r512b1504],
33	)	NN	O	)	dobj	13	SENT_92	[p4l305t1436r512b1504],
34	,	,	O	,	_	0	SENT_92	[p4l305t1436r512b1504],
35	it	PRP	O	it	nsubjpass	38	SENT_92	[p4l538t1436r580b1490],
36	was	VBD	O	be	auxpass	38	SENT_92	[p4l601t1451r720b1490],
37	not	RB	O	not	neg	38	SENT_92	[p4l746t1444r848b1490],
38	explained	VBN	O	explain	_	0	SENT_92	[p4l869t1435r1170b1504],
39	by	IN	O	by	prep	38	SENT_92	[p4l1194t1435r1269b1504],
40	either	CC	O	either	dep	38	SENT_92	[p4l1290t1435r1473b1490],
41	subscales	NNS	O	subscale	conj	38	SENT_92	[p4l1496t1435r1783b1490],
42	separately	RB	O	separately	advmod	41	SENT_92	[p4l1808t1435r2140b1504],
43	:	:	O	:	_	0	SENT_92	[p4l1808t1435r2140b1504],
44	lnattention	NN	O	lnattention	nn	45	SENT_92	[p4l10t1526r353b1580],
45	scores	NNS	O	score	nsubj	50	SENT_92	[p4l370t1541r558b1580],
46	of	IN	O	of	_	0	SENT_92	[p4l576t1525r641b1580],
47	the	DT	O	the	det	49	SENT_92	[p4l649t1525r749b1580],
48	Gly/Gly	JJ	O	gly/gly	amod	49	SENT_92	[p4l765t1525r995b1593],
49	group	NN	O	group	prep_of	45	SENT_92	[p4l1007t1541r1190b1593],
50	decreased	VBD	O	decrease	parataxis	38	SENT_92	[p4l1206t1525r1514b1580],
51	from	IN	O	from	_	0	SENT_92	[p4l1532t1525r1680b1580],
52	16.31	CD	NUMBER	16.31	prep_from	50	SENT_92	[p4l1699t1528r1849b1580],
53	:	:	O	:	_	0	SENT_92	[p4l1875t1533r1923b1579],
54	|	CD	NUMBER	|	dep	52	SENT_92	[p4l1875t1533r1923b1579],
55	:	:	O	:	_	0	SENT_92	[p4l1875t1533r1923b1579],
56	5.00	CD	NUMBER	5.00	num	58	SENT_92	[p4l1939t1528r2069b1580],
57	to	TO	O	to	dep	58	SENT_92	[p4l2086t1533r2145b1580],
58	12.25	CD	NUMBER	12.25	dep	52	SENT_92	[p4l13t1617r173b1669],
59	:	:	O	:	_	0	SENT_92	[p4l214t1622r261b1668],
60	I	PRP	O	I	dep	52	SENT_92	[p4l214t1622r261b1668],
61	:	:	O	:	_	0	SENT_92	[p4l214t1622r261b1668],
62	5.30	CD	NUMBER	5.30	dep	52	SENT_92	[p4l303t1617r445b1677],
63	,	,	O	,	_	0	SENT_92	[p4l303t1617r445b1677],
64	whereas	IN	O	whereas	mark	70	SENT_92	[p4l483t1614r744b1669],
65	the	DT	O	the	det	67	SENT_92	[p4l782t1614r881b1669],
66	Gly/Glu	NNP	O	Gly/Glu	nn	67	SENT_92	[p4l920t1614r1153b1682],
67	group	NN	O	group	poss	69	SENT_92	[p4l1188t1617r1415b1682],
68	's	POS	O	's	_	0	SENT_92	[p4l1188t1617r1415b1682],
69	score	NN	NUMBER	score	nsubj	70	SENT_92	[p4l1455t1630r1612b1669],
70	decreased	VBD	O	decrease	advcl	50	SENT_92	[p4l1651t1614r1959b1669],
71	from	IN	O	from	_	0	SENT_92	[p4l1998t1614r2146b1669],
72	15.00	CD	NUMBER	15.00	prep_from	70	SENT_92	[p4l12t1704r176b1757],
73	i	FW	O	i	dobj	70	SENT_92	[p4l193t1710r240b1756],
74	4.32	CD	NUMBER	4.32	num	76	SENT_92	[p4l258t1704r387b1757],
75	to	TO	O	to	dep	76	SENT_92	[p4l405t1709r464b1756],
76	12.14	CD	NUMBER	12.14	dep	73	SENT_92	[p4l484t1704r638b1757],
77	i	FW	O	i	dep	73	SENT_92	[p4l654t1710r701b1756],
78	5.27	CD	NUMBER	5.27	dep	77	SENT_92	[p4l721t1704r856b1765],
79	,	,	O	,	_	0	SENT_92	[p4l721t1704r856b1765],
80	F	NN	O	f	appos	73	SENT_92	[p4l871t1701r1111b1770],
81	(	CD	NUMBER	(	num	80	SENT_92	[p4l871t1701r1111b1770],
82	1,120	CD	NUMBER	1,120	num	83	SENT_92	[p4l871t1701r1111b1770],
83	)	NN	O	)	dep	80	SENT_92	[p4l871t1701r1111b1770],
84	=	JJ	O	=	amod	83	SENT_92	[p4l1128t1730r1175b1747],
85	1.22	CD	NUMBER	1.22	tmod	84	SENT_92	[p4l1197t1704r1331b1765],
86	,	,	O	,	_	0	SENT_92	[p4l1197t1704r1331b1765],
87	p	NN	O	p	appos	73	SENT_92	[p4l1343t1718r1382b1770],
88	=	JJ	O	=	amod	87	SENT_92	[p4l1400t1730r1448b1747],
89	0.272	CD	NUMBER	0.272	tmod	88	SENT_92	[p4l1466t1704r1646b1765],
90	,	,	O	,	_	0	SENT_92	[p4l1466t1704r1646b1765],
91	712	CD	NUMBER	712	appos	73	SENT_92	[p4l1663t1687r1726b1770],
92	=	JJ	O	=	amod	91	SENT_92	[p4l1744t1730r1791b1746],
93	0.01	CD	NUMBER	0.01	tmod	92	SENT_92	[p4l1810t1704r1945b1757],
94	.	.	O	.	_	0	SENT_92	[p4l1810t1704r1945b1757],

1	At	IN	O	at	_	0	SENT_93	[p4l1960t1704r2032b1756],
2	the	DT	O	the	det	3	SENT_93	[p4l2045t1701r2146b1756],
3	Hyperactivity	NN	O	hyperactivity	pobj	1	SENT_93	[p4l10t1790r837b1859],
4	.	.	O	.	_	0	SENT_93	[p4l10t1790r837b1859],

1	—	NN	O	—	_	0	SENT_94	[p4l10t1790r837b1859],
2	.	.	O	.	_	0	SENT_94	[p4l10t1790r837b1859],

1	Impulsivity	NN	MISC	impulsivity	nn	2	SENT_95	[p4l10t1790r837b1859],
2	scale	NN	O	scale	nsubj	9	SENT_95	[p4l852t1790r1019b1854],
3	,	,	O	,	_	0	SENT_95	[p4l852t1790r1019b1854],
4	the	DT	O	the	det	6	SENT_95	[p4l1036t1790r1137b1845],
5	Gly/Gly	NNP	O	Gly/Gly	nn	6	SENT_95	[p4l1154t1790r1389b1859],
6	group	NN	O	group	poss	8	SENT_95	[p4l1402t1793r1631b1859],
7	's	POS	O	's	_	0	SENT_95	[p4l1402t1793r1631b1859],
8	score	NN	NUMBER	score	appos	2	SENT_95	[p4l1651t1806r1812b1845],
9	decreased	VBD	O	decrease	_	0	SENT_95	[p4l1830t1790r2145b1845],
10	from	IN	O	from	_	0	SENT_95	[p4l10t1879r160b1934],
11	16.37	CD	NUMBER	16.37	prep_from	9	SENT_95	[p4l195t1882r356b1935],
12	i	FW	O	i	dep	11	SENT_95	[p4l392t1888r439b1934],
13	5.55	CD	NUMBER	5.55	number	15	SENT_95	[p4l476t1883r605b1935],
14	to	TO	O	to	dep	15	SENT_95	[p4l639t1887r699b1934],
15	12.56	CD	NUMBER	12.56	dep	12	SENT_95	[p4l737t1882r902b1935],
16	i	FW	O	i	tmod	9	SENT_95	[p4l937t1888r984b1934],
17	5.60	CD	NUMBER	5.60	dep	16	SENT_95	[p4l1020t1882r1167b1943],
18	,	,	O	,	_	0	SENT_95	[p4l1020t1882r1167b1943],
19	while	IN	O	while	mark	23	SENT_95	[p4l1199t1879r1376b1934],
20	the	DT	O	the	det	22	SENT_95	[p4l1409t1879r1509b1934],
21	Gly/Glu	NNP	O	Gly/Glu	nn	22	SENT_95	[p4l1543t1879r1780b1948],
22	group	NN	O	group	nsubj	23	SENT_95	[p4l1812t1895r1997b1948],
23	had	VBD	O	have	advcl	9	SENT_95	[p4l2030t1879r2145b1934],
24	18.57	CD	NUMBER	18.57	dobj	23	SENT_95	[p4l13t1971r172b2023],
25	i	FW	O	i	dep	24	SENT_95	[p4l216t1976r263b2022],
26	6.40	CD	NUMBER	6.40	dep	24	SENT_95	[p4l305t1971r436b2023],
27	at	IN	O	at	_	0	SENT_95	[p4l477t1976r536b2023],
28	baseline	NN	O	baseline	prep_at	26	SENT_95	[p4l575t1968r834b2023],
29	and	CC	O	and	_	0	SENT_95	[p4l875t1968r991b2023],
30	13.71	CD	NUMBER	13.71	dobj	23	SENT_95	[p4l1035t1971r1189b2023],
31	i	FW	O	i	dep	30	SENT_95	[p4l1240t1976r1287b2022],
32	5.41	CD	NUMBER	5.41	dep	30	SENT_95	[p4l1327t1971r1447b2023],
33	after	IN	O	after	_	0	SENT_95	[p4l1496t1968r1643b2023],
34	one	CD	DURATION	one	num	35	SENT_95	[p4l1681t1984r1796b2023],
35	month	NN	NUMBER	month	prep_after	23	SENT_95	[p4l1837t1968r2047b2023],
36	of	IN	O	of	_	0	SENT_95	[p4l2088t1968r2154b2023],
37	MPH	NN	O	mph	nn	39	SENT_95	[p4l10t2059r524b2119],
38	—	NN	O	—	nn	39	SENT_95	[p4l10t2059r524b2119],
39	treatment	NN	O	treatment	prep_of	35	SENT_95	[p4l10t2059r524b2119],
40	,	,	O	,	_	0	SENT_95	[p4l10t2059r524b2119],
41	F	NN	O	f	dep	44	SENT_95	[p4l544t2056r789b2124],
42	(	CD	NUMBER	(	num	41	SENT_95	[p4l544t2056r789b2124],
43	1,120	CD	NUMBER	1,120	num	44	SENT_95	[p4l544t2056r789b2124],
44	)	NN	O	)	ccomp	9	SENT_95	[p4l544t2056r789b2124],
45	=	JJ	O	=	amod	44	SENT_95	[p4l811t2085r859b2101],
46	0.81	CD	NUMBER	0.81	tmod	45	SENT_95	[p4l882t2059r1023b2119],
47	,	,	O	,	_	0	SENT_95	[p4l882t2059r1023b2119],
48	p	NN	O	p	dep	51	SENT_95	[p4l1041t2072r1080b2124],
49	=	JJ	O	=	amod	48	SENT_95	[p4l1103t2085r1151b2101],
50	0.37.112	CD	NUMBER	0.37.112	tmod	49	SENT_95	[p4l1174t2041r1399b2125],
51	=	JJ	O	=	ccomp	9	SENT_95	[p4l1423t2085r1471b2101],
52	0.007	CD	NUMBER	0.007	tmod	51	SENT_95	[p4l1494t2059r1676b2111],
53	.	.	O	.	_	0	SENT_95	[p4l1494t2059r1676b2111],

1	Finally	RB	O	finally	advmod	4	SENT_96	[p4l112t2145r332b2213],
2	,	,	O	,	_	0	SENT_96	[p4l112t2145r332b2213],
3	we	PRP	O	we	nsubj	4	SENT_96	[p4l356t2160r450b2200],
4	compared	VBD	O	compare	_	0	SENT_96	[p4l474t2145r790b2213],
5	the	DT	O	the	det	7	SENT_96	[p4l814t2145r915b2200],
6	average	JJ	O	average	amod	7	SENT_96	[p4l939t2160r1182b2213],
7	doses	NNS	O	dose	dobj	4	SENT_96	[p4l1206t2145r1381b2200],
8	required	VBN	O	require	partmod	7	SENT_96	[p4l1406t2145r1674b2213],
9	to	TO	O	to	aux	10	SENT_96	[p4l1698t2153r1758b2200],
10	achieve	VB	O	achieve	xcomp	8	SENT_96	[p4l1782t2145r2021b2200],
11	the	DT	O	the	det	13	SENT_96	[p4l2044t2145r2145b2200],
12	therapeutic	JJ	O	therapeutic	amod	13	SENT_96	[p4l9t2234r376b2302],
13	effect	NN	O	effect	dobj	10	SENT_96	[p4l421t2233r596b2289],
14	among	IN	O	among	_	0	SENT_96	[p4l641t2249r859b2302],
15	the	DT	O	the	det	16	SENT_96	[p4l903t2234r1004b2289],
16	responders	NNS	O	responder	prep_among	10	SENT_96	[p4l1052t2234r1420b2302],
17	.	.	O	.	_	0	SENT_96	[p4l1052t2234r1420b2302],

1	The	DT	O	the	det	3	SENT_97	[p4l1465t2234r1581b2289],
2	Gly/Glu	NN	O	gly/glu	nn	3	SENT_97	[p4l1628t2233r1867b2302],
3	heterozygotes	NNS	O	heterozygote	nsubj	4	SENT_97	[p4l1914t2234r2145b2289, p4l10t2330r246b2391],
4	(	VBP	O	(	_	0	SENT_97	[p4l294t2322r354b2390],
5	n	NN	O	n	nsubj	17	SENT_97	[p4l294t2322r354b2390],
6	=	JJ	O	=	dep	17	SENT_97	[p4l404t2351r451b2367],
7	5	CD	NUMBER	5	num	8	SENT_97	[p4l501t2322r562b2390],
8	)	NN	O	)	nsubj	17	SENT_97	[p4l501t2322r562b2390],
9	required	VBN	O	require	partmod	8	SENT_97	[p4l611t2322r879b2391],
10	less	JJR	O	less	amod	11	SENT_97	[p4l928t2322r1041b2377],
11	MPH	NN	O	mph	dobj	9	SENT_97	[p4l1090t2325r1242b2376],
12	compared	VBN	O	compare	_	0	SENT_97	[p4l1290t2322r1607b2391],
13	to	TO	O	to	prepc_compared_to	9	SENT_97	[p4l1655t2330r1716b2377],
14	the	DT	O	the	det	16	SENT_97	[p4l1762t2322r1863b2377],
15	Gly/Gly	JJ	O	gly/gly	amod	16	SENT_97	[p4l1912t2322r2149b2391],
16	homozygotes	NNS	O	homozygote	pobj	9	SENT_97	[p4l10t2411r431b2480],
17	(	VBP	O	(	xcomp	4	SENT_97	[p4l455t2411r516b2479],
18	n	NN	O	n	dobj	17	SENT_97	[p4l455t2411r516b2479],
19	=	JJ	O	=	amod	18	SENT_97	[p4l540t2440r588b2456],
20	85	CD	NUMBER	85	number	21	SENT_97	[p4l612t2411r733b2479],
21	)	CD	NUMBER	)	dep	19	SENT_97	[p4l612t2411r733b2479],
22	:	:	O	:	_	0	SENT_97	[p4l612t2411r733b2479],
23	the	DT	O	the	det	26	SENT_97	[p4l760t2411r861b2466],
24	average	JJ	O	average	amod	26	SENT_97	[p4l884t2427r1127b2480],
25	daily	JJ	SET	daily	amod	26	SENT_97	[p4l1149t2411r1303b2480],
26	dose	NN	O	dose	dep	21	SENT_97	[p4l1323t2411r1468b2466],
27	was	VBD	O	be	cop	29	SENT_97	[p4l1488t2427r1610b2466],
28	0.410	CD	NUMBER	0.410	number	29	SENT_97	[p4l1634t2414r1799b2467],
29	1	CD	NUMBER	1	rcmod	26	SENT_97	[p4l1822t2419r1870b2465],
30	0.127	CD	NUMBER	0.127	dep	29	SENT_97	[p4l1896t2414r2058b2467],
31	vs	CC	O	vs	_	0	SENT_97	[p4l2081t2427r2145b2466],
32	0.572	CD	NUMBER	0.572	number	33	SENT_97	[p4l10t2503r177b2556],
33	1	CD	NUMBER	1	rcmod	26	SENT_97	[p4l206t2508r254b2555],
34	0.153	CD	NUMBER	0.153	num	35	SENT_97	[p4l281t2503r441b2556],
35	mg/kg	NN	O	mg/kg	dep	33	SENT_97	[p4l471t2500r685b2569],
36	,	,	O	,	_	0	SENT_97	[p4l471t2500r685b2569],
37	t	NN	O	t	rcmod	26	SENT_97	[p4l714t2500r914b2569],
38	(	CD	NUMBER	(	number	39	SENT_97	[p4l714t2500r914b2569],
39	1,88	CD	NUMBER	1,88	num	40	SENT_97	[p4l714t2500r914b2569],
40	)	NN	O	)	dep	37	SENT_97	[p4l714t2500r914b2569],
41	=	JJ	O	=	amod	40	SENT_97	[p4l941t2529r989b2546],
42	2.33	CD	NUMBER	2.33	tmod	41	SENT_97	[p4l1016t2503r1164b2564],
43	,	,	O	,	_	0	SENT_97	[p4l1016t2503r1164b2564],
44	p	NN	O	p	conj_vs	29	SENT_97	[p4l1186t2516r1224b2569],
45	=	JJ	O	=	amod	44	SENT_97	[p4l1251t2529r1299b2546],
46	0.022	CD	NUMBER	0.022	tmod	45	SENT_97	[p4l1326t2503r1515b2556],
47	.	.	O	.	_	0	SENT_97	[p4l1326t2503r1515b2556],

1	4	LS	NUMBER	4	_	0	SENT_98	[p4l7t2684r64b2735],
2	.	.	O	.	_	0	SENT_98	[p4l7t2684r64b2735],

1	Discussion	NN	O	discussion	_	0	SENT_99	[p4l109t2681r466b2735],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_100	[p4l111t2858r662b2927],
2	analysis	NN	O	analysis	nsubjpass	13	SENT_100	[p4l681t2858r930b2927],
3	of	IN	O	of	_	0	SENT_100	[p4l951t2858r1017b2913],
4	the	DT	O	the	det	7	SENT_100	[p4l1029t2858r1130b2913],
5	CES1	NN	O	ces1	nn	7	SENT_100	[p4l1151t2861r1297b2913],
6	Gly143Glu	NN	O	gly143glu	nn	7	SENT_100	[p4l1326t2858r1657b2927],
7	polymorphism	NN	O	polymorphism	prep_of	2	SENT_100	[p4l1677t2858r2147b2927],
8	and	CC	O	and	_	0	SENT_100	[p4l10t2948r125b3003],
9	MPH	NN	O	mph	nn	11	SENT_100	[p4l157t2951r625b3016],
10	—	NN	O	—	nn	11	SENT_100	[p4l157t2951r625b3016],
11	response	NN	O	response	prep_of	2	SENT_100	[p4l157t2951r625b3016],
12	was	VBD	O	be	auxpass	13	SENT_100	[p4l654t2964r776b3003],
13	carried	VBN	O	carry	_	0	SENT_100	[p4l808t2948r1028b3003],
14	out	RP	O	out	prt	13	SENT_100	[p4l1060t2956r1165b3003],
15	among	IN	O	among	_	0	SENT_100	[p4l1194t2964r1412b3016],
16	122	CD	NUMBER	122	num	19	SENT_100	[p4l1445t2951r1553b3002],
17	Hungarian	JJ	MISC	hungarian	amod	19	SENT_100	[p4l1587t2949r1921b3016],
18	ADHD	NN	O	adhd	nn	19	SENT_100	[p4l1949t2950r2145b3002],
19	children	NNS	O	child	prep_among	13	SENT_100	[p4l10t3036r287b3092],
20	.	.	O	.	_	0	SENT_100	[p4l10t3036r287b3092],

1	To	TO	O	to	_	0	SENT_101	[p4l309t3040r382b3091],
2	our	PRP$	O	we	poss	4	SENT_101	[p4l407t3052r515b3091],
3	best	JJS	O	best	amod	4	SENT_101	[p4l537t3036r669b3091],
4	knowledge	NN	O	knowledge	prep_to	10	SENT_101	[p4l692t3036r1055b3105],
5	,	,	O	,	_	0	SENT_101	[p4l692t3036r1055b3105],
6	this	DT	O	this	nsubj	10	SENT_101	[p4l1081t3036r1196b3091],
7	is	VBZ	O	be	cop	10	SENT_101	[p4l1222t3037r1268b3091],
8	the	DT	O	the	det	10	SENT_101	[p4l1292t3036r1393b3091],
9	ﬁrst	NN	O	ﬁrst	nn	10	SENT_101	[p4l1419t3036r1544b3091],
10	report	NN	O	report	_	0	SENT_101	[p4l1567t3044r1765b3105],
11	about	IN	O	about	_	0	SENT_101	[p4l1788t3036r1969b3091],
12	CES1	NN	O	ces1	nn	14	SENT_101	[p4l1992t3039r2138b3091],
13	genetic	JJ	O	genetic	amod	14	SENT_101	[p4l9t3126r239b3194],
14	variant	NN	O	variant	prep_about	10	SENT_101	[p4l260t3126r486b3180],
15	in	IN	O	in	_	0	SENT_101	[p4l509t3126r567b3180],
16	an	DT	O	a	det	18	SENT_101	[p4l591t3141r666b3180],
17	ADHD	NN	O	adhd	nn	18	SENT_101	[p4l687t3128r883b3180],
18	sample	NN	O	sample	prep_in	14	SENT_101	[p4l909t3125r1149b3194],
19	.	.	O	.	_	0	SENT_101	[p4l909t3125r1149b3194],

1	Hitherto	NNP	O	Hitherto	nsubjpass	11	SENT_102	[p4l1175t3125r1456b3189],
2	,	,	O	,	_	0	SENT_102	[p4l1175t3125r1456b3189],
3	only	RB	O	only	advmod	5	SENT_102	[p4l1482t3125r1619b3194],
4	genetic	JJ	O	genetic	amod	5	SENT_102	[p4l1639t3126r1870b3194],
5	variants	NNS	O	variant	appos	1	SENT_102	[p4l1891t3126r2145b3180],
6	of	IN	O	of	_	0	SENT_102	[p4l10t3214r76b3270],
7	drug	NN	O	drug	nn	8	SENT_102	[p4l93t3215r240b3283],
8	targets	NNS	O	target	prep_of	5	SENT_102	[p4l263t3223r480b3283],
9	have	VBP	O	have	aux	11	SENT_102	[p4l506t3215r653b3270],
10	been	VBN	O	be	auxpass	11	SENT_102	[p4l677t3215r830b3270],
11	studied	VBN	O	study	_	0	SENT_102	[p4l856t3215r1089b3270],
12	in	IN	O	in	_	0	SENT_102	[p4l1116t3215r1174b3269],
13	connection	NN	O	connection	prep_in	11	SENT_102	[p4l1199t3215r1551b3270],
14	to	TO	O	to	_	0	SENT_102	[p4l1575t3223r1636b3270],
15	MPH	NN	O	mph	nn	17	SENT_102	[p4l1662t3218r2145b3283],
16	—	NN	O	—	nn	17	SENT_102	[p4l1662t3218r2145b3283],
17	response	NN	O	response	prep_to	11	SENT_102	[p4l1662t3218r2145b3283],
18	.	.	O	.	_	0	SENT_102	[p4l1662t3218r2145b3283],

1	In	IN	O	in	_	0	SENT_103	[p4l10t3307r70b3358],
2	the	DT	O	the	det	4	SENT_103	[p4l93t3304r193b3359],
3	therapeutic	JJ	O	therapeutic	amod	4	SENT_103	[p4l217t3304r583b3372],
4	effects	NNS	O	effect	prep_in	13	SENT_103	[p4l606t3303r809b3359],
5	of	IN	O	of	_	0	SENT_103	[p4l834t3303r900b3359],
6	MPH	NN	O	mph	nn	8	SENT_103	[p4l916t3307r1421b3359],
7	—	NN	O	—	nn	8	SENT_103	[p4l916t3307r1421b3359],
8	treatment	NN	O	treatment	prep_of	4	SENT_103	[p4l916t3307r1421b3359],
9	dopamine	NN	O	dopamine	nn	11	SENT_103	[p4l1443t3304r1762b3372],
10	transporter	NN	O	transporter	nn	11	SENT_103	[p4l1786t3312r2149b3372],
11	blockade	NN	O	blockade	nsubjpass	13	SENT_103	[p4l9t3392r292b3447],
12	is	VBZ	O	be	auxpass	13	SENT_103	[p4l333t3393r379b3447],
13	thought	VBN	O	think	_	0	SENT_103	[p4l419t3392r674b3461],
14	to	TO	O	to	aux	15	SENT_103	[p4l713t3400r774b3447],
15	have	VB	O	have	xcomp	13	SENT_103	[p4l815t3392r961b3447],
16	crucial	JJ	O	crucial	amod	17	SENT_103	[p4l1002t3392r1211b3447],
17	role	NN	O	role	dobj	15	SENT_103	[p4l1253t3392r1388b3455],
18	,	,	O	,	_	0	SENT_103	[p4l1253t3392r1388b3455],
19	although	IN	O	although	mark	21	SENT_103	[p4l1429t3392r1713b3461],
20	MPH	NN	O	mph	nsubj	21	SENT_103	[p4l1754t3395r1905b3446],
21	blocks	VBZ	O	block	advcl	15	SENT_103	[p4l1946t3392r2145b3447],
22	efﬁciently	RB	O	efﬁciently	advmod	24	SENT_103	[p4l10t3481r327b3550],
23	norepinephrine	NN	O	norepinephrine	nn	24	SENT_103	[p4l350t3481r847b3550],
24	transporter	NN	O	transporter	dobj	21	SENT_103	[p4l871t3489r1233b3550],
25	as	RB	O	as	_	0	SENT_103	[p4l1254t3497r1316b3536],
26	well	RB	O	well	_	0	SENT_103	[p4l1340t3481r1474b3536],
27	(	JJ	O	(	amod	28	SENT_103	[p4l1499t3481r1652b3549],
28	Han	NN	O	han	dobj	21	SENT_103	[p4l1499t3481r1652b3549],
29	and	CC	O	and	_	0	SENT_103	[p4l1676t3481r1791b3536],
30	Gu	NN	O	gu	conj_and	28	SENT_103	[p4l1817t3484r1918b3544],
31	,	,	O	,	_	0	SENT_103	[p4l1817t3484r1918b3544],
32	2006	CD	DATE	2006	num	33	SENT_103	[p4l1944t3481r2145b3549],
33	)	NN	O	)	appos	28	SENT_103	[p4l1944t3481r2145b3549],
34	.	.	O	.	_	0	SENT_103	[p4l1944t3481r2145b3549],

1	In	IN	O	in	_	0	SENT_104	[p4l10t3574r70b3625],
2	contrast	NN	O	contrast	prep_in	19	SENT_104	[p4l104t3578r362b3625],
3	to	TO	O	to	_	0	SENT_104	[p4l395t3578r456b3625],
4	selective	JJ	O	selective	amod	8	SENT_104	[p4l491t3570r764b3625],
5	norepinephrine	NN	O	norepinephrine	nn	8	SENT_104	[p4l799t3570r1296b3639],
6	reuptake	NN	O	reuptake	nn	8	SENT_104	[p4l1331t3570r1611b3639],
7	inhibitor	NN	O	inhibitor	nn	8	SENT_104	[p4l1647t3570r1924b3625],
8	atomoxetine	NN	O	atomoxetine	prep_to	2	SENT_104	[p4l1956t3578r2146b3625, p4l10t3660r258b3723],
9	,	,	O	,	_	0	SENT_104	[p4l1956t3578r2146b3625, p4l10t3660r258b3723],
10	genetic	JJ	O	genetic	amod	11	SENT_104	[p4l288t3660r519b3728],
11	analyses	NNS	O	analysis	nsubjpass	19	SENT_104	[p4l548t3659r814b3728],
12	of	IN	O	of	_	0	SENT_104	[p4l845t3659r911b3714],
13	drug	NN	O	drug	nn	15	SENT_104	[p4l933t3659r1081b3728],
14	metabolizing	VBG	O	metabolize	amod	15	SENT_104	[p4l1110t3659r1527b3728],
15	enzymes	NNS	O	enzyme	prep_of	11	SENT_104	[p4l1555t3675r1835b3728],
16	have	VBP	O	have	aux	19	SENT_104	[p4l1866t3659r2012b3714],
17	not	RB	O	not	neg	19	SENT_104	[p4l2043t3667r2148b3714],
18	been	VBN	O	be	auxpass	19	SENT_104	[p4l9t3749r162b3804],
19	carried	VBN	O	carry	_	0	SENT_104	[p4l203t3749r424b3804],
20	out	RP	O	out	prt	19	SENT_104	[p4l466t3757r570b3804],
21	in	IN	O	in	_	0	SENT_104	[p4l610t3749r669b3803],
22	relation	NN	O	relation	prep_in	19	SENT_104	[p4l710t3749r956b3804],
23	to	TO	O	to	_	0	SENT_104	[p4l997t3757r1057b3804],
24	MPH	NN	O	mph	prep_to	22	SENT_104	[p4l1099t3752r1267b3812],
25	,	,	O	,	_	0	SENT_104	[p4l1099t3752r1267b3812],
26	probably	RB	O	probably	advmod	19	SENT_104	[p4l1309t3749r1591b3817],
27	because	IN	O	because	_	0	SENT_104	[p4l1630t3749r1881b3804],
28	lack	NN	O	lack	prep_because	19	SENT_104	[p4l1924t3748r2050b3804],
29	of	IN	O	of	_	0	SENT_104	[p4l2088t3748r2154b3804],
30	knowledge	NN	O	knowledge	prep_of	28	SENT_104	[p5l10t19r359b87],
31	of	IN	O	of	_	0	SENT_104	[p5l403t18r469b74],
32	potentially	RB	O	potentially	advmod	33	SENT_104	[p5l504t19r849b87],
33	interesting	JJ	O	interesting	amod	35	SENT_104	[p5l890t19r1234b87],
34	candidate	NN	O	candidate	nn	35	SENT_104	[p5l1277t19r1586b74],
35	polymorphisms	NNS	O	polymorphism	prep_of	30	SENT_104	[p5l1630t19r2145b87],
36	.	.	O	.	_	0	SENT_104	[p5l1630t19r2145b87],

1	Atomoxetine	NNP	O	Atomoxetine	nsubjpass	3	SENT_105	[p5l7t108r418b162],
2	is	VBZ	O	be	auxpass	3	SENT_105	[p5l441t108r486b162],
3	metabolized	VBN	O	metabolize	_	0	SENT_105	[p5l509t107r902b162],
4	by	IN	O	by	_	0	SENT_105	[p5l924t107r1000b176],
5	CYP2D6	NN	O	cyp2d6	agent	3	SENT_105	[p5l1020t110r1286b171],
6	,	,	O	,	_	0	SENT_105	[p5l1020t110r1286b171],
7	which	WDT	O	which	dobj	12	SENT_105	[p5l1307t107r1503b162],
8	genetic	JJ	O	genetic	amod	9	SENT_105	[p5l1524t108r1755b176],
9	variants	NNS	O	variant	nsubjpass	12	SENT_105	[p5l1773t108r2027b162],
10	are	VBP	O	be	auxpass	12	SENT_105	[p5l2050t123r2146b162],
11	well	RB	O	well	advmod	12	SENT_105	[p5l8t196r142b251],
12	known	VBN	O	know	rcmod	5	SENT_105	[p5l173t196r392b251],
13	in	IN	O	in	_	0	SENT_105	[p5l422t197r481b250],
14	humans	NNS	O	human	prep_in	12	SENT_105	[p5l511t196r780b252],
15	.	.	O	.	_	0	SENT_105	[p5l511t196r780b252],

1	A	DT	O	a	det	3	SENT_106	[p5l808t198r855b250],
2	recent	JJ	O	recent	amod	3	SENT_106	[p5l884t204r1083b251],
3	meta-analysis	NN	O	meta-analysis	nsubj	8	SENT_106	[p5l1112t196r1552b265],
4	of	IN	O	of	_	0	SENT_106	[p5l1584t196r1650b251],
5	several	JJ	O	several	amod	7	SENT_106	[p5l1672t196r1893b251],
6	clinical	JJ	O	clinical	amod	7	SENT_106	[p5l1924t196r2145b251],
7	trials	NNS	O	trial	prep_of	3	SENT_106	[p5l9t285r167b340],
8	reported	VBD	O	report	dep	16	SENT_106	[p5l214t285r486b354],
9	pharmacogenetic	JJ	O	pharmacogenetic	amod	10	SENT_106	[p5l532t285r1085b354],
10	differences	NNS	O	difference	dobj	8	SENT_106	[p5l1129t285r1476b340],
11	between	IN	O	between	_	0	SENT_106	[p5l1521t285r1796b340],
12	poor	JJ	O	poor	amod	15	SENT_106	[p5l1841t301r1988b354],
13	and	CC	O	and	_	0	SENT_106	[p5l2030t285r2146b340],
14	extensive	JJ	O	extensive	amod	15	SENT_106	[p5l10t375r309b429],
15	metabolizers	NNS	O	metabolizer	prep_between	10	SENT_106	[p5l334t374r744b429],
16	(	VBP	O	(	_	0	SENT_106	[p5l770t374r1124b443],
17	Michelson	NNP	PERSON	Michelson	dobj	16	SENT_106	[p5l770t374r1124b443],
18	et	FW	O	et	nn	19	SENT_106	[p5l1149t382r1208b429],
19	al.	FW	O	al.	nsubj	16	SENT_106	[p5l1232t374r1315b438],
20	,	,	O	,	_	0	SENT_106	[p5l1232t374r1315b438],
21	2007	CD	DATE	2007	num	22	SENT_106	[p5l1341t375r1540b443],
22	)	NN	O	)	appos	19	SENT_106	[p5l1341t375r1540b443],
23	.	.	O	.	_	0	SENT_106	[p5l1341t375r1540b443],

1	Poor	NNP	O	Poor	nn	2	SENT_107	[p5l1567t378r1712b429],
2	metabolizers	NNS	O	metabolizer	nsubj	3	SENT_107	[p5l1736t374r2146b429],
3	displayed	VBD	O	display	_	0	SENT_107	[p5l10t464r311b532],
4	greater	JJR	O	greater	amod	6	SENT_107	[p5l338t472r567b532],
5	symptom	NN	O	symptom	nn	6	SENT_107	[p5l593t472r893b532],
6	improvement	NN	O	improvement	dobj	3	SENT_107	[p5l921t465r1355b532],
7	than	IN	O	than	_	0	SENT_107	[p5l1381t464r1524b519],
8	extensive	JJ	O	extensive	amod	9	SENT_107	[p5l1552t465r1850b519],
9	metabolizers	NNS	O	metabolizer	prep_than	3	SENT_107	[p5l1879t464r2145b519, p5l10t553r192b616],
10	,	,	O	,	_	0	SENT_107	[p5l1879t464r2145b519, p5l10t553r192b616],
11	but	CC	O	but	_	0	SENT_107	[p5l213t552r319b608],
12	several	JJ	O	several	amod	14	SENT_107	[p5l338t553r559b608],
13	side	JJ	O	side	amod	14	SENT_107	[p5l580t553r705b608],
14	effects	NNS	O	effect	nsubj	26	SENT_107	[p5l725t552r945b616],
15	,	,	O	,	_	0	SENT_107	[p5l725t552r945b616],
16	such	JJ	O	such	_	0	SENT_107	[p5l967t553r1110b608],
17	as	IN	O	as	_	0	SENT_107	[p5l1130t568r1191b608],
18	decreased	VBN	O	decrease	amod	19	SENT_107	[p5l1213t553r1529b608],
19	appetite	NN	O	appetite	prep_such_as	14	SENT_107	[p5l1550t553r1811b621],
20	or	CC	O	or	_	0	SENT_107	[p5l1831t568r1896b608],
21	tremor	NN	O	tremor	conj_or	19	SENT_107	[p5l1914t561r2145b616],
22	,	,	O	,	_	0	SENT_107	[p5l1914t561r2145b616],
23	were	VBD	O	be	cop	26	SENT_107	[p5l8t657r167b696],
24	also	RB	O	also	advmod	26	SENT_107	[p5l195t641r317b696],
25	more	RBR	O	more	advmod	26	SENT_107	[p5l348t657r512b696],
26	frequent	JJ	O	frequent	conj_but	3	SENT_107	[p5l541t641r812b710],
27	in	IN	O	in	_	0	SENT_107	[p5l840t642r898b695],
28	poor	JJ	O	poor	amod	29	SENT_107	[p5l926t657r1073b710],
29	metabolizers	NNS	O	metabolizer	prep_in	26	SENT_107	[p5l1100t641r1526b704],
30	,	,	O	,	_	0	SENT_107	[p5l1100t641r1526b704],
31	most	RBS	O	most	advmod	33	SENT_107	[p5l1556t649r1714b696],
32	likely	RB	O	likely	advmod	33	SENT_107	[p5l1741t641r1914b710],
33	due	JJ	O	due	acomp	26	SENT_107	[p5l1941t641r2057b696],
34	to	TO	O	to	_	0	SENT_107	[p5l2085t649r2146b696],
35	higher	JJR	O	higher	amod	38	SENT_107	[p5l10t730r217b799],
36	plasma	NN	O	plasma	nn	38	SENT_107	[p5l241t730r467b799],
37	drug	NN	O	drug	nn	38	SENT_107	[p5l492t730r640b799],
38	concentration	NN	O	concentration	prep_to	33	SENT_107	[p5l664t731r1121b786],
39	.	.	O	.	_	0	SENT_107	[p5l664t731r1121b786],

1	Our	PRP$	O	we	poss	3	SENT_108	[p5l111t822r230b874],
2	genetic	JJ	O	genetic	amod	3	SENT_108	[p5l252t820r483b888],
3	analyses	NNS	O	analysis	nsubj	8	SENT_108	[p5l507t819r773b888],
4	of	IN	O	of	_	0	SENT_108	[p5l799t819r865b874],
5	MPH	NN	O	mph	nn	7	SENT_108	[p5l882t823r1350b888],
6	—	NN	O	—	nn	7	SENT_108	[p5l882t823r1350b888],
7	response	NN	O	response	prep_of	3	SENT_108	[p5l882t823r1350b888],
8	indicated	VBD	O	indicate	_	0	SENT_108	[p5l1376t819r1669b874],
9	an	DT	O	a	det	10	SENT_108	[p5l1695t835r1770b874],
10	association	NN	O	association	dobj	8	SENT_108	[p5l1795t820r2146b874],
11	with	IN	O	with	_	0	SENT_108	[p5l8t908r155b963],
12	the	DT	O	the	det	17	SENT_108	[p5l178t908r279b963],
13	rare	JJ	O	rare	amod	17	SENT_108	[p5l304t924r427b963],
14	CES1	NN	O	ces1	nn	17	SENT_108	[p5l452t911r597b963],
15	143Glu	NN	O	143glu	nn	17	SENT_108	[p5l625t908r1120b964],
16	—	CD	NUMBER	—	num	17	SENT_108	[p5l625t908r1120b964],
17	variant	NN	O	variant	prep_with	8	SENT_108	[p5l625t908r1120b964],
18	:	:	O	:	_	0	SENT_108	[p5l625t908r1120b964],
19	patients	NNS	O	patient	nsubj	25	SENT_108	[p5l1149t909r1404b977],
20	carrying	VBG	O	carry	partmod	19	SENT_108	[p5l1429t909r1692b977],
21	the	DT	O	the	det	24	SENT_108	[p5l1714t908r1814b963],
22	Glu	NNP	O	Glu	nn	24	SENT_108	[p5l1839t908r2146b963],
23	—	CD	NUMBER	—	num	24	SENT_108	[p5l1839t908r2146b963],
24	allele	NN	O	allele	dobj	20	SENT_108	[p5l1839t908r2146b963],
25	required	VBD	O	require	parataxis	8	SENT_108	[p5l10t998r279b1066],
26	lower	JJR	O	lower	amod	27	SENT_108	[p5l298t998r480b1053],
27	doses	NNS	O	dose	dobj	25	SENT_108	[p5l496t998r671b1053],
28	of	IN	O	of	_	0	SENT_108	[p5l691t998r757b1053],
29	MPH	NN	O	mph	prep_of	27	SENT_108	[p5l768t1001r920b1052],
30	for	IN	O	for	_	0	SENT_108	[p5l940t998r1029b1053],
31	symptom	NN	O	symptom	nn	32	SENT_108	[p5l1047t1006r1347b1066],
32	reduction	NN	O	reduction	prep_for	25	SENT_108	[p5l1366t998r1686b1053],
33	.	.	O	.	_	0	SENT_108	[p5l1366t998r1686b1053],

1	Since	IN	O	since	mark	5	SENT_109	[p5l1706t999r1871b1053],
2	the	DT	O	the	det	3	SENT_109	[p5l1890t998r1991b1053],
3	Gluvariant	NNP	O	Gluvariant	nsubj	5	SENT_109	[p5l2010t998r2145b1053, p5l8t1088r233b1142],
4	has	VBZ	O	have	aux	5	SENT_109	[p5l275t1087r379b1142],
5	reduced	VBN	O	reduce	advcl	15	SENT_109	[p5l423t1087r678b1142],
6	enzyme	NN	O	enzyme	nn	7	SENT_109	[p5l722t1103r970b1155],
7	activity	NN	O	activity	dobj	5	SENT_109	[p5l1014t1088r1259b1155],
8	,	,	O	,	_	0	SENT_109	[p5l1014t1088r1259b1155],
9	patient	NN	O	patient	nsubj	15	SENT_109	[p5l1303t1088r1530b1155],
10	with	IN	O	with	_	0	SENT_109	[p5l1570t1087r1716b1142],
11	this	DT	O	this	det	13	SENT_109	[p5l1759t1087r1874b1142],
12	genetic	JJ	O	genetic	amod	13	SENT_109	[p5l1916t1088r2147b1155],
13	variant	NN	O	variant	prep_with	9	SENT_109	[p5l8t1176r233b1230],
14	might	MD	O	might	aux	15	SENT_109	[p5l252t1175r441b1244],
15	have	VB	O	have	_	0	SENT_109	[p5l459t1175r607b1230],
16	higher	JJR	O	higher	amod	19	SENT_109	[p5l627t1175r834b1244],
17	plasma	NN	O	plasma	nn	19	SENT_109	[p5l851t1175r1078b1244],
18	drug	NN	O	drug	nn	19	SENT_109	[p5l1097t1175r1244b1244],
19	level	NN	O	level	dobj	15	SENT_109	[p5l1264t1175r1426b1239],
20	,	,	O	,	_	0	SENT_109	[p5l1264t1175r1426b1239],
21	similarly	RB	O	similarly	amod	28	SENT_109	[p5l1448t1175r1724b1244],
22	to	TO	O	to	_	0	SENT_109	[p5l1741t1183r1802b1230],
23	that	DT	O	that	prep_to	21	SENT_109	[p5l1821t1175r1949b1230],
24	of	IN	O	of	_	0	SENT_109	[p5l1967t1175r2033b1230],
25	the	DT	O	the	det	26	SENT_109	[p5l2044t1175r2146b1230],
26	CYP2D6	NN	O	cyp2d6	prep_of	23	SENT_109	[p5l10t1267r261b1320],
27	poor	JJ	O	poor	amod	28	SENT_109	[p5l297t1280r445b1333],
28	metabolizers	NNS	O	metabolizer	appos	19	SENT_109	[p5l480t1265r889b1320],
29	treated	VBN	O	treat	partmod	28	SENT_109	[p5l925t1265r1151b1320],
30	with	IN	O	with	_	0	SENT_109	[p5l1186t1265r1333b1320],
31	atomoxetine	NN	O	atomoxetine	prep_with	29	SENT_109	[p5l1368t1265r1783b1320],
32	.	.	O	.	_	0	SENT_109	[p5l1368t1265r1783b1320],

1	Our	PRP$	O	we	poss	2	SENT_110	[p5l1820t1267r1938b1320],
2	study	NN	O	study	nsubj	7	SENT_110	[p5l1973t1265r2148b1333],
3	was	VBD	O	be	cop	7	SENT_110	[p5l8t1369r130b1408],
4	not	RB	O	not	neg	7	SENT_110	[p5l162t1361r265b1408],
5	a	DT	O	a	det	7	SENT_110	[p5l294t1369r326b1408],
6	placebo	NN	O	placebo	nn	7	SENT_110	[p5l356t1353r956b1422],
7	—	NN	O	—	ccomp	19	SENT_110	[p5l356t1353r956b1422],
8	controlled	VBN	O	control	partmod	7	SENT_110	[p5l356t1353r956b1422],
9	clinical	JJ	O	clinical	amod	10	SENT_110	[p5l987t1353r1209b1408],
10	trial	NN	O	trial	dobj	8	SENT_110	[p5l1239t1353r1382b1417],
11	,	,	O	,	_	0	SENT_110	[p5l1239t1353r1382b1417],
12	the	DT	O	the	det	15	SENT_110	[p5l1413t1353r1514b1408],
13	starting	VBG	O	start	amod	15	SENT_110	[p5l1545t1354r1790b1422],
14	MPH	NN	O	mph	nn	15	SENT_110	[p5l1819t1357r1971b1408],
15	dose	NN	O	dose	nsubj	19	SENT_110	[p5l2001t1353r2146b1408],
16	was	VBD	O	be	cop	19	SENT_110	[p5l8t1459r130b1498],
17	5-15	CD	NUMBER	5-15	num	19	SENT_110	[p5l159t1446r309b1498],
18	mg	NN	O	mg	nn	19	SENT_110	[p5l339t1459r438b1511],
19	(	NN	O	(	_	0	SENT_110	[p5l465t1443r831b1511],
20	depending	VBG	O	depend	_	0	SENT_110	[p5l465t1443r831b1511],
21	on	IN	O	on	prepc_depending_on	19	SENT_110	[p5l856t1459r934b1498],
22	the	DT	O	the	det	25	SENT_110	[p5l961t1443r1061b1498],
23	body	NN	O	body	nn	25	SENT_110	[p5l1089t1443r1247b1511],
24	weight	NN	O	weight	nn	25	SENT_110	[p5l1271t1443r1517b1511],
25	)	NN	O	)	pobj	19	SENT_110	[p5l1271t1443r1517b1511],
26	in	IN	O	in	_	0	SENT_110	[p5l1545t1444r1604b1497],
27	the	DT	O	the	det	28	SENT_110	[p5l1630t1443r1731b1498],
28	morning	NN	TIME	morning	prep_in	25	SENT_110	[p5l1760t1444r2033b1511],
29	for	IN	O	for	_	0	SENT_110	[p5l2060t1443r2148b1498],
30	every	DT	O	every	det	31	SENT_110	[p5l10t1548r185b1600],
31	patient	NN	O	patient	prep_for	28	SENT_110	[p5l220t1533r446b1600],
32	and	CC	O	and	_	0	SENT_110	[p5l480t1532r596b1587],
33	supplemented	VBN	O	supplement	conj_and	19	SENT_110	[p5l633t1532r1089b1600],
34	with	IN	O	with	_	0	SENT_110	[p5l1124t1532r1271b1587],
35	another	DT	O	another	det	36	SENT_110	[p5l1306t1532r1555b1587],
36	dose	NN	O	dose	prep_with	33	SENT_110	[p5l1589t1532r1733b1587],
37	at	IN	O	at	_	0	SENT_110	[p5l1769t1540r1829b1587],
38	noon	NN	TIME	noon	prep_at	36	SENT_110	[p5l1863t1548r2023b1587],
39	for	IN	O	for	_	0	SENT_110	[p5l2060t1532r2148b1587],
40	those	DT	O	those	prep_for	33	SENT_110	[p5l9t1620r181b1674],
41	who	WP	O	who	nsubj	42	SENT_110	[p5l209t1620r349b1674],
42	needed	VBD	O	need	rcmod	40	SENT_110	[p5l381t1620r612b1674],
43	it	PRP	O	it	dobj	42	SENT_110	[p5l644t1621r687b1674],
44	for	IN	O	for	_	0	SENT_110	[p5l716t1620r804b1674],
45	afternoon	NN	TIME	afternoon	nn	46	SENT_110	[p5l833t1620r1143b1674],
46	activities	NNS	O	activity	prep_for	42	SENT_110	[p5l1173t1621r1456b1674],
47	at	IN	O	at	_	0	SENT_110	[p5l1488t1628r1547b1674],
48	school	NN	O	school	prep_at	42	SENT_110	[p5l1577t1620r1793b1675],
49	.	.	O	.	_	0	SENT_110	[p5l1577t1620r1793b1675],

1	The	DT	O	the	det	2	SENT_111	[p5l1822t1620r1938b1674],
2	effectiveness	NN	O	effectiveness	nsubjpass	6	SENT_111	[p5l1970t1620r2145b1674, p5l9t1709r265b1763],
3	of	IN	O	of	_	0	SENT_111	[p5l292t1708r358b1763],
4	MPH	NN	O	mph	prep_of	2	SENT_111	[p5l376t1712r528b1763],
5	was	VBD	O	be	auxpass	6	SENT_111	[p5l552t1724r674b1763],
6	assessed	VBN	O	assess	_	0	SENT_111	[p5l701t1708r970b1763],
7	every	DT	SET	every	det	8	SENT_111	[p5l997t1724r1173b1777],
8	month	NN	SET	month	tmod	6	SENT_111	[p5l1196t1708r1407b1763],
9	in	IN	O	in	_	0	SENT_111	[p5l1433t1709r1491b1763],
10	the	DT	O	the	det	11	SENT_111	[p5l1516t1708r1617b1763],
11	ﬁrst	NN	O	ﬁrst	prep_in	6	SENT_111	[p5l1643t1708r1769b1763],
12	six	CD	DURATION	six	num	13	SENT_111	[p5l1794t1709r1880b1763],
13	months	NNS	NUMBER	month	tmod	11	SENT_111	[p5l1905t1708r2146b1763],
14	when	WRB	O	when	advmod	20	SENT_111	[p5l8t1798r188b1853],
15	the	DT	O	the	det	16	SENT_111	[p5l215t1798r315b1853],
16	children	NNS	O	child	nsubj	20	SENT_111	[p5l343t1798r605b1853],
17	and	CC	O	and	_	0	SENT_111	[p5l632t1798r747b1853],
18	their	PRP$	O	they	poss	19	SENT_111	[p5l774t1798r927b1853],
19	parents	NNS	O	parent	conj_and	16	SENT_111	[p5l953t1806r1189b1866],
20	came	VBD	O	come	dep	11	SENT_111	[p5l1217t1813r1383b1853],
21	back	RB	O	back	advmod	20	SENT_111	[p5l1410t1798r1557b1853],
22	for	IN	O	for	_	0	SENT_111	[p5l1582t1797r1670b1853],
23	control	NN	O	control	nn	24	SENT_111	[p5l1695t1798r1919b1853],
24	examinations	NNS	O	examination	prep_for	20	SENT_111	[p5l1947t1813r2146b1853, p5l10t1887r263b1941],
25	and	CC	O	and	_	0	SENT_111	[p5l284t1886r399b1941],
26	drug	NN	O	drug	nn	28	SENT_111	[p5l420t1886r1000b1955],
27	—	NN	O	—	nn	28	SENT_111	[p5l420t1886r1000b1955],
28	prescription	NN	O	prescription	prep_for	20	SENT_111	[p5l420t1886r1000b1955],
29	.	.	O	.	_	0	SENT_111	[p5l420t1886r1000b1955],

1	Unfortunately	RB	O	unfortunately	advmod	7	SENT_112	[p5l1020t1886r1477b1955],
2	,	,	O	,	_	0	SENT_112	[p5l1020t1886r1477b1955],
3	no	DT	O	no	det	5	SENT_112	[p5l1499t1902r1575b1941],
4	detailed	JJ	O	detailed	amod	5	SENT_112	[p5l1596t1886r1850b1941],
5	data	NNS	O	datum	nsubj	7	SENT_112	[p5l1871t1886r2007b1941],
6	was	VBD	O	be	cop	7	SENT_112	[p5l2023t1902r2145b1941],
7	available	JJ	O	available	_	0	SENT_112	[p5l10t1975r287b2030],
8	about	IN	O	about	_	0	SENT_112	[p5l313t1975r494b2030],
9	side	JJ	O	side	amod	10	SENT_112	[p5l519t1975r643b2030],
10	effects	NNS	O	effect	prep_about	7	SENT_112	[p5l670t1975r873b2030],
11	in	IN	O	in	_	0	SENT_112	[p5l900t1976r959b2029],
12	our	PRP$	O	we	poss	13	SENT_112	[p5l984t1991r1092b2030],
13	sample	NN	O	sample	prep_in	7	SENT_112	[p5l1116t1975r1357b2044],
14	.	.	O	.	_	0	SENT_112	[p5l1116t1975r1357b2044],

1	The	DT	O	the	det	3	SENT_113	[p5l109t2065r225b2120],
2	main	JJ	O	main	amod	3	SENT_113	[p5l248t2066r407b2120],
3	limitation	NN	O	limitation	nsubj	12	SENT_113	[p5l429t2065r742b2120],
4	of	IN	O	of	_	0	SENT_113	[p5l763t2065r830b2120],
5	the	DT	O	the	det	7	SENT_113	[p5l843t2065r944b2120],
6	present	JJ	DATE	present	amod	7	SENT_113	[p5l967t2073r1206b2133],
7	study	NN	O	study	prep_of	3	SENT_113	[p5l1228t2065r1403b2133],
8	is	VBZ	O	be	cop	12	SENT_113	[p5l1423t2066r1469b2120],
9	the	DT	O	the	det	12	SENT_113	[p5l1491t2065r1592b2120],
10	small	JJ	O	small	amod	12	SENT_113	[p5l1615t2065r1782b2120],
11	group	NN	O	group	nn	12	SENT_113	[p5l1803t2081r1990b2133],
12	size	NN	O	size	_	0	SENT_113	[p5l2013t2066r2145b2128],
13	,	,	O	,	_	0	SENT_113	[p5l2013t2066r2145b2128],
14	there	EX	O	there	expl	19	SENT_113	[p5l9t2153r175b2208],
15	were	VBD	O	be	aux	19	SENT_113	[p5l210t2169r368b2208],
16	only	RB	O	only	advmod	19	SENT_113	[p5l406t2153r543b2222],
17	7	CD	NUMBER	7	num	18	SENT_113	[p5l580t2157r613b2208],
18	patients	NNS	O	patient	pobj	16	SENT_113	[p5l652t2154r907b2222],
19	carrying	VBG	O	carry	dep	12	SENT_113	[p5l945t2154r1208b2222],
20	the	DT	O	the	det	24	SENT_113	[p5l1243t2153r1344b2208],
21	143	CD	NUMBER	143	num	24	SENT_113	[p5l1385t2156r1491b2208],
22	Glu	NNP	O	Glu	nn	24	SENT_113	[p5l1532t2153r1854b2217],
23	—	CD	NUMBER	—	num	24	SENT_113	[p5l1532t2153r1854b2217],
24	allele	NN	O	allele	dobj	19	SENT_113	[p5l1532t2153r1854b2217],
25	,	,	O	,	_	0	SENT_113	[p5l1532t2153r1854b2217],
26	and	CC	O	and	_	0	SENT_113	[p5l1892t2153r2008b2208],
27	the	DT	O	the	det	28	SENT_113	[p5l2045t2153r2146b2208],
28	difference	NN	O	difference	nsubj	34	SENT_113	[p5l10t2242r327b2297],
29	in	IN	O	in	_	0	SENT_113	[p5l348t2243r406b2297],
30	daily	JJ	SET	daily	amod	31	SENT_113	[p5l426t2242r580b2311],
31	doses	NNS	O	dose	prep_in	34	SENT_113	[p5l598t2242r773b2297],
32	was	VBD	O	be	cop	34	SENT_113	[p5l792t2258r914b2297],
33	relatively	RB	O	relatively	advmod	34	SENT_113	[p5l935t2242r1232b2311],
34	small	JJ	O	small	conj_and	12	SENT_113	[p5l1249t2242r1416b2297],
35	(	CD	NUMBER	(	number	36	SENT_113	[p5l1436t2242r1627b2311],
36	0.410	CD	NUMBER	0.410	dep	34	SENT_113	[p5l1436t2242r1627b2311],
37	vs	CC	O	vs	_	0	SENT_113	[p5l1645t2258r1710b2297],
38	0.572	CD	NUMBER	0.572	num	39	SENT_113	[p5l1731t2245r1898b2298],
39	mg/kg	NN	O	mg/kg	conj_vs	34	SENT_113	[p5l1921t2242r2146b2311],
40	)	NN	O	)	dep	39	SENT_113	[p5l1921t2242r2146b2311],
41	and	CC	O	and	_	0	SENT_113	[p5l10t2332r125b2387],
42	was	VBD	O	be	auxpass	43	SENT_113	[p5l149t2347r271b2387],
43	based	VBN	O	base	conj_and	34	SENT_113	[p5l296t2332r478b2387],
44	on	IN	O	on	_	0	SENT_113	[p5l504t2347r582b2387],
45	5	CD	NUMBER	5	num	46	SENT_113	[p5l608t2335r641b2387],
46	patients	NNS	O	patient	prep_on	43	SENT_113	[p5l668t2332r923b2400],
47	with	IN	O	with	_	0	SENT_113	[p5l947t2332r1094b2387],
48	Gly/Glu	NN	O	gly/glu	nn	49	SENT_113	[p5l1119t2331r1358b2400],
49	genotype	NN	O	genotype	prep_with	43	SENT_113	[p5l1382t2340r1676b2400],
50	responding	VBG	O	respond	partmod	49	SENT_113	[p5l1703t2332r2062b2400],
51	to	TO	O	to	_	0	SENT_113	[p5l2085t2340r2146b2387],
52	MPH	NN	O	mph	prep_to	50	SENT_113	[p5l10t2424r178b2476],
53	.	.	O	.	_	0	SENT_113	[p5l10t2424r178b2476],

1	Therefore	RB	O	therefore	advmod	7	SENT_114	[p5l199t2420r524b2484],
2	,	,	O	,	_	0	SENT_114	[p5l199t2420r524b2484],
3	our	PRP$	O	we	poss	4	SENT_114	[p5l547t2436r655b2476],
4	results	NNS	O	result	nsubjpass	7	SENT_114	[p5l677t2421r886b2476],
5	should	MD	O	should	aux	7	SENT_114	[p5l910t2421r1122b2476],
6	be	VB	O	be	auxpass	7	SENT_114	[p5l1145t2421r1218b2476],
7	regarded	VBN	O	regard	_	0	SENT_114	[p5l1243t2421r1525b2489],
8	as	IN	O	as	_	0	SENT_114	[p5l1548t2436r1610b2476],
9	preliminary	JJ	O	preliminary	prep_as	7	SENT_114	[p5l1634t2421r2010b2489],
10	and	CC	O	and	_	0	SENT_114	[p5l2030t2421r2146b2476],
11	require	VB	O	require	conj_and	7	SENT_114	[p5l10t2510r237b2578],
12	further	JJ	O	further	amod	13	SENT_114	[p5l263t2509r487b2564],
13	analyses	NNS	O	analysis	dobj	11	SENT_114	[p5l510t2509r776b2578],
14	in	IN	O	in	_	0	SENT_114	[p5l802t2510r861b2563],
15	larger	JJR	O	larger	amod	17	SENT_114	[p5l887t2509r1072b2578],
16	patient	NN	O	patient	nn	17	SENT_114	[p5l1096t2510r1322b2578],
17	samples	NNS	O	sample	prep_in	11	SENT_114	[p5l1347t2509r1619b2578],
18	.	.	O	.	_	0	SENT_114	[p5l1347t2509r1619b2578],

1	Acknowledgement	NN	O	acknowledgement	_	0	SENT_115	[p5l6t2655r638b2723],

1	This	DT	O	this	det	2	SENT_116	[p5l109t2833r239b2888],
2	work	NN	O	work	nsubjpass	4	SENT_116	[p5l265t2833r430b2888],
3	was	VBD	O	be	auxpass	4	SENT_116	[p5l451t2849r574b2888],
4	supported	VBN	O	support	_	0	SENT_116	[p5l601t2833r923b2902],
5	by	IN	O	by	_	0	SENT_116	[p5l950t2833r1026b2902],
6	Hungarian	JJ	MISC	hungarian	amod	9	SENT_116	[p5l1050t2834r1384b2902],
7	OTKA	NN	O	otka	nn	9	SENT_116	[p5l1410t2835r1588b2888],
8	fund	NN	O	fund	nn	9	SENT_116	[p5l1612t2833r1756b2888],
9	F67784	NN	O	f67784	agent	4	SENT_116	[p5l1782t2836r2029b2889],
10	.	.	O	.	_	0	SENT_116	[p5l1782t2836r2029b2889],

1	Appendix	NN	O	appendix	_	0	SENT_117	[p5l6t3013r346b3082],
2	.	.	O	.	_	0	SENT_117	[p5l6t3013r346b3082],

1	Supplementary	NNP	O	Supplementary	nn	2	SENT_118	[p5l390t3013r907b3082],
2	data	NNS	O	datum	_	0	SENT_118	[p5l930t3013r1076b3068],

1	Supplementary	NNP	O	Supplementary	nn	2	SENT_119	[p5l112t3192r602b3260],
2	data	NNS	O	datum	nsubjpass	9	SENT_119	[p5l621t3192r756b3247],
3	associated	VBN	O	associate	partmod	2	SENT_119	[p5l776t3192r1102b3247],
4	with	IN	O	with	_	0	SENT_119	[p5l1122t3192r1269b3247],
5	this	DT	O	this	det	6	SENT_119	[p5l1289t3192r1404b3247],
6	article	NN	O	article	prep_with	3	SENT_119	[p5l1426t3192r1623b3247],
7	can	MD	O	can	aux	9	SENT_119	[p5l1644t3207r1751b3247],
8	be	VB	O	be	auxpass	9	SENT_119	[p5l1771t3192r1844b3247],
9	found	VBN	O	find	_	0	SENT_119	[p5l1866t3191r2065b3255],
10	,	,	O	,	_	0	SENT_119	[p5l1866t3191r2065b3255],
11	in	IN	O	in	_	0	SENT_119	[p5l2088t3192r2146b3246],
12	the	DT	O	the	det	14	SENT_119	[p5l9t3281r110b3336],
13	online	JJ	O	online	amod	14	SENT_119	[p5l136t3281r334b3336],
14	version	NN	O	version	prep_in	9	SENT_119	[p5l359t3282r608b3344],
15	,	,	O	,	_	0	SENT_119	[p5l359t3282r608b3344],
16	at	IN	O	at	_	0	SENT_119	[p5l634t3289r694b3336],
17	doi	FW	O	doi	nn	18	SENT_119	[p5l717t3281r1966b3350],
18	:10.1016	FW	O	:10.1016	prep_at	9	SENT_119	[p5l717t3281r1966b3350],
19	/	:	O	/	punct	21	SENT_119	[p5l717t3281r1966b3350],
20	j.	NN	O	j.	nn	21	SENT_119	[p5l717t3281r1966b3350],
21	neuropharm	NN	O	neuropharm	dep	18	SENT_119	[p5l717t3281r1966b3350],
22	.2009.08.014	CD	NUMBER	.2009.08.014	dep	21	SENT_119	[p5l717t3281r1966b3350],
23	.	.	O	.	_	0	SENT_119	[p5l717t3281r1966b3350],

1	References	NNS	O	reference	_	0	SENT_120	[p5l9t3461r370b3515],

1	Biederman	NNP	PERSON	Biederman	nn	7	SENT_121	[p6l10t62r298b112],
2	,	,	O	,	_	0	SENT_121	[p6l10t62r298b112],
3	J.	NNP	O	J.	appos	7	SENT_121	[p6l333t64r379b116],
4	,	,	O	,	_	0	SENT_121	[p6l333t64r379b116],
5	Spencer	NNP	LOCATION	Spencer	appos	7	SENT_121	[p6l421t64r632b116],
6	,	,	O	,	_	0	SENT_121	[p6l421t64r632b116],
7	T.J.	NNP	LOCATION	T.J.	_	0	SENT_121	[p6l672t64r754b116],
8	,	,	O	,	_	0	SENT_121	[p6l672t64r754b116],
9	2008	CD	DATE	2008	appos	7	SENT_121	[p6l796t64r936b105],
10	.	.	O	.	_	0	SENT_121	[p6l796t64r936b105],

1	Psychopharmacological	JJ	O	psychopharmacological	amod	2	SENT_122	[p6l979t61r1579b116],
2	interventions	NNS	O	intervention	_	0	SENT_122	[p6l1621t62r1973b105],
3	.	.	O	.	_	0	SENT_122	[p6l1621t62r1973b105],

1	Child	NN	O	child	_	0	SENT_123	[p6l2016t61r2146b105],

1	Adolesc	NNP	O	Adolesc	_	0	SENT_124	[p6l108t128r319b172],
2	.	.	O	.	_	0	SENT_124	[p6l108t128r319b172],

1	Psychiatr	NN	O	psychiatr	_	0	SENT_125	[p6l342t128r583b182],
2	.	.	O	.	_	0	SENT_125	[p6l342t128r583b182],

1	Clin	NNP	O	Clin	_	0	SENT_126	[p6l607t128r716b172],
2	.	.	O	.	_	0	SENT_126	[p6l607t128r716b172],

1	N.	NNP	O	N.	nn	2	SENT_127	[p6l739t131r789b172],
2	Am	NNP	O	Am	_	0	SENT_127	[p6l809t130r909b172],
3	.	.	O	.	_	0	SENT_127	[p6l809t130r909b172],

1	17	CD	NUMBER	17	num	2	SENT_128	[p6l931t130r983b171],
2	(	NN	O	(	_	0	SENT_128	[p6l1007t128r1089b182],
3	2	CD	NUMBER	2	num	4	SENT_128	[p6l1007t128r1089b182],
4	)	NN	O	)	dep	2	SENT_128	[p6l1007t128r1089b182],
5	,	,	O	,	_	0	SENT_128	[p6l1007t128r1089b182],
6	439-458	CD	NUMBER	439-458	number	7	SENT_128	[p6l1110t130r1333b172],
7	(	CD	NUMBER	(	num	9	SENT_128	[p6l1357t128r1455b182],
8	xi	NN	O	xi	nn	9	SENT_128	[p6l1357t128r1455b182],
9	)	NN	O	)	appos	4	SENT_128	[p6l1357t128r1455b182],
10	.	.	O	.	_	0	SENT_128	[p6l1357t128r1455b182],

1	DuPaul	NNP	O	DuPaul	nn	3	SENT_129	[p6l10t194r201b244],
2	,	,	O	,	_	0	SENT_129	[p6l10t194r201b244],
3	G.J.	NNP	LOCATION	G.J.	_	0	SENT_129	[p6l235t196r326b249],
4	,	,	O	,	_	0	SENT_129	[p6l235t196r326b249],
5	1998	CD	DATE	1998	appos	3	SENT_129	[p6l358t196r490b238],
6	.	.	O	.	_	0	SENT_129	[p6l358t196r490b238],

1	ADHD	NNP	O	ADHD	nn	3	SENT_130	[p6l521t196r678b237],
2	Rating	NNP	O	Rating	nn	3	SENT_130	[p6l712t195r874b249],
3	Scale-IV	NNP	O	Scale-IV	_	0	SENT_130	[p6l906t194r1126b238],
4	:	:	O	:	_	0	SENT_130	[p6l906t194r1126b238],
5	Checklists	NNS	O	checklist	dep	3	SENT_130	[p6l1162t194r1429b244],
6	,	,	O	,	_	0	SENT_130	[p6l1162t194r1429b244],
7	Norms	NNS	O	norm	dep	3	SENT_130	[p6l1462t197r1630b238],
8	and	CC	O	and	_	0	SENT_130	[p6l1663t194r1755b238],
9	Clinical	JJ	O	clinical	amod	10	SENT_130	[p6l1788t194r1973b238],
10	Interpretations	NNS	O	interpretation	dep	3	SENT_130	[p6l2007t197r2146b238, p6l111t260r383b314],
11	.	.	O	.	_	0	SENT_130	[p6l2007t197r2146b238, p6l111t260r383b314],

1	Guilford	NNP	ORGANIZATION	Guilford	nn	2	SENT_131	[p6l406t260r613b303],
2	Press	NNP	ORGANIZATION	Press	_	0	SENT_131	[p6l637t263r779b310],
3	,	,	O	,	_	0	SENT_131	[p6l637t263r779b310],
4	New	NNP	LOCATION	New	nn	5	SENT_131	[p6l801t263r917b303],
5	York	NNP	LOCATION	York	appos	2	SENT_131	[p6l935t260r1063b304],
6	.	.	O	.	_	0	SENT_131	[p6l935t260r1063b304],

1	Han	NNP	LOCATION	Han	nn	7	SENT_132	[p6l10t329r123b376],
2	,	,	O	,	_	0	SENT_132	[p6l10t329r123b376],
3	D.D.	NNP	LOCATION	D.D.	appos	7	SENT_132	[p6l163t329r277b376],
4	,	,	O	,	_	0	SENT_132	[p6l163t329r277b376],
5	Gu	NNP	O	Gu	appos	7	SENT_132	[p6l317t328r398b376],
6	,	,	O	,	_	0	SENT_132	[p6l317t328r398b376],
7	H.H.	NNP	LOCATION	H.H.	_	0	SENT_132	[p6l439t329r557b376],
8	,	,	O	,	_	0	SENT_132	[p6l439t329r557b376],
9	2006	CD	DATE	2006	appos	7	SENT_132	[p6l596t328r736b370],
10	.	.	O	.	_	0	SENT_132	[p6l596t328r736b370],

1	Comparison	NN	O	comparison	_	0	SENT_133	[p6l777t327r1083b380],
2	of	IN	O	of	_	0	SENT_133	[p6l1122t326r1175b370],
3	the	DT	O	the	det	5	SENT_133	[p6l1208t326r1288b370],
4	monoamine	NN	O	monoamine	nn	5	SENT_133	[p6l1328t327r1634b370],
5	transporters	NNS	O	transporter	prep_of	1	SENT_133	[p6l1673t332r1986b380],
6	from	IN	O	from	_	0	SENT_133	[p6l2026t326r2147b370],
7	human	JJ	O	human	prep_from	5	SENT_133	[p6l111t392r290b435],
8	and	CC	O	and	_	0	SENT_133	[p6l332t392r425b435],
9	mouse	NN	O	mouse	prep_from	5	SENT_133	[p6l469t404r636b435],
10	in	IN	O	in	_	0	SENT_133	[p6l679t392r726b435],
11	their	PRP$	O	they	poss	12	SENT_133	[p6l768t392r890b435],
12	sensitivities	NNS	O	sensitivity	prep_in	1	SENT_133	[p6l932t392r1231b435],
13	to	TO	O	to	_	0	SENT_133	[p6l1275t398r1324b435],
14	psychostimulant	JJ	O	psychostimulant	amod	15	SENT_133	[p6l1367t392r1791b446],
15	drugs	NNS	O	drug	prep_to	1	SENT_133	[p6l1833t392r1987b446],
16	.	.	O	.	_	0	SENT_133	[p6l1833t392r1987b446],

1	BMC	NNP	O	BMC	nn	2	SENT_134	[p6l2031t394r2148b435],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_134	[p6l111t458r392b502],
3	.	.	O	.	_	0	SENT_134	[p6l111t458r392b502],

1	3	CD	NUMBER	3	num	2	SENT_135	[p6l422t460r449b502],
2	(	NN	O	(	_	0	SENT_135	[p6l480t458r562b512],
3	6	CD	NUMBER	6	num	4	SENT_135	[p6l480t458r562b512],
4	)	NN	O	)	dep	2	SENT_135	[p6l480t458r562b512],
5	,	,	O	,	_	0	SENT_135	[p6l480t458r562b512],
6	6	CD	NUMBER	6	appos	4	SENT_135	[p6l592t460r633b502],
7	.	.	O	.	_	0	SENT_135	[p6l592t460r633b502],

1	Z.	NNP	PERSON	Z.	nn	2	SENT_136	[p6l726t589r745b609],
2	Nemoda	NNP	PERSON	Nemoda	_	0	SENT_136	[p6l756t587r852b609],
3	et	FW	O	et	nn	4	SENT_136	[p6l862t590r884b609],
4	al.	FW	O	al.	dep	2	SENT_136	[p6l893t587r917b609],
5	/	:	O	/	punct	2	SENT_136	[p6l926t587r937b614],
6	Neuropharmacology	NNP	O	Neuropharmacology	dep	2	SENT_136	[p6l945t587r1181b614],
7	57	CD	NUMBER	57	number	8	SENT_136	[p6l1190t588r1220b609],
8	(	CD	NUMBER	(	num	9	SENT_136	[p6l1228t587r1306b614],
9	2009	CD	DATE	2009	dep	6	SENT_136	[p6l1228t587r1306b614],
10	)	CD	NUMBER	)	number	11	SENT_136	[p6l1228t587r1306b614],
11	731-733 733	CD	NUMBER	731-733 733	num	9	SENT_136	[p6l2112t588r2154b609],[p6l1318t588r1416b609],

1	Kereszturi	NNP	PERSON	Kereszturi	nn	13	SENT_137	[p6l6t664r138b689],
2	,	,	O	,	_	0	SENT_137	[p6l6t664r138b689],
3	E.	NNP	O	E.	appos	13	SENT_137	[p6l171t665r196b689],
4	,	,	O	,	_	0	SENT_137	[p6l171t665r196b689],
5	Tarnok	NNP	PERSON	Tarnok	appos	13	SENT_137	[p6l228t664r320b689],
6	,	,	O	,	_	0	SENT_137	[p6l228t664r320b689],
7	Z.	NNP	O	Z.	appos	13	SENT_137	[p6l351t665r378b689],
8	,	,	O	,	_	0	SENT_137	[p6l351t665r378b689],
9	Bognar	NNP	PERSON	Bognar	appos	13	SENT_137	[p6l411t665r502b691],
10	,	,	O	,	_	0	SENT_137	[p6l411t665r502b691],
11	E.	NNP	O	E.	appos	13	SENT_137	[p6l535t665r560b689],
12	,	,	O	,	_	0	SENT_137	[p6l535t665r560b689],
13	Lakatos	NNP	PERSON	Lakatos	_	0	SENT_137	[p6l593t664r692b689],
14	,	,	O	,	_	0	SENT_137	[p6l593t664r692b689],
15	I	PRP	O	I	dep	13	SENT_137	[p6l724t665r752b689],
16	<	JJR	O	<	dep	15	SENT_137	[p6l724t665r752b689],
17	.	.	O	.	_	0	SENT_137	[p6l724t665r752b689],

1	,	,	O	,	_	0	SENT_138	[p6l724t665r752b689],
2	Farkas	NNP	PERSON	Farkas	nn	10	SENT_138	[p6l785t664r868b689],
3	,	,	O	,	_	0	SENT_138	[p6l785t664r868b689],
4	L.	NNP	O	L.	appos	10	SENT_138	[p6l900t665r924b689],
5	,	,	O	,	_	0	SENT_138	[p6l900t665r924b689],
6	Gadoros	NNP	O	Gadoros	appos	10	SENT_138	[p6l957t664r1064b689],
7	,	,	O	,	_	0	SENT_138	[p6l957t664r1064b689],
8	J.	NNP	O	J.	appos	10	SENT_138	[p6l1093t665r1116b691],
9	,	,	O	,	_	0	SENT_138	[p6l1093t665r1116b691],
10	Singh	NNP	PERSON	Singh	dep	12	SENT_138	[p6l1199t664r1274b691],
11	,	,	O	,	_	0	SENT_138	[p6l1199t664r1274b691],
12	1.	CD	NUMBER	1.	_	0	SENT_138	[p6l1290t665r1309b689],
13	,	,	O	,	_	0	SENT_138	[p6l1290t665r1309b689],
14	2008	CD	DATE	2008	dep	12	SENT_138	[p6l1325t665r1394b686],
15	.	.	O	.	_	0	SENT_138	[p6l1325t665r1394b686],

1	Beyond	IN	O	beyond	dep	4	SENT_139	[p6l1410t664r1502b691],
2	polemics	NNS	O	polemic	pobj	1	SENT_139	[p6l1518t664r1637b691],
3	:	:	O	:	_	0	SENT_139	[p6l1518t664r1637b691],
4	science	NN	O	science	_	0	SENT_139	[p6l1655t664r1744b686],
5	and	CC	O	and	_	0	SENT_139	[p6l1760t664r1805b686],
6	ethics	NNS	O	ethic	conj_and	4	SENT_139	[p6l1821t664r1894b686],
7	of	IN	O	of	_	0	SENT_139	[p6l1910t664r1936b686],
8	ADHD	NNP	O	ADHD	prep_of	4	SENT_139	[p6l1942t665r2025b686],
9	.	.	O	.	_	0	SENT_139	[p6l1942t665r2025b686],

1	Nat	NN	PERSON	nat	_	0	SENT_140	[p6l2041t665r2089b686],
2	.	.	O	.	_	0	SENT_140	[p6l2041t665r2089b686],

1	Rev.	NNP	O	Rev.	nn	2	SENT_141	[p6l2106t665r2154b686],
2	Neurosci	NNP	PERSON	Neurosci	_	0	SENT_141	[p6l6t697r145b719],
3	.9	NN	NUMBER	.9	dep	2	SENT_141	[p6l6t697r145b719],

1	Sasvari	NNP	PERSON	Sasvari	_	0	SENT_142	[p6l56t730r253b757],
2	.	.	O	.	_	0	SENT_142	[p6l56t730r253b757],

1	—	NN	O	—	_	0	SENT_143	[p6l56t730r253b757],
2	.	.	O	.	_	0	SENT_143	[p6l56t730r253b757],

1	Szekely	NNP	PERSON	Szekely	nn	7	SENT_144	[p6l56t730r253b757],
2	,	,	O	,	_	0	SENT_144	[p6l56t730r253b757],
3	M.	NNP	O	M.	appos	7	SENT_144	[p6l289t731r325b755],
4	,	,	O	,	_	0	SENT_144	[p6l289t731r325b755],
5	Nemoda	NNP	LOCATION	Nemoda	appos	7	SENT_144	[p6l362t730r472b755],
6	,	,	O	,	_	0	SENT_144	[p6l362t730r472b755],
7	Z.	NNP	O	Z.	_	0	SENT_144	[p6l507t731r534b755],
8	,	,	O	,	_	0	SENT_144	[p6l507t731r534b755],
9	2008	CD	DATE	2008	appos	7	SENT_144	[p6l570t731r639b752],
10	.	.	O	.	_	0	SENT_144	[p6l570t731r639b752],

1	Catechol	NNP	O	Catechol	_	0	SENT_145	[p6l675t730r1050b757],
2	.	.	O	.	_	0	SENT_145	[p6l675t730r1050b757],

1	—	NN	O	—	_	0	SENT_146	[p6l675t730r1050b757],
2	.	.	O	.	_	0	SENT_146	[p6l675t730r1050b757],

1	O	NN	O	o	_	0	SENT_147	[p6l675t730r1050b757],
2	.	.	O	.	_	0	SENT_147	[p6l675t730r1050b757],

1	—	NN	O	—	_	0	SENT_148	[p6l675t730r1050b757],
2	.	.	O	.	_	0	SENT_148	[p6l675t730r1050b757],

1	methyltransferase	NN	O	methyltransferase	_	0	SENT_149	[p6l675t730r1050b757],
2	(	CD	NUMBER	(	number	3	SENT_149	[p6l1177t730r1231b757],
3	12	CD	NUMBER	12	num	4	SENT_149	[p6l1177t730r1231b757],
4	)	NN	O	)	dep	1	SENT_149	[p6l1177t730r1231b757],
5	,	,	O	,	_	0	SENT_149	[p6l1177t730r1231b757],
6	957-964	CD	NUMBER	957-964	appos	4	SENT_149	[p6l1243t731r1357b752],
7	.	.	O	.	_	0	SENT_149	[p6l1243t731r1357b752],

1	Val158Met	NN	O	val158met	nn	2	SENT_150	[p6l55t763r191b784],
2	polymorphism	NN	O	polymorphism	nsubjpass	4	SENT_150	[p6l210t763r394b790],
3	is	VBZ	O	be	auxpass	4	SENT_150	[p6l415t763r433b784],
4	associated	VBN	O	associate	_	0	SENT_150	[p6l453t763r581b784],
5	with	IN	O	with	_	0	SENT_150	[p6l602t763r659b784],
6	methylphenidate	NN	O	methylphenidate	nn	7	SENT_150	[p6l680t763r893b790],
7	response	NN	O	response	prep_with	4	SENT_150	[p6l914t769r1025b790],
8	in	IN	O	in	_	0	SENT_150	[p6l1045t763r1068b784],
9	Stein	NNP	LOCATION	Stein	nn	17	SENT_150	[p6l1148t763r1215b788],
10	,	,	O	,	_	0	SENT_150	[p6l1148t763r1215b788],
11	M.A.	NNP	LOCATION	M.A.	appos	17	SENT_150	[p6l1243t764r1304b788],
12	,	,	O	,	_	0	SENT_150	[p6l1243t764r1304b788],
13	McGough	NNP	PERSON	McGough	appos	17	SENT_150	[p6l1332t763r1458b790],
14	,	,	O	,	_	0	SENT_150	[p6l1332t763r1458b790],
15	J.	NNP	O	J.	appos	17	SENT_150	[p6l1483t764r1520b790],
16	_	NNP	O	_	nn	17	SENT_150	[p6l1483t764r1520b790],
17	J.	NNP	O	J.	prep_in	4	SENT_150	[p6l1483t764r1520b790],
18	,	,	O	,	_	0	SENT_150	[p6l1483t764r1520b790],
19	2008	CD	DATE	2008	appos	17	SENT_150	[p6l1548t764r1617b785],
20	.	.	O	.	_	0	SENT_150	[p6l1548t764r1617b785],

1	The	DT	O	the	det	3	SENT_151	[p6l1644t763r1689b785],
2	pharmacogenomic	JJ	O	pharmacogenomic	amod	3	SENT_151	[p6l1717t763r1950b790],
3	era	NN	O	era	_	0	SENT_151	[p6l1977t769r2023b785],
4	:	:	O	:	_	0	SENT_151	[p6l1977t769r2023b785],
5	promise	NN	O	promise	dep	3	SENT_151	[p6l2053t763r2154b790],
6	for	IN	O	for	_	0	SENT_151	[p6l6t796r41b818],
7	ADHD	NNP	O	ADHD	nn	8	SENT_151	[p6l55t830r131b850],
8	children	NNS	O	child	prep_for	5	SENT_151	[p6l148t829r257b851],
9	.	.	O	.	_	0	SENT_151	[p6l148t829r257b851],

1	Am	NNP	O	Am	_	0	SENT_152	[p6l273t830r322b851],
2	.	.	O	.	_	0	SENT_152	[p6l273t830r322b851],

1	J.	NNP	O	J.	nn	2	SENT_153	[p6l336t830r352b856],
2	Med	NNP	O	Med	_	0	SENT_153	[p6l370t829r430b851],
3	.	.	O	.	_	0	SENT_153	[p6l370t829r430b851],

1	Genet	NNP	PERSON	Genet	_	0	SENT_154	[p6l448t830r527b851],
2	.	.	O	.	_	0	SENT_154	[p6l448t830r527b851],

1	B	NN	O	b	nn	2	SENT_155	[p6l545t830r559b850],
2	147B	NN	O	147b	_	0	SENT_155	[p6l577t830r635b850],
3	(	CD	NUMBER	(	number	4	SENT_155	[p6l653t829r693b856],
4	8	CD	NUMBER	8	num	5	SENT_155	[p6l653t829r693b856],
5	)	NN	O	)	dep	2	SENT_155	[p6l653t829r693b856],
6	,	,	O	,	_	0	SENT_155	[p6l653t829r693b856],
7	1431-1435	CD	DATE	1431-1435	appos	5	SENT_155	[p6l710t830r850b851],
8	.	.	O	.	_	0	SENT_155	[p6l710t830r850b851],

1	personalizing	VBG	O	personalize	amod	3	SENT_156	[p6l1239t829r1408b856],
2	attention	NN	O	attention	nn	3	SENT_156	[p6l1428t829r1542b851],
3	deﬁcit	NN	O	deﬁcit	_	0	SENT_156	[p6l1563t829r1640b851],
4	hyperactivity	NN	O	hyperactivity	nn	6	SENT_156	[p6l1661t829r1825b856],
5	disorder	NN	O	disorder	nn	6	SENT_156	[p6l1845t829r1949b851],
6	therapy	NN	O	therapy	dep	3	SENT_156	[p6l1969t829r2069b856],
7	.	.	O	.	_	0	SENT_156	[p6l1969t829r2069b856],

1	Child	NN	O	child	_	0	SENT_157	[p6l2091t829r2154b851],
2	Adolesc	NNP	O	Adolesc	dep	1	SENT_157	[p6l6t862r108b884],
3	.	.	O	.	_	0	SENT_157	[p6l6t862r108b884],

1	Marsh	NNP	PERSON	Marsh	_	0	SENT_158	[p6l119t862r203b887],
2	,	,	O	,	_	0	SENT_158	[p6l119t862r203b887],
3	5	CD	NUMBER	5	appos	1	SENT_158	[p6l218t863r243b887],
4	.	.	O	.	_	0	SENT_158	[p6l218t863r243b887],

1	.	.	O	.	_	0	SENT_159	[p6l218t863r243b887],

1	Xiao	NNP	PERSON	Xiao	_	0	SENT_160	[p6l258t862r319b887],
2	,	,	O	,	_	0	SENT_160	[p6l258t862r319b887],
3	M.	NNP	O	M.	nn	7	SENT_160	[p6l335t863r371b887],
4	,	,	O	,	_	0	SENT_160	[p6l335t863r371b887],
5	Yu	NNP	O	Yu	appos	7	SENT_160	[p6l385t863r423b887],
6	,	,	O	,	_	0	SENT_160	[p6l385t863r423b887],
7	J.	NNP	O	J.	appos	1	SENT_160	[p6l435t863r457b889],
8	.	.	O	.	_	0	SENT_160	[p6l435t863r457b889],

1	Ahluwalia	NNP	PERSON	Ahluwalia	_	0	SENT_161	[p6l472t862r603b887],
2	,	,	O	,	_	0	SENT_161	[p6l472t862r603b887],
3	R.	NNP	O	R.	nn	17	SENT_161	[p6l619t863r646b887],
4	,	,	O	,	_	0	SENT_161	[p6l619t863r646b887],
5	Minton	NNP	PERSON	Minton	appos	17	SENT_161	[p6l662t862r759b887],
6	,	,	O	,	_	0	SENT_161	[p6l662t862r759b887],
7	M.	NNP	O	M.	appos	17	SENT_161	[p6l774t863r810b887],
8	,	,	O	,	_	0	SENT_161	[p6l774t863r810b887],
9	Freimuth	NNP	PERSON	Freimuth	appos	17	SENT_161	[p6l826t862r945b887],
10	,	,	O	,	_	0	SENT_161	[p6l826t862r945b887],
11	R.R.	NNP	LOCATION	R.R.	appos	17	SENT_161	[p6l960t863r1011b887],
12	,	,	O	,	_	0	SENT_161	[p6l960t863r1011b887],
13	Kwok	NNP	PERSON	Kwok	appos	17	SENT_161	[p6l1027t862r1103b887],
14	,	,	O	,	_	0	SENT_161	[p6l1027t862r1103b887],
15	P.Y.	NNP	O	P.Y.	appos	17	SENT_161	[p6l1118t863r1163b887],
16	,	,	O	,	_	0	SENT_161	[p6l1118t863r1163b887],
17	Psychiatr	NNP	O	Psychiatr	appos	1	SENT_161	[p6l1290t862r1408b889],
18	.	.	O	.	_	0	SENT_161	[p6l1290t862r1408b889],

1	Clin	NNP	O	Clin	_	0	SENT_162	[p6l1423t862r1476b884],
2	.	.	O	.	_	0	SENT_162	[p6l1423t862r1476b884],

1	N.	NNP	O	N.	nn	2	SENT_163	[p6l1491t863r1515b884],
2	Am	NNP	O	Am	_	0	SENT_163	[p6l1528t863r1577b884],
3	.	.	O	.	_	0	SENT_163	[p6l1528t863r1577b884],

1	17	CD	NUMBER	17	num	2	SENT_164	[p6l1591t863r1616b884],
2	(	NN	O	(	_	0	SENT_164	[p6l1631t862r1671b889],
3	2	CD	NUMBER	2	num	4	SENT_164	[p6l1631t862r1671b889],
4	)	NN	O	)	dep	2	SENT_164	[p6l1631t862r1671b889],
5	.	.	O	.	_	0	SENT_164	[p6l1631t862r1671b889],

1	475-490	CD	NUMBER	475-490	num	2	SENT_165	[p6l1685t863r1793b884],
2	(	CD	NUMBER	(	_	0	SENT_165	[p6l1808t862r1903b889],
3	xi	NN	O	xi	nn	6	SENT_165	[p6l1808t862r1903b889],
4	—	CD	NUMBER	—	num	6	SENT_165	[p6l1808t862r1903b889],
5	xii	NN	O	xii	nn	6	SENT_165	[p6l1808t862r1903b889],
6	)	NN	O	)	dep	2	SENT_165	[p6l1808t862r1903b889],
7	.	.	O	.	_	0	SENT_165	[p6l1808t862r1903b889],

1	McLeod	NNP	PERSON	McLeod	nn	3	SENT_166	[p6l56t894r158b919],
2	,	,	O	,	_	0	SENT_166	[p6l56t894r158b919],
3	H.L.	NNP	O	H.L.	_	0	SENT_166	[p6l169t895r220b919],
4	,	,	O	,	_	0	SENT_166	[p6l169t895r220b919],
5	2004	CD	DATE	2004	appos	3	SENT_166	[p6l231t895r299b916],
6	.	.	O	.	_	0	SENT_166	[p6l231t895r299b916],

1	Pharmacogenomic	JJ	O	pharmacogenomic	amod	2	SENT_167	[p6l311t894r542b921],
2	assessment	NN	O	assessment	_	0	SENT_167	[p6l552t897r695b916],
3	of	IN	O	of	_	0	SENT_167	[p6l704t894r730b916],
4	carboxylesterases	NNS	O	carboxylesterase	prep_of	2	SENT_167	[p6l736t894r955b921],
5	1	CD	NUMBER	1	num	4	SENT_167	[p6l967t895r976b915],
6	and	CC	O	and	_	0	SENT_167	[p6l991t894r1036b916],
7	2	CD	NUMBER	2	conj_and	4	SENT_167	[p6l1047t895r1067b916],
8	.	.	O	.	_	0	SENT_167	[p6l1047t895r1067b916],

1	Sun	NNP	O	Sun	_	0	SENT_168	[p6l1146t895r1197b919],
2	,	,	O	,	_	0	SENT_168	[p6l1146t895r1197b919],
3	Z.	NNP	O	Z.	nn	25	SENT_168	[p6l1210t896r1237b919],
4	,	,	O	,	_	0	SENT_168	[p6l1210t896r1237b919],
5	Murry	NNP	PERSON	Murry	appos	25	SENT_168	[p6l1251t896r1334b921],
6	,	,	O	,	_	0	SENT_168	[p6l1251t896r1334b921],
7	D.J.	NNP	PERSON	D.J.	appos	25	SENT_168	[p6l1347t896r1392b921],
8	,	,	O	,	_	0	SENT_168	[p6l1347t896r1392b921],
9	Sanghani	NNP	LOCATION	Sanghani	appos	25	SENT_168	[p6l1405t894r1525b921],
10	,	,	O	,	_	0	SENT_168	[p6l1405t894r1525b921],
11	S.P.	NNP	LOCATION	S.P.	appos	25	SENT_168	[p6l1539t895r1584b919],
12	,	,	O	,	_	0	SENT_168	[p6l1539t895r1584b919],
13	Davis	NNP	PERSON	Davis	appos	25	SENT_168	[p6l1598t895r1670b919],
14	,	,	O	,	_	0	SENT_168	[p6l1598t895r1670b919],
15	W.l.	NNP	PERSON	W.l.	appos	25	SENT_168	[p6l1682t896r1736b919],
16	,	,	O	,	_	0	SENT_168	[p6l1682t896r1736b919],
17	Kedishvili	NNP	LOCATION	Kedishvili	appos	25	SENT_168	[p6l1749t894r1877b919],
18	,	,	O	,	_	0	SENT_168	[p6l1749t894r1877b919],
19	N.Y.	NNP	LOCATION	N.Y.	appos	25	SENT_168	[p6l1892t896r1943b919],
20	,	,	O	,	_	0	SENT_168	[p6l1892t896r1943b919],
21	Zou	NNP	PERSON	Zou	appos	25	SENT_168	[p6l1956t896r2009b919],
22	,	,	O	,	_	0	SENT_168	[p6l1956t896r2009b919],
23	Q.	NNP	O	Q.	appos	25	SENT_168	[p6l2022t895r2052b920],
24	,	,	O	,	_	0	SENT_168	[p6l2022t895r2052b920],
25	Hurley	NNP	PERSON	Hurley	appos	1	SENT_168	[p6l2067t894r2154b921],
26	,	,	O	,	_	0	SENT_168	[p6l2067t894r2154b921],

1	T.D.	NNP	O	T.D.	_	0	SENT_169	[p6l6t928r58b952],
2	,	,	O	,	_	0	SENT_169	[p6l6t928r58b952],

1	Genomics	NNS	O	genomic	_	0	SENT_170	[p6l56t960r178b981],
2	84	CD	NUMBER	84	num	1	SENT_170	[p6l196t961r226b981],
3	(	CD	NUMBER	(	number	4	SENT_170	[p6l244t960r284b987],
4	4	CD	NUMBER	4	num	5	SENT_170	[p6l244t960r284b987],
5	)	NN	O	)	dep	1	SENT_170	[p6l244t960r284b987],
6	,	,	O	,	_	0	SENT_170	[p6l244t960r284b987],
7	661-668	CD	NUMBER	661-668	appos	5	SENT_170	[p6l303t961r418b982],
8	.	.	O	.	_	0	SENT_170	[p6l303t961r418b982],

1	Bosron	NNP	PERSON	Bosron	nn	3	SENT_171	[p6l1205t961r1297b985],
2	,	,	O	,	_	0	SENT_171	[p6l1205t961r1297b985],
3	W.F.	NNP	O	W.F.	_	0	SENT_171	[p6l1313t961r1371b985],
4	,	,	O	,	_	0	SENT_171	[p6l1313t961r1371b985],
5	2004	CD	DATE	2004	appos	3	SENT_171	[p6l1389t961r1457b982],
6	.	.	O	.	_	0	SENT_171	[p6l1389t961r1457b982],

1	Methylphenidate	NNP	O	Methylphenidate	nsubjpass	4	SENT_172	[p6l1476t960r1689b987],
2	is	VBZ	O	be	auxpass	4	SENT_172	[p6l1707t960r1725b982],
3	stereoselectively	RB	O	stereoselectively	advmod	4	SENT_172	[p6l1743t960r1950b987],
4	hydrolyzed	VBN	O	hydrolyze	_	0	SENT_172	[p6l1967t960r2106b987],
5	by	IN	O	by	_	0	SENT_172	[p6l2124t960r2154b987],
6	human	JJ	O	human	amod	29	SENT_172	[p6l6t993r93b1014],
7	Michelson	NNP	PERSON	Michelson	nn	29	SENT_172	[p6l105t992r239b1017],
8	,	,	O	,	_	0	SENT_172	[p6l105t992r239b1017],
9	D.	NNP	O	D.	appos	29	SENT_172	[p6l255t993r285b1017],
10	,	,	O	,	_	0	SENT_172	[p6l255t993r285b1017],
11	Read	NNP	O	Read	appos	29	SENT_172	[p6l301t992r366b1017],
12	,	,	O	,	_	0	SENT_172	[p6l301t992r366b1017],
13	H.A.	NNP	PERSON	H.A.	appos	29	SENT_172	[p6l382t993r437b1017],
14	,	,	O	,	_	0	SENT_172	[p6l382t993r437b1017],
15	Ruff	NNP	PERSON	Ruff	appos	29	SENT_172	[p6l453t992r508b1017],
16	,	,	O	,	_	0	SENT_172	[p6l453t992r508b1017],
17	D.D.	NNP	LOCATION	D.D.	appos	29	SENT_172	[p6l524t993r580b1017],
18	,	,	O	,	_	0	SENT_172	[p6l524t993r580b1017],
19	Witcher	NNP	PERSON	Witcher	appos	29	SENT_172	[p6l595t992r700b1017],
20	,	,	O	,	_	0	SENT_172	[p6l595t992r700b1017],
21	J.	NNP	O	J.	appos	29	SENT_172	[p6l713t993r735b1019],
22	,	,	O	,	_	0	SENT_172	[p6l713t993r735b1019],
23	Zhang	NNP	PERSON	Zhang	appos	29	SENT_172	[p6l750t992r833b1019],
24	,	,	O	,	_	0	SENT_172	[p6l750t992r833b1019],
25	S.	NNP	O	S.	appos	29	SENT_172	[p6l849t993r874b1017],
26	,	,	O	,	_	0	SENT_172	[p6l849t993r874b1017],
27	McCracken	NNP	PERSON	McCracken	appos	29	SENT_172	[p6l889t992r1032b1017],
28	,	,	O	,	_	0	SENT_172	[p6l889t992r1032b1017],
29	J.	NNP	O	J.	agent	4	SENT_172	[p6l1045t993r1067b1019],
30	,	,	O	,	_	0	SENT_172	[p6l1045t993r1067b1019],
31	2007	CD	DATE	2007	tmod	4	SENT_172	[p6l1083t993r1149b1014],
32	.	.	O	.	_	0	SENT_172	[p6l1083t993r1149b1014],

1	carboxylesterase	NN	O	carboxylesterase	_	0	SENT_173	[p6l1275t992r1483b1019],
2	CES1A1	NN	O	ces1a1	dep	1	SENT_173	[p6l1494t993r1592b1014],
3	.	.	O	.	_	0	SENT_173	[p6l1494t993r1592b1014],

1	J.	NNP	PERSON	J.	nn	2	SENT_174	[p6l1600t993r1615b1019],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_174	[p6l1627t992r1764b1014],
3	.	.	O	.	_	0	SENT_174	[p6l1627t992r1764b1014],

1	Exp	NN	O	exp	_	0	SENT_175	[p6l1776t993r1827b1019],
2	.	.	O	.	_	0	SENT_175	[p6l1776t993r1827b1019],

1	Ther	NNP	O	Ther	_	0	SENT_176	[p6l1837t992r1899b1014],
2	.	.	O	.	_	0	SENT_176	[p6l1837t992r1899b1014],

1	310	CD	NUMBER	310	num	2	SENT_177	[p6l1909t993r1953b1014],
2	(	NN	O	(	_	0	SENT_177	[p6l1964t992r2004b1019],
3	2	CD	NUMBER	2	num	4	SENT_177	[p6l1964t992r2004b1019],
4	)	NN	O	)	dep	2	SENT_177	[p6l1964t992r2004b1019],
5	,	,	O	,	_	0	SENT_177	[p6l1964t992r2004b1019],
6	469-476	CD	NUMBER	469-476	appos	4	SENT_177	[p6l2014t993r2128b1014],
7	.	.	O	.	_	0	SENT_177	[p6l2014t993r2128b1014],

1	CYP2D6	NN	O	cyp2d6	nn	4	SENT_178	[p6l56t1026r154b1047],
2	and	CC	O	and	_	0	SENT_178	[p6l164t1025r210b1047],
3	clinical	JJ	O	clinical	conj_and	1	SENT_178	[p6l221t1025r308b1047],
4	response	NN	O	response	_	0	SENT_178	[p6l319t1031r430b1052],
5	to	TO	O	to	_	0	SENT_178	[p6l441t1028r465b1047],
6	atomoxetine	NN	O	atomoxetine	prep_to	4	SENT_178	[p6l475t1025r632b1047],
7	in	IN	O	in	dep	4	SENT_178	[p6l643t1025r665b1047],
8	children	NNS	O	child	pobj	7	SENT_178	[p6l676t1025r779b1047],
9	and	CC	O	and	_	0	SENT_178	[p6l790t1025r835b1047],
10	adolescents	NNS	O	adolescent	pobj	7	SENT_178	[p6l846t1025r991b1047],
11	with	IN	O	with	dep	4	SENT_178	[p6l1002t1025r1059b1047],
12	Zhu	NNP	PERSON	Zhu	nn	36	SENT_178	[p6l1136t1025r1190b1050],
13	,	,	O	,	_	0	SENT_178	[p6l1136t1025r1190b1050],
14	H.J.	NNP	LOCATION	H.J.	appos	36	SENT_178	[p6l1200t1026r1246b1052],
15	,	,	O	,	_	0	SENT_178	[p6l1200t1026r1246b1052],
16	Patrick	NNP	PERSON	Patrick	appos	36	SENT_178	[p6l1257t1025r1348b1050],
17	,	,	O	,	_	0	SENT_178	[p6l1257t1025r1348b1050],
18	K.S.	NNP	LOCATION	K.S.	appos	36	SENT_178	[p6l1359t1026r1408b1050],
19	,	,	O	,	_	0	SENT_178	[p6l1359t1026r1408b1050],
20	Yuan	NNP	O	Yuan	appos	36	SENT_178	[p6l1418t1026r1487b1050],
21	,	,	O	,	_	0	SENT_178	[p6l1418t1026r1487b1050],
22	H.J.	NNP	LOCATION	H.J.	appos	36	SENT_178	[p6l1498t1026r1543b1052],
23	,	,	O	,	_	0	SENT_178	[p6l1498t1026r1543b1052],
24	Wang	NNP	PERSON	Wang	appos	36	SENT_178	[p6l1553t1026r1632b1052],
25	,	,	O	,	_	0	SENT_178	[p6l1553t1026r1632b1052],
26	J.S.	NNP	LOCATION	J.S.	appos	36	SENT_178	[p6l1639t1026r1682b1052],
27	,	,	O	,	_	0	SENT_178	[p6l1639t1026r1682b1052],
28	Donovan	NNP	PERSON	Donovan	appos	36	SENT_178	[p6l1693t1026r1809b1050],
29	,	,	O	,	_	0	SENT_178	[p6l1693t1026r1809b1050],
30	J.L.	NNP	PERSON	J.L.	appos	36	SENT_178	[p6l1817t1026r1859b1052],
31	,	,	O	,	_	0	SENT_178	[p6l1817t1026r1859b1052],
32	DeVane	NNP	PERSON	DeVane	appos	36	SENT_178	[p6l1870t1026r1972b1050],
33	,	,	O	,	_	0	SENT_178	[p6l1870t1026r1972b1050],
34	C.L.	NNP	PERSON	C.L.	appos	36	SENT_178	[p6l1983t1026r2029b1050],
35	,	,	O	,	_	0	SENT_178	[p6l1983t1026r2029b1050],
36	Malcolm	NNP	PERSON	Malcolm	pobj	11	SENT_178	[p6l2041t1025r2154b1050],
37	,	,	O	,	_	0	SENT_178	[p6l2041t1025r2154b1050],

1	R.	NNP	O	R.	_	0	SENT_179	[p6l6t1059r33b1082],
2	,	,	O	,	_	0	SENT_179	[p6l6t1059r33b1082],
3	ADHD	NNP	O	ADHD	appos	1	SENT_179	[p6l55t1091r137b1112],
4	.	.	O	.	_	0	SENT_179	[p6l55t1091r137b1112],

1	J.	NNP	O	J.	nn	2	SENT_180	[p6l148t1091r164b1117],
2	Am	NNP	O	Am	_	0	SENT_180	[p6l178t1091r227b1112],
3	.	.	O	.	_	0	SENT_180	[p6l178t1091r227b1112],

1	Acad	NNP	O	Acad	_	0	SENT_181	[p6l240t1090r307b1112],
2	.	.	O	.	_	0	SENT_181	[p6l240t1090r307b1112],

1	Child	NN	O	child	_	0	SENT_182	[p6l321t1090r385b1112],
2	Adolesc	NNP	O	Adolesc	dep	1	SENT_182	[p6l398t1090r500b1112],
3	.	.	O	.	_	0	SENT_182	[p6l398t1090r500b1112],

1	Psychiatry	NNP	O	Psychiatry	nn	3	SENT_183	[p6l516t1090r644b1117],
2	46	CD	NUMBER	46	num	3	SENT_183	[p6l657t1091r688b1112],
3	(	NN	O	(	_	0	SENT_183	[p6l702t1090r742b1117],
4	2	CD	NUMBER	2	num	5	SENT_183	[p6l702t1090r742b1117],
5	)	NN	O	)	dep	3	SENT_183	[p6l702t1090r742b1117],
6	,	,	O	,	_	0	SENT_183	[p6l702t1090r742b1117],
7	242-251	CD	NUMBER	242-251	appos	5	SENT_183	[p6l756t1091r867b1112],
8	.	.	O	.	_	0	SENT_183	[p6l756t1091r867b1112],

1	Johnson	NNP	PERSON	Johnson	nn	19	SENT_184	[p6l1206t1090r1315b1117],
2	,	,	O	,	_	0	SENT_184	[p6l1206t1090r1315b1117],
3	J.A.	NNP	PERSON	J.A.	appos	19	SENT_184	[p6l1325t1091r1372b1117],
4	,	,	O	,	_	0	SENT_184	[p6l1325t1091r1372b1117],
5	Youngblood	NNP	PERSON	Youngblood	appos	19	SENT_184	[p6l1384t1090r1540b1117],
6	,	,	O	,	_	0	SENT_184	[p6l1384t1090r1540b1117],
7	G.L.	NNP	O	G.L.	appos	19	SENT_184	[p6l1553t1091r1603b1115],
8	,	,	O	,	_	0	SENT_184	[p6l1553t1091r1603b1115],
9	Sweet	NNP	O	Sweet	appos	19	SENT_184	[p6l1617t1091r1697b1115],
10	,	,	O	,	_	0	SENT_184	[p6l1617t1091r1697b1115],
11	D.H.	NNP	PERSON	D.H.	appos	19	SENT_184	[p6l1711t1091r1768b1115],
12	,	,	O	,	_	0	SENT_184	[p6l1711t1091r1768b1115],
13	Langaee	NNP	LOCATION	Langaee	appos	19	SENT_184	[p6l1781t1091r1888b1117],
14	,	,	O	,	_	0	SENT_184	[p6l1781t1091r1888b1117],
15	T.Y.	NNP	O	T.Y.	appos	19	SENT_184	[p6l1900t1091r1946b1115],
16	,	,	O	,	_	0	SENT_184	[p6l1900t1091r1946b1115],
17	Markowitz	NNP	PERSON	Markowitz	appos	19	SENT_184	[p6l1960t1090r2101b1115],
18	,	,	O	,	_	0	SENT_184	[p6l1960t1090r2101b1115],
19	J.S.	NNP	LOCATION	J.S.	_	0	SENT_184	[p6l2111t1091r2154b1117],
20	,	,	O	,	_	0	SENT_184	[p6l2111t1091r2154b1117],
21	2008	CD	DATE	2008	appos	19	SENT_184	[p6l6t1124r74b1145],
22	.	.	O	.	_	0	SENT_184	[p6l6t1124r74b1145],

1	Polanczyk	NNP	O	Polanczyk	_	0	SENT_185	[p6l87t1123r217b1150],
2	,	,	O	,	_	0	SENT_185	[p6l87t1123r217b1150],
3	G.	NNP	O	G.	appos	1	SENT_185	[p6l237t1124r267b1148],
4	,	,	O	,	_	0	SENT_185	[p6l237t1124r267b1148],
5	de	FW	O	de	dep	1	SENT_185	[p6l286t1123r315b1145],
6	Lima	NNP	LOCATION	Lima	nn	20	SENT_185	[p6l334t1123r399b1148],
7	,	,	O	,	_	0	SENT_185	[p6l334t1123r399b1148],
8	M.S.	NNP	LOCATION	M.S.	appos	20	SENT_185	[p6l419t1124r475b1148],
9	,	,	O	,	_	0	SENT_185	[p6l419t1124r475b1148],
10	Horta	NNP	PERSON	Horta	appos	20	SENT_185	[p6l495t1124r570b1148],
11	,	,	O	,	_	0	SENT_185	[p6l495t1124r570b1148],
12	B.L.	NNP	LOCATION	B.L.	appos	20	SENT_185	[p6l590t1124r636b1148],
13	,	,	O	,	_	0	SENT_185	[p6l590t1124r636b1148],
14	Biederman	NNP	PERSON	Biederman	appos	20	SENT_185	[p6l656t1123r797b1148],
15	,	,	O	,	_	0	SENT_185	[p6l656t1123r797b1148],
16	J.	NNP	O	J.	appos	20	SENT_185	[p6l813t1124r835b1150],
17	,	,	O	,	_	0	SENT_185	[p6l813t1124r835b1150],
18	Rohde	NNP	PERSON	Rohde	appos	20	SENT_185	[p6l855t1123r938b1148],
19	,	,	O	,	_	0	SENT_185	[p6l855t1123r938b1148],
20	L.A.	NNP	LOCATION	L.A.	dep	1	SENT_185	[p6l958t1124r1007b1148],
21	,	,	O	,	_	0	SENT_185	[p6l958t1124r1007b1148],
22	2007	CD	DATE	2007	dep	20	SENT_185	[p6l1026t1124r1092b1145],
23	.	.	O	.	_	0	SENT_185	[p6l1026t1124r1092b1145],

1	The	DT	O	the	det	5	SENT_186	[p6l1110t1123r1156b1145],
2	Two	CD	NUMBER	two	num	5	SENT_186	[p6l1283t1124r1337b1145],
3	CES1	NN	O	ces1	nn	5	SENT_186	[p6l1350t1124r1407b1145],
4	gene	NN	O	gene	nn	5	SENT_186	[p6l1424t1129r1483b1150],
5	mutations	NNS	O	mutation	nsubj	6	SENT_186	[p6l1497t1123r1623b1145],
6	lead	VBP	O	lead	_	0	SENT_186	[p6l1637t1123r1688b1145],
7	to	TO	O	to	_	0	SENT_186	[p6l1701t1126r1725b1145],
8	dysfunctional	JJ	O	dysfunctional	amod	11	SENT_186	[p6l1739t1123r1908b1150],
9	carboxylesterase	NN	O	carboxylesterase	nn	11	SENT_186	[p6l1922t1123r2129b1150],
10	1	CD	NUMBER	1	num	11	SENT_186	[p6l2145t1124r2154b1145],
11	activity	NN	O	activity	prep_to	6	SENT_186	[p6l6t1156r98b1183],
12	in	IN	O	in	_	0	SENT_186	[p6l109t1156r132b1178],
13	worldwide	JJ	O	worldwide	amod	14	SENT_186	[p6l55t1189r190b1211],
14	prevalence	NN	O	prevalence	prep_in	6	SENT_186	[p6l211t1189r346b1216],
15	of	IN	O	of	_	0	SENT_186	[p6l367t1189r393b1211],
16	ADHD	NNP	O	ADHD	prep_of	14	SENT_186	[p6l410t1190r494b1211],
17	:	:	O	:	_	0	SENT_186	[p6l410t1190r494b1211],
18	a	DT	O	a	det	20	SENT_186	[p6l517t1195r530b1211],
19	systematic	JJ	O	systematic	amod	20	SENT_186	[p6l551t1189r683b1216],
20	review	NN	O	review	conj_and	14	SENT_186	[p6l704t1189r788b1211],
21	and	CC	O	and	_	0	SENT_186	[p6l808t1189r853b1211],
22	metaregression	NN	O	metaregression	nn	23	SENT_186	[p6l875t1189r1067b1216],
23	man	NN	O	man	conj_and	14	SENT_186	[p6l1196t1195r1257b1211],
24	:	:	O	:	_	0	SENT_186	[p6l1196t1195r1257b1211],
25	clinical	JJ	O	clinical	amod	26	SENT_186	[p6l1278t1189r1365b1211],
26	signiﬁcance	NN	O	signiﬁcance	conj_and	14	SENT_186	[p6l1384t1189r1530b1216],
27	and	CC	O	and	_	0	SENT_186	[p6l1549t1189r1594b1211],
28	molecular	JJ	O	molecular	amod	29	SENT_186	[p6l1614t1189r1738b1211],
29	basis	NN	O	basis	conj_and	14	SENT_186	[p6l1756t1189r1823b1211],
30	.	.	O	.	_	0	SENT_186	[p6l1756t1189r1823b1211],

1	Am	NNP	O	Am	_	0	SENT_187	[p6l1841t1190r1890b1211],
2	.	.	O	.	_	0	SENT_187	[p6l1841t1190r1890b1211],

1	J.	NNP	O	J.	nn	2	SENT_188	[p6l1906t1190r1922b1216],
2	Hum	NNP	O	Hum	_	0	SENT_188	[p6l1941t1190r2007b1211],
3	.	.	O	.	_	0	SENT_188	[p6l1941t1190r2007b1211],

1	Genet	NNP	PERSON	Genet	_	0	SENT_189	[p6l2026t1190r2105b1211],
2	.	.	O	.	_	0	SENT_189	[p6l2026t1190r2105b1211],

1	82	CD	NUMBER	82	num	2	SENT_190	[p6l2125t1190r2154b1211],
2	(	CD	NUMBER	(	_	0	SENT_190	[p6l6t1222r47b1249],
3	6	CD	NUMBER	6	num	4	SENT_190	[p6l6t1222r47b1249],
4	)	NN	O	)	dep	2	SENT_190	[p6l6t1222r47b1249],
5	,	,	O	,	_	0	SENT_190	[p6l6t1222r47b1249],
6	analysis	NN	O	analysis	appos	4	SENT_190	[p6l55t1254r159b1281],
7	.	.	O	.	_	0	SENT_190	[p6l55t1254r159b1281],

1	Am	NNP	O	Am	_	0	SENT_191	[p6l170t1255r218b1276],
2	.	.	O	.	_	0	SENT_191	[p6l170t1255r218b1276],

1	J.	NNP	O	J.	_	0	SENT_192	[p6l226t1255r242b1281],
2	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_192	[p6l254t1254r382b1281],
3	164	CD	NUMBER	164	num	2	SENT_192	[p6l394t1255r443b1279],
4	,	,	O	,	_	0	SENT_192	[p6l394t1255r443b1279],
5	942-948	CD	NUMBER	942-948	num	2	SENT_192	[p6l454t1255r569b1276],
6	.	.	O	.	_	0	SENT_192	[p6l454t1255r569b1276],

1	1241-1248	CD	DATE	1241-1248	_	0	SENT_193	[p6l1178t1255r1319b1276],
2	.	.	O	.	_	0	SENT_193	[p6l1178t1255r1319b1276],

